Brain-Computer Interface industry news, research breakthroughs, and market analysis.https://insidebci.com/en-ushttps://insidebci.com/news/2026-10-04-tianjin-university-shengong-xumi-brain-cube-3-gram-non-invasive-bci-worker-safety/https://insidebci.com/news/2026-10-04-tianjin-university-shengong-xumi-brain-cube-3-gram-non-invasive-bci-worker-safety/Tianjin University's Haihe Laboratory of Brain-Computer Interaction and Human-Machine Integration and its partner Shengong Diting (Tianjin) Technology announced the Shengong Xumi Brain Cube on 30 September 2026, a non-invasive EEG device weighing 3 grams and measuring about 2 cubic centimetres, with electrodes, circuitry, battery and wireless link in one unit fixed to the scalp among the hair. It records at 1,000 samples a second for 8 to 10 hours, and its developers call it the smallest and lightest non-invasive brain-computer interface system yet made. The lab says it is building safety management models around the device for workers in China's licensed high-risk trades, with guidance from special-operations and emergency-management departments. China's national BCI plan names hazardous materials, nuclear, mining and power as industries to pilot the technology first.Sun, 04 Oct 2026 00:00:00 GMTnewsnewsChinaTianjinTianjin-UniversityHaihe-LaboratoryMing-DongShengong-DitingShengong-Xumi-Brain-Cubenon-invasive-BCIEEGwearable-EEGworkplace-neurotechworker-safetyspecial-operationsGB-9706-226MIIThttps://insidebci.com/news/2026-10-03-neuralink-pretraining-50000-hours-brain-data-calibration-decoder-11-bps/https://insidebci.com/news/2026-10-03-neuralink-pretraining-50000-hours-brain-data-calibration-decoder-11-bps/Neuralink said on 1 October 2026 that participants in its clinical trial have streamed more than 50,000 hours of unlabelled brain recordings during everyday use of its implant, and that it has used participants' own recordings to pretrain participant-specific models that steady the software turning brain signals into cursor movement. Calibration had averaged 55 minutes a week across participants, typically 10 minutes at the start of each day; some participants now calibrate for 10 minutes a week. Six participants set personal bests on Neuralink's cursor test, and one reached 11.32 bits per second, which the company calls a record for a brain-computer interface. Every live result came from a model trained on a single participant's data, and models pooled across participants have not yet performed better. Neuralink's stated next goals are calibrating once, never calibrating, and a shared 'API for the motor cortex' for developers.Sat, 03 Oct 2026 00:00:00 GMTnewsnewsNeuralinkPRIME-trialfoundation-modelneural-decodercalibrationbits-per-secondneural-dataNoland-ArbaughAPI-for-the-motor-cortexSynchronChiralNvidiaParadromicsSONIC-benchmarkhttps://insidebci.com/policy/2026-10-02-california-ab-1883-signed-employer-ai-neural-data-emotion-ban-newsom-neurable-one/https://insidebci.com/policy/2026-10-02-california-ab-1883-signed-employer-ai-neural-data-emotion-ban-newsom-neurable-one/California Governor Gavin Newsom signed AB 1883 on 30 September 2026, the last day he could act on bills this session. From 1 January 2027 the law, by Assemblymember Isaac Bryan (D-Los Angeles), bars employers from using workplace surveillance tools that use artificial intelligence to collect employees' neural data or to recognise, infer or predict their emotional state. It defines neural data as information generated by measuring activity in an employee's central or peripheral nervous system, covers public as well as private employers, and allows penalties of up to $500 per violation, enforced by the Labor Commissioner and public prosecutors. Tools used to ensure safety, and some federally regulated aerospace and defence work, are exempt. In his signing message Newsom said the law lacks key definitions and asked the Legislature to refine it. Three days earlier he vetoed AB 1542, leaving consumers with an opt-out over the sale of the same category of data.Fri, 02 Oct 2026 00:00:00 GMTpolicypolicyCaliforniaAB-1883Isaac-BryanGavin-Newsomneural-dataemotion-recognitionworkplace-neurotechworkplace-surveillanceLabor-CommissionerAB-1331SB-947AB-1542SB-354SB-1223CCPAPAGAEU-AI-ActNeurableNeurable-OneState-Patchwork-postureIssue-01https://insidebci.com/news/2026-10-02-neuroxess-triple-full-bci-ai-3d-printed-figurine-smart-glasses-huashan-registration-trial/https://insidebci.com/news/2026-10-02-neuroxess-triple-full-bci-ai-3d-printed-figurine-smart-glasses-huashan-registration-trial/NeuroXess (脑虎科技), the Shanghai brain-computer interface developer, disclosed on 30 September 2026 that a man with a C4 spinal cord injury, implanted in April 2026 with its fully implanted, fully wireless Triple-Full system, used it to draw a sketch and enter prompts, from which a large AI model generated design options and one was 3D-printed as a figurine. Using AI smart glasses and NeuroXess's XessOS software, he also adjusted his hospital bed and switched lights and household devices by confirming his intent. NeuroXess describes the work as clinical exploration and released no speed or accuracy figures. The Triple-Full system is in a registration trial led at Huashan Hospital that began on 7 July 2026, with an estimated 32 participants and primary completion estimated for 30 January 2027, and entered the National Medical Products Administration's innovative device review in July.Fri, 02 Oct 2026 00:00:00 GMTnewsnewsChinaNeuroXess脑虎科技Triple-FullTao-HuXessOSHuashan-HospitalNCT07720882NMPAgenerative-AIAI-glasses3D-printingNeuracleNEO-ONE-SCIHuhuibaomedical-insurancehttps://insidebci.com/market/2026-10-01-neuracle-13-brain-implants-sold-rmb-475000-neo-one-sci-star-market-ipo/https://insidebci.com/market/2026-10-01-neuracle-13-brain-implants-sold-rmb-475000-neo-one-sci-star-market-ipo/Neuracle Technology (Shanghai) (博睿康), maker of China's first approved invasive brain-computer interface, has sold 13 NEO-ONE SCI implant systems and implanted 8 since its first commercial sale in July 2026, with more than 70 more in firm and intended orders. The system is listed at RMB 475,000 per set on procurement platforms in 27 provinces and is not covered by any basic medical insurance catalogue. Neuracle made the figures public on 29 September 2026 in its answers to the Shanghai Stock Exchange's first round of questions on its STAR Market listing application, 110 days after the application was accepted. First-half 2026 revenue was RMB 46.3 million, almost all from its non-invasive business and none from the implant, with a net loss of RMB 65.5 million. No listing committee meeting has been scheduled. None of the best-known Western developers of implanted BCIs, Neuralink, Synchron, Precision Neuroscience, Paradromics and Blackrock Neurotech, is publicly listed.Thu, 01 Oct 2026 00:00:00 GMTmarketmarketChinaNeuracle博睿康NEO-ONE-SCISTAR-MarketShanghai-Stock-ExchangeCITIC-SecuritiesIPOHuhuibaomedical-insuranceUnitreeBrainCoArfysicaCortigentNeuroPaceONWARD-MedicalIndustrial-Builder-postureIssue-01https://insidebci.com/policy/2026-09-30-chinese-academy-of-sciences-15th-five-year-plan-bci-priority-field-cebsit-stairmed/https://insidebci.com/policy/2026-09-30-chinese-academy-of-sciences-15th-five-year-plan-bci-priority-field-cebsit-stairmed/The Chinese Academy of Sciences (CAS), China's top state research body, announced on 28 September 2026 that it had released its 15th Five-Year development plan covering 2026 to 2030. The plan lists brain-computer interfaces among its 'important priority fields' (重要优先领域), alongside integrated circuits, artificial intelligence, quantum science and technology, life sciences and biotechnology, and controlled nuclear fusion. CAS will organise research around a '3+4+X' regional layout with Shanghai as one of three strategic highlands, and will explore forming field-based research consortia, mission-based task forces and platform-based facility clusters across its institutes. CAS already runs its own invasive BCI programme: a system developed at its Shanghai Center for Excellence in Brain Science and Intelligence Technology (CEBSIT) was implanted in its first trial participant at Huashan Hospital in March 2025, and StairMed, founded by CEBSIT researcher Zhao Zhengtuo, entered the National Medical Products Administration's innovative device green channel in November 2025 with a market target of around 2028. CAS was one of the seven co-signatories of the 2025 BCI industry implementation opinions. The plan lands six days after Premier Li Qiang inspected BCI products in Shanghai and called future industries a blue ocean for advanced manufacturing. No BCI budget, programme names or milestones have been made public.Wed, 30 Sep 2026 00:00:00 GMTpolicypolicyChinaChinese-Academy-of-SciencesCASCEBSITStairMedZhao-ZhengtuoHuashan-HospitalFudan-University15th-Five-Year-Planfuture-industriesShanghaiNMPAgreen-channelNeuracleSeven-Ministry-Implementation-OpinionsLi-QiangIndustrial-Builder-postureIssue-01https://insidebci.com/market/2026-09-25-precision-neuroscience-250m-series-d-pershing-square-ackman-oxman-institute-layer-7-cortical-interface/https://insidebci.com/market/2026-09-25-precision-neuroscience-250m-series-d-pershing-square-ackman-oxman-institute-layer-7-cortical-interface/New York-headquartered invasive brain-computer interface operator Precision Neuroscience closed a $250 million oversubscribed Series D on Thursday 24 September 2026. Three co-leads: Pershing Square (Bill Ackman's investment firm), the Ackman Oxman Institute (the philanthropic BCI-and-neurotechnology venture Bill Ackman and Neri Oxman announced in August 2026 after their daughter Lucy's brain hemorrhage), and an undisclosed leading life-sciences investment fund. Additional participation from Duquesne Family Office (Stanley Druckenmiller), B Capital, ARK Invest, Invus, Mubadala Capital, Mirae Asset Capital, Korea Investment Partners, Hitachi Ventures, JSL Health Capital, and others. Total capital raised since 2021 founding is now $430 million. Proceeds will expand the clinical programme, advance Layer 7 through the next stages of FDA review, and build the infrastructure required for commercialisation. Precision was founded in 2021 by Ben Rapoport (Neuralink founding-team scientist, left Neuralink in 2018, Mount Sinai neurosurgeon), Michael Mager (CEO), Demetrios Papageorgiou, and Mark Hettick. Layer 7 is a thin-film 4,096-electrode microelectrode array that conforms to the cortical surface, non-penetrating, safely removable. Layer 7 holds an FDA 510(k) clearance authorising commercial use for recording, monitoring, and stimulating on the cortical surface for implantation durations of up to thirty days (granted April 2025), and has been used across 100-plus patient procedures at 18 medical institutions including the University of Pennsylvania Perelman, University of Chicago Medicine, Mount Sinai, and WVU Rockefeller Neuroscience Institute. Precision runs a wholly-owned MEMS manufacturing facility in Texas and holds a Medtronic commercial partnership. BrainGate founder and 2026 Queen Elizabeth Prize for Engineering laureate John Donoghue joined as Scientific Advisor on 23 July 2026. The Series D closes two days after Chinese non-invasive BCI operator BCI-Sonics closed a HongShan and Yunqi Partners-led RMB 200 million Pre-A in Shanghai on 22 September, the same day Premier Li Qiang inspected brain-computer interface products in Shanghai. Two top-tier private-capital signals into invasive and non-invasive brain-computer interface operators, one on each side of the Pacific, inside a single week.Fri, 25 Sep 2026 00:00:00 GMTmarketmarketPrecision-NeuroscienceLayer-7Pershing-SquareBill-AckmanNeri-OxmanAckman-Oxman-InstituteSeries-DBen-RapoportMichael-MagerMount-SinaiNeuralink-alumniJohn-DonoghueBrainGateMedtronicDuquesne-Family-OfficeB-CapitalARK-InvestMubadala-CapitalKorea-Investment-PartnersHitachi-Venturescortical-surfacethin-film-microelectrodeMEMSTexasNew-YorkIndustrial-Builder-postureIssue-01https://insidebci.com/market/2026-09-24-bci-sonics-hongshan-yunqi-200m-pre-a-shanghai-focused-ultrasound-li-xin/https://insidebci.com/market/2026-09-24-bci-sonics-hongshan-yunqi-200m-pre-a-shanghai-focused-ultrasound-li-xin/Shanghai-headquartered non-invasive brain-computer interface company BCI-Sonics closed a RMB 200 million (~USD 28 million) Pre-A financing round on Tuesday 22 September 2026, co-led by HongShan (the post-2023 rebrand of Sequoia China under Neil Shen) and Yunqi Partners. New participants included Proxima Capital, Oriza Holdings, Shanghai's Xuhui Sci-Tech Innovation Investment, and Moral Stone Investment. Existing investors Matrix Partners China (MPCi) and Delian Capital followed on. Xunguang Capital served as exclusive financial advisor. Total capital raised since 2025 founding is roughly RMB 300 million. The company was founded by Dr. Li Xin, formerly Head of GE Global Research Center China and a joint PhD graduate of the Chinese Academy of Sciences and Fraunhofer IGD in Germany. BCI-Sonics' modality is low-intensity transcranial focused ultrasound (tFUS/LIFU) for brain stimulation, paired with a multimodal reading system combining functional ultrasound (fUS), EEG, fMRI and PET, and passive cavitation detection for safety monitoring. Three product lines are in development: a Research toolchain for neuroscience labs (unveiled at CNS 2026 in September), a Clinical portfolio targeting pain, Parkinson's, Alzheimer's, addiction, sleep, and ultrasound-mediated blood-brain-barrier opening for CNS drug delivery, and a Technology/Consumer wearable BCI terminal for sleep, focus and emotion. Closed-loop ultrasound BCI clinical trials are scheduled to enter Q1 2027. The Pre-A closed the same day Premier Li Qiang inspected BCI products in Shanghai and directed the establishment of future-industry investment-growth and risk-sharing mechanisms and 'patient capital' (耐心资本) expansion.Thu, 24 Sep 2026 00:00:00 GMTmarketmarketChinaBCI-SonicsHongShanYunqi-CapitalSequoia-ChinaNeil-ShenMatrix-Partners-ChinaDelian-CapitalProxima-CapitalOriza-HoldingsXuhui-Sci-Tech-Innovation-InvestmentMoral-Stone-InvestmentXunguang-CapitalLi-Xinfocused-ultrasoundtFUSLIFUfunctional-ultrasoundnon-invasive-BCIShanghaiPre-AMerge-LabsNudgeIndustrial-Builder-postureIssue-01https://insidebci.com/policy/2026-09-23-li-qiang-shanghai-brain-computer-interfaces-blue-ocean-future-industry-advanced-manufacturing/https://insidebci.com/policy/2026-09-23-li-qiang-shanghai-brain-computer-interfaces-blue-ocean-future-industry-advanced-manufacturing/China's Premier Li Qiang, a member of the Politburo Standing Committee, spent Tuesday 22 September 2026 on a Shanghai inspection tour of two innovation venues. At the second, the Shanghai Future Kick-off Community (上海未来启点社区) sci-tech innovation and incubation platform for future industries, he inspected technology products in two named categories: brain-computer interfaces and quantum computing. He then framed future industries as 'a potential blue ocean for advanced manufacturing' (先进制造业发展的潜在蓝海). Shanghai Party Secretary Chen Jining and State Council Secretary-General Wu Zhenglong accompanied the tour. The remarks operationalise General Secretary Xi Jinping's prior directive on advanced manufacturing and the spirit of the National Conference on Advanced Manufacturing. The visit lands Li Qiang's on-record inspection of BCI products above the March 2026 Government Work Report first-mention, above the 15th Five-Year Plan naming of BCI as a future industry (CPC 4th Plenum, 20 to 23 October 2025), and above the seven-ministry BCI Implementation Opinions of July 2025. The venue itself is not disclosed to have featured named Chinese BCI operators. Shanghai's Minhang District already hosts the country's first BCI industry cluster at Brain Intelligence World, which by mid-2026 housed 61 BCI companies, roughly 30 percent of the national BCI operator field.Wed, 23 Sep 2026 00:00:00 GMTpolicypolicyChinaLi-QiangPolitburo-Standing-CommitteeState-CouncilXi-Jinpingfuture-industriesblue-oceanadvanced-manufacturingShanghaiMinhangChen-JiningWu-Zhenglongquantum-computingbrain-computer-interfaces15th-Five-Year-PlanSeven-Ministry-Implementation-Opinionspatient-capitalIndustrial-Builder-postureIssue-01https://insidebci.com/news/2026-09-23-neuralink-voice-trial-terry-als-third-participant-grok-voice-thought-to-audio/https://insidebci.com/news/2026-09-23-neuralink-voice-trial-terry-als-third-participant-grok-voice-thought-to-audio/Neuralink published a video this week showing Terry, a married man with bulbar-onset ALS, saying 'Hello, how are you doing today?' and 'I, I love you' to his wife through an implanted N1 brain-computer interface. The output routed through Grok Voice, xAI's speech engine, using a clone of Terry's own pre-ALS recordings. It is Neuralink's most detailed publicly disclosed thought-to-speech demonstration to date and the first to route through xAI's Grok Voice engine for personalised voice synthesis. Another VOICE participant, Kenneth Shock, appeared in a Neuralink clip on 16 September 2026, two days before Terry's disclosure, saying 'I love you' to his wife. Terry is the third participant in Neuralink's VOICE early-feasibility trial (ClinicalTrials.gov NCT07224256), formally titled 'VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration.' VOICE is a separate protocol from Neuralink's PRIME motor-decoding trial and its CAN-PRIME and GB-PRIME international arms. The N1 implant holds an FDA Breakthrough Device Designation; it is not FDA-approved and not commercially available. Prior Neuralink participants Noland Arbaugh (PRIME P1), Alex (PRIME P2), and Brad Smith (PRIME first ALS participant) are on the motor decoding track. Brad Smith's earlier speech restoration used cursor-typed text through a cloned voice; Terry's demonstration is the first Neuralink disclosure of direct neural-to-audio decoding. Neuralink has not published words-per-minute, word-error-rate, latency, or vocabulary-size metrics. No peer-reviewed methods paper accompanies the demonstration.Wed, 23 Sep 2026 00:00:00 GMTnewsnewsNeuralinkVOICE-trialN1-implantTerryALSbulbar-onset-ALSGrok-VoicexAIvoice-cloningspeech-decodingPRIME-trialDJ-SeoElon-MuskFDA-Breakthrough-DeviceClinicalTrials-govNCT07224256thought-to-audioBrad-SmithNoland-Arbaughhttps://insidebci.com/news/2026-09-19-science-corporation-darius-shahida-president-butterfly-network-alameda-prima/https://insidebci.com/news/2026-09-19-science-corporation-darius-shahida-president-butterfly-network-alameda-prima/Science Corporation, Max Hodak's Alameda-headquartered neural engineering and brain-computer interface company, announced on 17 September 2026 that Chief Strategy Officer Darius Shahida has been appointed President in a dual role. Shahida joined full-time in January 2026 as CSO after eight years at Butterfly Network and after first participating in Science's Series B as an investor. He is the second senior Butterfly Network alumnus hired by Science this year; Nevada Sanchez, a Butterfly Network co-founder, joined as EVP Engineering on 29 July 2026. The Shahida appointment lands two months into the European commercial rollout of PRIMA, Science's photovoltaic subretinal implant for geographic atrophy in age-related macular degeneration, which received CE mark from DEKRA in July 2026 (30 European countries; commercial launch also covers the UK) and simultaneous FDA Breakthrough Device and Humanitarian Use Device designations. Science closed a $230 million Series C on 5 March 2026 from Khosla Ventures, Lightspeed, Y Combinator, IQT, Quiet Capital and others, bringing total capital raised to roughly $490 million since founding in 2021. Hodak remains CEO. The company operates from Alameda with offices in Paris and Research Triangle Park.Sat, 19 Sep 2026 00:00:00 GMTnewsnewsScience-CorporationMax-HodakDarius-ShahidaNevada-SanchezPRIMAretinal-implantgeographic-atrophyage-related-macular-degenerationButterfly-NetworkAlamedaKhosla-VenturesLightspeedY-CombinatorIQTQuiet-CapitalSeries-CFDA-Breakthrough-DeviceFDA-HUDCE-markhttps://insidebci.com/news/2026-09-19-philip-sabes-arbor-neuroscience-shanghai-bci-inno-salon-fudan-forest-neurotech-rebrand/https://insidebci.com/news/2026-09-19-philip-sabes-arbor-neuroscience-shanghai-bci-inno-salon-fudan-forest-neurotech-rebrand/Philip Sabes, a Neuralink co-founder (full-time 2017 to 2020) and now CEO of Arbor Neuroscience, delivered a keynote at the BCI Inno+ Salon International Symposium on Brain-Computer Interface in Shanghai on 14 September 2026. His stated thesis was that the real bottleneck in neuromodulation is prediction: because clinicians cannot reliably predict what will happen after brain stimulation, treatment outcomes are inconsistent. Sabes summarised current practice as 'poke and hope' and positioned Arbor's approach as 'predict and treat'. Arbor Neuroscience is the September 2026 rebrand of Forest Neurotech, a functional-ultrasound-imaging Focused Research Organization founded by Sumner Norman, Tyson Aflalo and Will Biederman inside Convergent Research. The symposium was hosted by the BCI Innovation and Transformation Center at Brain Intelligence World in Shanghai's Minhang District, a Shanghai state-backed partnership between Minhang District, Lingang Group, Shanghai State Investment Corp and Huashan Hospital (a Fudan University teaching hospital), positioned as China's first BCI industry cluster. Sabes made no public statement on US and China BCI competition, export controls, or the recent NSCEB and BIS enforcement actions.Sat, 19 Sep 2026 00:00:00 GMTnewsnewsPhilip-SabesArbor-NeuroscienceForest-NeurotechConvergent-ResearchNeuralink-alumniShanghaiFudan-UniversityBCI-Inno-SalonBrain-Intelligence-WorldMinhang-Districtfunctional-ultrasoundneuromodulationSumner-NormanTyson-AflaloWill-BiedermanWhitney-GriggsUS-China-BCIhttps://insidebci.com/research/2026-09-18-brosler-chang-ucsf-speech-gesture-bci-nature-neuroscience-bravo-1r-bravo-6/https://insidebci.com/research/2026-09-18-brosler-chang-ucsf-speech-gesture-bci-nature-neuroscience-bravo-1r-bravo-6/A Nature Neuroscience paper published on 14 September 2026 by Samantha C. Brosler, Jessie R. Liu, Alexander B. Silva and senior author Edward F. Chang at UCSF reports the first single-implant, single-session, real-time simultaneous decoding of speech and upper-body gestures in people with paralysis. Two of three BRAVO-trial participants (Bravo-1r, brainstem stroke, seven years enrolled; Bravo-6, ALS, implanted March 2025) controlled a personalized virtual avatar with parallel speech and gesture decoders reading from a 253-channel high-density ECoG surface array manufactured by PMT Corporation. Bravo-1r reached median 100 percent accuracy on both decoders in the real-time conversation paradigm; Bravo-6 reached 85 percent gesture and 75 percent speech. The design finding is that multimodal neural signals are not the linear sum of isolated speech and gesture signals: decoders trained on simultaneous data outperform decoders trained on isolated data, and cross-training drops opposite-modality false-positive rates from 76 percent (Bravo-1r) and 31 percent (Bravo-6) to zero. Chang has stated a fully implantable wireless successor is the next step. Hardware footprint is PMT surface ECoG plus a Blackrock Neurotech digital headstage per prior Chang-lab methods, with no overlap with Neuralink Threads, Paradromics Connexus, or Synchron Stentrode. This is the fourth UCSF Chang-lab BRAVO paper in the peer-reviewed communication-BCI sequence: Moses NEJM 2021, Metzger Nature 2023, Littlejohn Nature Neuroscience 2025, Brosler Nature Neuroscience 2026.Fri, 18 Sep 2026 00:00:00 GMTresearchresearchUCSFEdward-ChangSamantha-BroslerJessie-LiuAlexander-SilvaKarunesh-GangulyBRAVO-trialECoGhigh-density-ECoGPMT-CorporationBlackrock-Neurotechspeech-decodinggesture-decodingmulti-effector-BCINature-Neurosciencebrainstem-strokeALSavatarwireless-BCIhttps://insidebci.com/policy/2026-09-17-china-nmpa-ai-bci-medical-device-standard-eeg-data-nifdc-yuan-peng-industrial-builder/https://insidebci.com/policy/2026-09-17-china-nmpa-ai-bci-medical-device-standard-eeg-data-nifdc-yuan-peng-industrial-builder/China's National Medical Products Administration (NMPA) has issued what state news agency Xinhua characterises as the world's first medical-device standard covering AI-processed electroencephalogram (EEG) data in brain-computer interfaces, announced on 14 September 2026. The standard was drafted by the National Institutes for Food and Drug Control (NIFDC) under an expedited procedure and becomes effective on 1 September 2027. Scope: quality requirements and evaluation methods for EEG datasets used by AI algorithms in BCI medical devices, covering collection, processing, annotation, storage, and access across R&D, production, and quality-control stages. Named NMPA and NIFDC officials: Yuan Peng (Deputy Director, NMPA Department of Medical Device Registration), Li Shu (Deputy Director, NIFDC medical device institute), Zheng Jia (Deputy Director, NIFDC Institute for Medical Device Standardization). This is the third BCI-related medical-device standard issued by China in twelve months, following 2025 standards on BCI terminology and on test methods for implantable closed-loop neural stimulators. The US FDA has no BCI-specific AI/EEG data-quality standard. The EU has no BCI-specific standard, only horizontal AI Act coverage of medical BCI as high-risk. On the narrow AI-EEG-BCI slice, China's world-first framing holds up.Thu, 17 Sep 2026 00:00:00 GMTpolicypolicyChinaNMPANIFDCAI-BCI-standardEEG-data-qualityYuan-PengLi-ShuZheng-Jiamedical-device-standardIndustrial-Builder-postureUS-China-regulatory-competitionFDAEU-AI-ActMIIT-15th-Five-Year-PlanNeuracleSTAR-MarketIssue-01https://insidebci.com/news/2026-09-16-paradromics-connexus-real-time-speech-michigan-motor-neuron-disease-university-michigan/https://insidebci.com/news/2026-09-16-paradromics-connexus-real-time-speech-michigan-motor-neuron-disease-university-michigan/Paradromics announced on 14 September 2026 that the first participant in its Connect-One Early Feasibility Study, a Michigan woman in her 60s with progressive motor neuron disease and severe dysarthria, has used the Connexus intracortical brain-computer interface to generate her own words, answer open-ended questions, and hold a live phone call with her grandchildren, three months after her June 2026 implant at University of Michigan Health. Verbatim first sentence: 'Okay, I have a lot to say.' Second sentence: 'Don't be afraid. It's a wonderful experience to be able to help others by your participation in the research study.' Both were decoded in real time, word for word, with no errors, according to Paradromics. Output modality is text plus synthesized speech (not avatar-mediated). Quantitative benchmarks (words per minute, word-error rate, vocabulary size, decoding latency) were not disclosed. The Connect-One EFS runs across three sites (University of Michigan Health, UC Davis Health, Mass General Brigham) under FDA IDE approval granted in November 2025. Same-day academic milestone at UCSF (Edward Chang team, Nature Neuroscience) demonstrates simultaneous speech and gesture decoding via animated avatar. The two results are categorically different (commercial vs academic, text-plus-audio vs avatar-mediated) and should not be conflated.Wed, 16 Sep 2026 00:00:00 GMTnewsnewsParadromicsConnexusConnect-OneMatt-AngleVikash-GiljaMatthew-WillseyDavid-BrandmanDaniel-RubinUniversity-of-Michigan-HealthUC-Davis-HealthMass-General-Brighammotor-neuron-diseaseMNDALSPLSdysarthriareal-time-speechintracortical-BCIFDA-IDEEFSprecentral-gyrus421-microelectrodesEdward-Chang-UCSFNature-NeuroscienceIssue-01https://insidebci.com/market/2026-09-14-neuracle-medical-brainco-arfysica-chinese-bci-ipo-queue-star-market-hkex-industrial-builder/https://insidebci.com/market/2026-09-14-neuracle-medical-brainco-arfysica-chinese-bci-ipo-queue-star-market-hkex-industrial-builder/Three Chinese brain-computer interface operators are simultaneously moving through IPO processes on two exchanges. Neuracle Medical Technology (博睿康技术（上海）股份有限公司) is the leader: its Shanghai STAR Market prospectus was accepted 11 June 2026 with a planned RMB 2.5 billion (~US$345M) raise. Neuracle received China's first commercial invasive BCI approval from NMPA in March 2026 (NEO-ONE SCI for spinal cord injury). BrainCo (强脑科技) filed a confidential Hong Kong Exchange application in January 2026 (joint sponsors CICC and UBS), with the September 2026 pricing calendar showing no imminent hearing. Arfysica Innovation (术理创新), led by female founder Wang Wei, registered STAR Market pre-IPO tutoring in early September 2026 with Huatai United Securities, entering the pipeline three months behind Neuracle at the earliest stage. Neuracle's disclosed prospectus reveals RMB 108 million 2025 revenue, all from non-invasive EEG systems, with the NEO invasive product still at zero commercial revenue and 32 patients implanted by end-2025.Mon, 14 Sep 2026 00:00:00 GMTmarketmarketChinaChinese-BCI-IPONeuracle-Medical博睿康NEOBrainCo强脑科技Han-BichengArfysica术理创新Wang-WeiXu-HonglaiHuang-XiaoshanGao-ShangkaiSTAR-MarketHKEXIndustrial-Builder-postureCITIC-SecuritiesHuatai-UnitedCICCUBSSequoia-ChinaIDG-CapitalWalden-InternationalLip-Bu-TanSix-Little-Dragonshttps://insidebci.com/policy/2026-09-13-nerve-attacks-arxiv-cambridge-tarkhani-madhavapeddy-ai-powered-bci-security/https://insidebci.com/policy/2026-09-13-nerve-attacks-arxiv-cambridge-tarkhani-madhavapeddy-ai-powered-bci-security/A team led by Zahra Tarkhani (Microsoft), Georgios Akkogiounoglou (KTH Royal Institute of Technology), Lorena Qendro (Nokia Bell Labs), Isabel Tscherniak (TU Munich), and senior author Anil Madhavapeddy (University of Cambridge) published NERVE Attacks: Breaking AI-Powered Brain-Computer Interfaces on arXiv on 8 September 2026. The paper introduces a taxonomy of five attack families that together span the complete BCI signal chain: Neuro-mimetic Forgery, Evasion via Desynchronization, Replay-based Hijacking, Vein Tapping, and Embedded Backdoors. It releases EEGle, an AI-assisted extensible framework for systematic BCI security analysis, and reports 17 novel neuro-specific attack instances plus a stealth-effectiveness spectrum for BCI backdoor design. The submission lands four days after Germany's outgoing federal data protection commissioner used the BfDI's annual Bonn conference on 4 September 2026 to press for tighter European handling of neurodata, and one day after four senior clinician-scientists published a Comment in Nature Neuroscience setting out four ethical priorities for implantable BCI research. The empirical attack surface has now caught up with the governance framing.Sun, 13 Sep 2026 00:00:00 GMTpolicypolicysecurityNERVE-AttacksEEGleZahra-TarkhaniAnil-MadhavapeddyGeorgios-AkkogiounoglouLorena-QendroIsabel-TscherniakUniversity-of-CambridgeMicrosoftKTHNokia-Bell-LabsTU-Munichconsumer-EEGAI-decoderadversarial-machine-learningcoordinated-disclosureFDA-524BEU-Cyber-Resilience-ActBfDIMiller-SchalkIssue-01https://insidebci.com/policy/2026-09-11-plexon-inc-bis-1-7m-export-settlement-amms-china-omniplex-bci-equipment/https://insidebci.com/policy/2026-09-11-plexon-inc-bis-1-7m-export-settlement-amms-china-omniplex-bci-equipment/The US Department of Commerce Bureau of Industry and Security (BIS) announced on 14 August 2026 an administrative enforcement settlement with Dallas, Texas neural-instrumentation maker Plexon, Inc. over eight unlicensed exports between 10 February 2022 and 30 August 2023 to the Academy of Military Medical Sciences (AMMS), the People's Liberation Army's biomedical research arm and a party on the BIS Entity List since December 2021. The shipments comprised eight OmniPlex Neural Recording Data Acquisition Systems and accessories, valued at approximately US$178,721. The civil penalty is US$1.7 million, suspended in full for five years contingent on Plexon completing an external export-compliance audit and committing no further violations. AMMS was added to the Entity List in part for supporting Chinese military end uses including 'purported brain-control weaponry.' The settlement is the first BIS enforcement action publicly involving commercial brain-computer interface research instrumentation, and lands eight years after BIS's November 2018 emerging-technology framework flagged BCI and AI for brain modeling as candidate export-control categories.Fri, 11 Sep 2026 00:00:00 GMTpolicypolicyUSChinaexport-controlBureau-of-Industry-and-SecurityBISPlexonOmniPlexAMMSAcademy-of-Military-Medical-SciencesPLAEntity-ListExport-Administration-RegulationsEAREmerging-Technologybrain-computer-interfaceState-Patchwork-posturegeopolitics-of-neurotechhttps://insidebci.com/market/2026-09-10-onward-medical-h1-2026-results-arc-ex-revenue-arc-bci-wimagine-seven-implants/https://insidebci.com/market/2026-09-10-onward-medical-h1-2026-results-arc-ex-revenue-arc-bci-wimagine-seven-implants/Dutch-Swiss neurotech ONWARD Medical (Euronext ONWD) reported First Half 2026 results on 9 September 2026 with total revenue of EUR 4.2 million (up from EUR 1.2 million H1 2025), ARC-EX external spinal-stimulator commercial revenue up 240 percent to EUR 3.4 million, and cumulative ARC-BCI Therapy participants now at seven, with two additional implants completed in the half. ARC-BCI is ONWARD's flagship platform pairing the CEA/Clinatec WIMAGINE 64-electrode epidural cortical brain-computer interface (exclusive-licensed 15 October 2024) with the ARC-IM implantable spinal cord stimulator. ONWARD is accepted into the FDA Total Product Life Cycle Advisory Program for ARC-BCI. Cash position was EUR 81.5 million at 30 June 2026 following the April 2026 EUR 40.6 million equity raise led by EQT Life Sciences and a new BlackRock debt facility up to EUR 50 million. ARC-EX (FDA De Novo cleared December 2024) is now available in more than 130 US clinics and shipped 159 systems in the half.Thu, 10 Sep 2026 00:00:00 GMTmarketmarketONWARD-MedicalONWDARC-BCIARC-IMARC-EXWIMAGINECEA-ClinatecDave-MarverGregoire-CourtineJocelyne-BlochNeuroRestoreCHUVEPFLSPZ-NottwilCraig-HospitalEmpower-BPEIGERFDA-TAPEQT-Life-SciencesBlackRockChristopher-Dana-Reeve-Foundationspinal-cord-injurydigital-bridgeIssue-01https://insidebci.com/news/2026-09-09-apple-sonera-magnetics-acquisition-eu-dma-disclosure-adfmr-neural-sensor-berkeley/https://insidebci.com/news/2026-09-09-apple-sonera-magnetics-acquisition-eu-dma-disclosure-adfmr-neural-sensor-berkeley/Apple's acquisition of Berkeley-based magnetic-sensor startup Sonera Magnetics, closed in May 2026 and disclosed publicly on 8 September 2026 via the European Commission's Digital Markets Act acquisitions database, is the company's first move from hosting third-party brain-computer interface signals to owning proprietary neural-sensor IP. Sonera builds solid-state acoustically-driven ferromagnetic resonance (ADFMR) magnetometers, a room-temperature alternative to SQUID-based magnetoencephalography (MEG). The company raised US$11 million in seed financing in September 2023 from a lead-heavy syndicate including Founders Fund, Benchmark, Amplify Partners, IVP, Craft Ventures, and 8VC. Deal terms were not disclosed. Sonera's website was taken offline post-acquisition. Apple's prior BCI-adjacent moves were the AirPods ear-canal biosignal patent (filed January 2023), the BCI HID accessibility protocol for iOS 26, iPadOS 26 and visionOS 26 launched with Synchron on 13 May 2025, and hosting of Cognixion's non-invasive EEG clinical trial on Vision Pro from October 2025. Owning Sonera's magnetic-sensor IP puts Apple directly against Meta's Neural Band (surface EMG) and the non-surgical BCI operator field (Merge Labs ultrasound, Subsense nanoparticle, Neurable EEG earbuds).Wed, 09 Sep 2026 00:00:00 GMTnewsnewsAppleSonera-MagneticsNishita-DekaDominic-LabanowskiSayeef-SalahuddinUC-BerkeleyCyclotron-RoadActivateADFMRacoustically-driven-ferromagnetic-resonancemagnetometerMEGnon-invasive-BCIconsumer-BCISynchronBCI-HIDCognixionVision-ProMeta-Neural-BandMerge-LabsSubsenseEU-DMADigital-Markets-Acthttps://insidebci.com/policy/2026-09-08-nature-neuroscience-miller-schalk-implantable-bci-ethics-comment-mayo-ucl-sichuan/https://insidebci.com/policy/2026-09-08-nature-neuroscience-miller-schalk-implantable-bci-ethics-comment-mayo-ucl-sichuan/Four clinician-scientists from Mayo Clinic, University College London, and Sichuan University published a Comment in Nature Neuroscience on 7 September 2026 setting out four ethical priorities for implantable brain-computer interface research: separating research participation from patient care, ensuring long-term support for study participants, avoiding disproportionate risks to participants for benefits realised mainly by others, and grounding research in meaningful clinical purpose. Lead author Kai J. Miller (Mayo Clinic) is the corresponding author. Senior author Gerwin Schalk (West China Hospital, Sichuan University) is the second corresponding author. Co-author Harith Akram (UCL Queen Square) declares a conflict of interest as Chief Investigator of Neuralink's GB-PRIME UK study. The Comment lands one day after Germany's outgoing federal data protection commissioner pressed Europe for tighter rules on bidirectional BCI, and ten months after UNESCO's General Conference adopted the first global standard on the ethics of neurotechnology in November 2025.Tue, 08 Sep 2026 00:00:00 GMTpolicypolicyethicsNature-NeuroscienceKai-MillerGerwin-SchalkHarith-AkramDavide-GiampiccoloMayo-ClinicUCLSichuan-UniversityWest-China-HospitalNeuralink-GB-PRIMEMarcello-IencaiBCI-CCpost-trial-accessTCCITianqiao-Chrissy-Chen-InstituteUNESCO-RecommendationIssue-01https://insidebci.com/policy/2026-09-06-germany-bfdi-specht-riemenschneider-neurodata-brain-computer-interfaces-berlin-group-hennemann/https://insidebci.com/policy/2026-09-06-germany-bfdi-specht-riemenschneider-neurodata-brain-computer-interfaces-berlin-group-hennemann/Prof. Dr. Louisa Specht-Riemenschneider, the outgoing German Federal Data Protection and Freedom of Information Commissioner (BfDI), used a BCI-themed academic conference at the University of Bonn on 4 September 2026 to press for tighter European handling of neural data. Her formal underpinning is a Berlin Group Working Paper on Emerging Neurotechnologies published on 15 May 2025 through BfDI, which invokes GDPR Article 9 (health and biometric data) and the EU AI Act (Article 5 subliminal-manipulation ban, Annex III high-risk classification for medical BCI) as existing legal ground. The intervention lands one month before Specht-Riemenschneider steps down for health reasons on 30 September 2026. Her Bundestag-elected successor Prof. Dr. Moritz Hennemann of Freiburg takes office on 1 October 2026, and his own position on neurodata is not publicly disclosed.Sun, 06 Sep 2026 00:00:00 GMTpolicypolicyGermanyEuropean-UnionBfDILouisa-Specht-RiemenschneiderMoritz-HennemannBerlin-GroupIWGDPTneurodataGDPREU-AI-ActMDRHorizontal-Regulator-postureCorTecbidirectional-BCIbrain-malwareRuben-Plum-SchneiderUniversity-of-BonnZMDTIssue-01https://insidebci.com/news/2026-09-04-ray-kurzweil-subsense-product-vision-advisor-nanoparticle-bci-palo-alto/https://insidebci.com/news/2026-09-04-ray-kurzweil-subsense-product-vision-advisor-nanoparticle-bci-palo-alto/Ray Kurzweil, the futurist and inventor who has argued for two decades that brain-computer interfaces will arrive through molecular-scale machines rather than through skull-drilled implants, has joined Palo Alto-based Subsense as Product and Vision Advisor. Subsense unveiled the appointment on the evening of 2 September 2026 at its Palo Alto headquarters. Subsense, founded 2022 by CEO Tetiana Aleksandrova and Artem Sokolov, is developing a non-surgical BCI based on intranasally-delivered nanoparticles paired with a wearable magnetic-coil headset. The company has raised US$27 million in seed financing led by Sokolov's Golden Falcon Capital and remains in preclinical mouse-model work. The appointment lands one week after Merge Labs and Butterfly Network's chip-supply deal established the ultrasound-BCI industrial base, and adds a molecular modality to the non-surgical BCI landscape.Fri, 04 Sep 2026 00:00:00 GMTnewsnewsSubsenseRay-KurzweilTetiana-AleksandrovaArtem-SokolovGolden-Falcon-Capitalnanoparticle-BCInon-surgical-BCIPalo-AltoUC-Santa-CruzETH-ZurichParkinsonsepilepsyBeyond-ImaginationUnited-Therapeuticshttps://insidebci.com/market/2026-09-03-tiankai-suishi-nmpa-approval-cognitive-assessment-eeg-cap-tianjin-china/https://insidebci.com/market/2026-09-03-tiankai-suishi-nmpa-approval-cognitive-assessment-eeg-cap-tianjin-china/China's National Medical Products Administration approved a non-invasive EEG-cap diagnostic device made by Tianjin-based Tiankai Suishi Intelligent Technology on 19 August 2026 for assessing cognitive impairment. The device sits in the diagnostic tier of China's growing brain-computer interface pipeline: Class II non-invasive rather than the Class III invasive category cleared by Neuracle in March 2026. Tiankai Suishi is a Tianjin University-linked startup founded 2023, led by Gu Bin, with a depression-diagnosis product also filed with NMPA. The approval extends China's Industrial Builder posture from a single invasive-BCI flagship into diagnostic-device territory anchored on the country's ageing-population indications: Alzheimer's, schizophrenia-linked cognitive dysfunction, and depression.Thu, 03 Sep 2026 00:00:00 GMTmarketmarketChinaNMPATiankai-SuishiTianjinGu-BinTianjin-Universitynon-invasive-BCIEEG-capcognitive-assessmentAlzheimersschizophreniadepression-diagnosisChina-BCINeuracleIndustrial-Builder-posturediagnostic-BCIhttps://insidebci.com/news/2026-09-01-cortec-second-fda-breakthrough-device-designation-brain-interchange-communication-quadriplegia/https://insidebci.com/news/2026-09-01-cortec-second-fda-breakthrough-device-designation-brain-interchange-communication-quadriplegia/German BCI operator CorTec GmbH announced on 31 August 2026 that FDA has granted a second Breakthrough Device Designation for its Brain Interchange implant, covering computer cursor control for people with non-progressive quadriplegia. The company's first Breakthrough Designation, in April 2026, covered stroke motor rehabilitation. Both designations apply to the same fully implantable, wireless, battery-free, bidirectional closed-loop platform with non-penetrating cortical surface electrodes. CorTec is now running two parallel FDA regulatory processes on identical hardware. The European regulatory route (EMA, CE Mark) is absent from the announcement.Tue, 01 Sep 2026 00:00:00 GMTnewsnewsCorTecBrain-InterchangeFDA-Breakthrough-Device-DesignationFrank-DesiereFreiburgGermanyEuropean-BCI-cohortspinal-cord-injuryquadriplegiastroke-rehabilitationepicorticalbidirectional-BCIUMC-UtrechtINTENSEMayo-ClinicUniversity-of-WashingtonFDA-TAPINBRAIN-Neuroelectronicshttps://insidebci.com/market/2026-09-01-cortical-labs-brett-kagan-ceo-hon-weng-chong-transition-melbourne-sbi/https://insidebci.com/market/2026-09-01-cortical-labs-brett-kagan-ceo-hon-weng-chong-transition-melbourne-sbi/Melbourne-based Cortical Labs, the synthetic biological intelligence company behind the CL1 biological computer and the 2022 DishBrain neuron-on-chip study, appointed co-founder Brett Kagan as Chief Executive Officer on 28 August 2026, effective immediately. Kagan was previously Chief Scientific Officer and Chief Operating Officer. Co-founder Hon Weng Chong steps down as CEO after seven years. Long-time investor Radar Ventures spoke publicly for the investor base. Cortical Labs is not a brain-computer interface operator; the CL1 platform runs computation on lab-grown human neurons rather than reading signals from an implanted human brain. InsideBCI covers this as adjacent-category leadership news.Tue, 01 Sep 2026 00:00:00 GMTmarketmarketCortical-LabsBrett-KaganHon-Weng-ChongAndy-KitchenMelbourneAustraliaCL1Cortical-CloudDishBrainsynthetic-biological-intelligenceSBIbiological-computingwet-computingleadership-transitionBlackbird-VenturesHorizons-VenturesIn-Q-TelRadar-VenturesNUS-MedicineDayOnehttps://insidebci.com/news/2026-09-01-merge-labs-butterfly-network-poseidon-ultrasound-chip-bci-licensing-deal/https://insidebci.com/news/2026-09-01-merge-labs-butterfly-network-poseidon-ultrasound-chip-bci-licensing-deal/Merge Labs, the US$252 million OpenAI-backed neural interface startup, has selected Butterfly Network (NYSE:BFLY) as its exclusive ultrasound-on-chip supplier under a multi-year Butterfly Embedded licensing deal announced 1 September 2026. The agreement covers Butterfly's Poseidon Family of Ultrasound-on-Chip for Merge's neural interface development, with upfront payments, milestones, hardware purchase commitments, technology access fees, and future royalties. Financial figures were not disclosed. Butterfly retains the right to license the same technology to other companies in the field. Ultrasound BCI now has a US-listed industrial supply chain.Tue, 01 Sep 2026 00:00:00 GMTnewsnewsMerge-LabsButterfly-NetworkBFLYPoseidonUltrasound-on-ChipButterfly-Embeddedultrasound-BCISam-AltmanTyson-AflaloAlex-BlaniaMikhail-ShapiroSumner-NormanJoseph-DeVivoOpenAIBain-CapitalUS-commercial-BCI-cohorthttps://insidebci.com/policy/2026-08-30-india-neuro-privacy-dpdpa-srivastava-livelaw-brain-data-sensitive-personal-data/https://insidebci.com/policy/2026-08-30-india-neuro-privacy-dpdpa-srivastava-livelaw-brain-data-sensitive-personal-data/In a LiveLaw analysis published 30 August 2026, CHRIST University Assistant Professor Namit Srivastava argues that India's Digital Personal Data Protection Act 2023 applies the same consent framework to neural data as it applies to a shopping cart, and that MeitY should add neural data as a sensitive category via delegated rule-making under Section 40 without reopening the Act. The piece is legal-scholar analysis, not Indian government policy. It lands two days after the 28 August ADI Neuroscience US$1 billion India neurotech fund announcement.Sun, 30 Aug 2026 00:00:00 GMTpolicypolicyIndianeuro-privacyDPDPADigital-Personal-Data-Protection-Actbrain-datasensitive-personal-dataNamit-SrivastavaCHRIST-UniversityLiveLawMeitYData-Protection-Board-of-IndiaPuttaswamyArticle-21cognitive-libertyChile-neurorightsUNESCOADI-Neurosciencehttps://insidebci.com/market/2026-08-28-adi-neuroscience-india-1-billion-neurotech-fund-spec-finance-panov-neiry/https://insidebci.com/market/2026-08-28-adi-neuroscience-india-1-billion-neurotech-fund-spec-finance-panov-neiry/ADI Neuroscience, an India-based neurotechnology investment vehicle backed by SPEC Finance India and announced 28 August 2026, targets US$1 billion of investment into India's neurotechnology sector over five years. SPEC Finance Group CEO Karan Dinesh Singh Rawat runs the fund. Neiry founder Alexander Panov and Moscow State University professor Mikhail Lebedev sit on the scientific side. The scale is roughly two orders of magnitude above the entire prior decade of Indian BCI startup funding, and the fund moves India onto the same neurotech-capital map as the United States, China, and the alliance-adjacent European infrastructure.Fri, 28 Aug 2026 00:00:00 GMTmarketmarketIndiaADI-NeuroscienceSPEC-Finance-IndiaKaran-Dinesh-Singh-RawatAlexander-PanovNeiryMikhail-LebedevIndia-neurotechSputnik-BrainMotorica-IndiaNexStembillion-dollar-fundIndia-BCI-capitalhttps://insidebci.com/policy/2026-08-27-china-miit-15th-five-year-plan-bcis-future-industry-standards-work-plan/https://insidebci.com/policy/2026-08-27-china-miit-15th-five-year-plan-bcis-future-industry-standards-work-plan/China's Ministry of Industry and Information Technology named brain-computer interfaces among six future industries in a State Council Information Office press conference on 26 August 2026, alongside quantum technology, biomanufacturing, hydrogen and nuclear fusion energy, embodied intelligence, and 6G. Retail News Asia reports MIIT's draft standards roadmap targets more than 40 BCI national standards by 2028 and more than 80 brain-tech standards by 2030, though the specific count is single-sourced and should be attributed accordingly.Thu, 27 Aug 2026 00:00:00 GMTpolicypolicyChinaMIIT15th-Five-Year-PlanSCIOXin-Guobinfuture-industriesBCI-standardsIndustrial-BuilderNeuracleBrainCoStairMedNeuroXessbrain-inspired-intelligencehttps://insidebci.com/news/2026-08-27-china-umr-shenguan-mri-integrated-closed-loop-bci-tianjin-university-united-imaging/https://insidebci.com/news/2026-08-27-china-umr-shenguan-mri-integrated-closed-loop-bci-tianjin-university-united-imaging/Tianjin University and Shanghai-listed United Imaging Healthcare (688271.SS) jointly unveiled uMR Shenguan on 23 August 2026 in Tianjin, described by the developer team as a full-stack MRI-integrated brain-computer interface framework. The system is designed to combine neural signal capture, decoding, modulation, and evaluation within a single MRI-based closed loop across 3T and 5T United Imaging systems. Named clinical verticals: motor rehabilitation, neuro-critical care, psychiatry, ophthalmology, and audiology.Thu, 27 Aug 2026 00:00:00 GMTnewsnewsChinauMR-ShenguanMRI-based-BCIUnited-Imaging-HealthcareTianjin-UniversityHaihe-LaboratoryMing-DongYuan-JianminFan-Qiuyunclosed-loop-BCISTAR-MarketIndustrial-Builderhttps://insidebci.com/news/2026-08-26-paradromics-fda-approval-expand-bci-personal-computing-devices-connect-one-connexus/https://insidebci.com/news/2026-08-26-paradromics-fda-approval-expand-bci-personal-computing-devices-connect-one-connexus/Paradromics announced on 26 August 2026 that the US Food and Drug Administration has issued an approval letter expanding the types of computing devices that may be used with its Connexus brain-computer interface inside the Connect-One Early Feasibility Study. Compatible personal, internet-connected devices (laptops, tablets, phones) can now be added into the study without a per-device FDA approval. Paradromics also identified a second patient for the feasibility study, and its first patient has progressed to closed-loop stage.Wed, 26 Aug 2026 00:00:00 GMTnewsnewsParadromicsConnexusConnect-OneConveyFDAIDEpersonal-computing-devicesMatt-AngleWilliam-J-Marks-JrAustin-TexasMichigan-MedicineUS-commercial-BCI-cohortintracorticalearly-feasibility-studyhttps://insidebci.com/policy/2026-08-24-turkiye-norom-nato-diana-neuroscience-neurotechnology-center-yok/https://insidebci.com/policy/2026-08-24-turkiye-norom-nato-diana-neuroscience-neurotechnology-center-yok/Türkiye's Council of Higher Education announced on 23 August 2026 that the Neuroscience and Neurotechnology Center of Excellence Joint Application and Research Center (NOROM) has been admitted to NATO's Defence Innovation Accelerator for the North Atlantic (DIANA) test network. NOROM is a joint centre between Gazi University, Ankara University and Middle East Technical University (METU), founded in 2023. Scope covers brain-computer interfaces, cognitive performance assessment, brain imaging, neuromodulation, robotic systems, and AI-assisted signal analysis. It is Türkiye's first and only DIANA test centre in the fields of neuroscience and neurotechnology.Mon, 24 Aug 2026 00:00:00 GMTpolicypolicyTürkiyeNOROMNATODIANAdefence-innovation-acceleratorYOKCouncil-of-Higher-EducationGazi-UniversityAnkara-UniversityMETUMiddle-East-Technical-UniversityHayrunnisa-Bolay-BelenMeltem-BahceliogluErol-Ozvartransatlantic-neurotechalliance-tier-neurotechhttps://insidebci.com/news/2026-08-22-ability-neurotech-tum-munich-intraoperative-first-in-human-ecog-umc-utrecht-tu-graz-als/https://insidebci.com/news/2026-08-22-ability-neurotech-tum-munich-intraoperative-first-in-human-ecog-umc-utrecht-tu-graz-als/Geneva-based ABILITY Neurotech has run a first-in-human intraoperative trial of its fully implantable brain-computer interface at TUM University Hospital in Munich, with up to five brain tumour surgery patients recorded over 20 to 30 minute sessions. A chronic ALS implant with UMC Utrecht and TU Graz is scheduled for Q4 2026. The device is an ECoG surface-electrode implant powered inductively through the scalp, using a laser-based optical link to move raw high-bandwidth neural data through intact skin, not an optical neural-sensing BCI.Sat, 22 Aug 2026 00:00:00 GMTnewsnewsAbility-NeurotechABILITYWyss-CenterGenevaRotem-KopelJohn-DonoghueTUM-MunichUMC-UtrechtTU-GrazINTRECOMECoGepicorticalsurface-electrodebattery-freetransdermal-opticalALSbrain-tumorfirst-in-humanhttps://insidebci.com/policy/2026-08-22-white-house-critical-emerging-technologies-strategy-bcis-future-computing-plexon-bis-export/https://insidebci.com/policy/2026-08-22-white-house-critical-emerging-technologies-strategy-bcis-future-computing-plexon-bis-export/The Office of Science and Technology Policy released its National Security Science and Technology Strategy on 19 August 2026, narrowing the Critical and Emerging Technologies (CET) list from 18 domains to 14. Brain-computer interfaces were moved from the retired 'Human-Machine Interfaces' category into 'Future Computing Technologies'. Neurotechnologies were separately moved into 'Biotechnology'. In parallel, US Bureau of Industry and Security enforcement is running through the existing Entity List rather than a BCI-specific export rule: Dallas-based neuroscience equipment manufacturer Plexon accepted a $1.7 million suspended civil penalty for unlicensed exports to Entity-Listed parties in China. BIS's 2021 Advance Notice of Proposed Rulemaking on BCI export controls has never been finalised.Sat, 22 Aug 2026 00:00:00 GMTpolicypolicyWhite-HouseOSTPcritical-and-emerging-technologiesCETFuture-Computingbrain-computer-interfacesBISBureau-of-Industry-and-Securityexport-controlsEntity-ListPlexonChinaState-PatchworkIndustrial-BuilderDargentic-Intelligence-ReportUS-federal-policyhttps://insidebci.com/market/2026-08-22-bill-ackman-neri-oxman-institute-400-million-brain-research-bcis-mount-sinai/https://insidebci.com/market/2026-08-22-bill-ackman-neri-oxman-institute-400-million-brain-research-bcis-mount-sinai/Hedge fund manager Bill Ackman and designer Neri Oxman announced the Ackman Oxman Institute (AOI) on 19-20 August 2026, seeded with $400 million in Pershing Square Inc. stock and a stated further commitment of similar or greater size in a form other than Pershing Square stock. The institute focuses on brain research, rehabilitation, longevity, and human optimization, with Mount Sinai as an important clinical partner. Ackman cited Neuralink, Precision Neuroscience, Synchron, Science Corp and Nudge as examples of the BCI field the institute will engage with, without claiming direct equity in any of them.Sat, 22 Aug 2026 00:00:00 GMTmarketmarketBill-AckmanNeri-OxmanAckman-Oxman-InstituteAOIPershing-SquareMount-SinaiNeuralinkPrecision-NeuroscienceSynchronScience-CorpNudgeFred-Ehrsamphilanthropybrain-researchDean-KamenGeorge-YancopoulosJames-RothmanBernardo-Sabatinihttps://insidebci.com/research/2026-08-20-darpa-firefox-100-channel-non-invasive-optical-bci-pedro-irazoqui-bto/https://insidebci.com/research/2026-08-20-darpa-firefox-100-channel-non-invasive-optical-bci-pedro-irazoqui-bto/DARPA has opened its Firefox programme, run out of the Biological Technologies Office by program manager Dr Pedro Irazoqui, targeting a coherent-optical non-invasive brain-computer interface at 100 channels with 50-micron spatial and 100-microsecond temporal resolution. The stated goal is to replace surgically implanted electrodes. Proposers Day is 1 September 2026, registration closes 21 August. Firefox appears to follow directly from the coherent-optical track first funded under DARPA's N3 program at Johns Hopkins Applied Physics Laboratory in 2019.Thu, 20 Aug 2026 00:00:00 GMTresearchresearchDARPAFirefoxBiological-Technologies-OfficeBTOPedro-Irazoquinon-invasiveoptical-BCIcoherent-opticalN3Johns-Hopkins-APLDavid-BlodgettSHINEDefense-Sciences-OfficeUS-federal-researchhttps://insidebci.com/market/2026-08-20-weiling-medical-rmb-100m-surface-electrode-cortical-bci-shenzhen-innotek-junzhong/https://insidebci.com/market/2026-08-20-weiling-medical-rmb-100m-surface-electrode-cortical-bci-shenzhen-innotek-junzhong/Shenzhen's Weiling Medical Technology closed a new funding round of over RMB 100 million on 17 August 2026, led by Junzhong Capital with STAR Market-listed Innotek (688253.SH) as core industrial investor via the Jiaxing Innotek Industrial Fund. Weiling develops a fully implantable, flexible thin-film cortical electrode that sits on the cortical surface rather than penetrating brain tissue. A first-in-human implant in Guangdong in mid-June 2026 was reported by the company to restore forearm and wrist movement in the left upper limb of a locked-in syndrome patient.Thu, 20 Aug 2026 00:00:00 GMTmarketmarketChinaWeiling-MedicalShenzhenJunzhong-CapitalInnotekSTAR-Marketsurface-ECoGepicorticalcortical-BCILi-XiaojianCAS-SIATZhujiang-HospitalChinese-BCI-landscapelocked-in-syndromeflexible-electrodehttps://insidebci.com/news/2026-08-16-bluewind-medical-revi-extend-fda-510k-tibial-neuromodulation-15-year/https://insidebci.com/news/2026-08-16-bluewind-medical-revi-extend-fda-510k-tibial-neuromodulation-15-year/BlueWind Medical received FDA 510(k) clearance on 5 August 2026 for Revi Extend, an updated version of its implantable posterior-tibial-nerve neuromodulation device with implant longevity extended from 10 to 15 years. Revi Extend is the second 510(k) in the Revi family; the base Revi System was authorised in August 2023 via FDA De Novo classification grant. OASIS three-year data supported the update. Revi is a peripheral-nerve stimulator, not a brain-computer interface, and is covered under InsideBCI's bioelectronic-medicine adjacency scope.Sun, 16 Aug 2026 00:00:00 GMTnewsnewsBlueWind-MedicalReviRevi-ExtendFDA-510kDe-Novotibial-neuromodulationposterior-tibial-nerveurgency-urinary-incontinenceUUIbioelectronic-medicineperipheral-nerveOASIS-trialKerry-NelsonRoger-Dmochowskisacral-neuromodulationMedtronic-InterStimAxonicshttps://insidebci.com/policy/2026-08-16-china-gb-t-47023-47127-bci-foundational-national-standards-effective-august/https://insidebci.com/policy/2026-08-16-china-gb-t-47023-47127-bci-foundational-national-standards-effective-august/China has published its first national-level rulebook for how brain-computer interfaces should be built and how their data should be shared. Two recommended national standards, GB/T 47023-2026 and GB/T 47127-2026, took effect on 1 August 2026, setting a common technical vocabulary and a shared data format for Chinese BCI companies, hospitals, and researchers. A third standard covering visual-evoked-potential data follows on 1 October 2026. Jointly issued by SAMR and SAC. Published 28 January 2026.Sun, 16 Aug 2026 00:00:00 GMTpolicypolicyChinaGB-T-47023GB-T-47127GB-T-47346national-standardsSAMRSACBCI-reference-architectureBCI-multimodal-dataIndustrial-Builderrecommended-standardshttps://insidebci.com/market/2026-08-16-picc-property-casualty-china-first-commercial-insurance-invasive-bci-surgery-zhejiang/https://insidebci.com/market/2026-08-16-picc-property-casualty-china-first-commercial-insurance-invasive-bci-surgery-zhejiang/State-owned PICC Property and Casualty signed China's first commercial insurance policy covering invasive brain-computer interface surgery on Wednesday 12 August 2026. Counterparty is the Second Affiliated Hospital of Zhejiang University School of Medicine. Zhejiang Provincial Government Office released a same-day industry-policy package. Hong Kong and Shenzhen BCI-tagged stocks rallied.Sun, 16 Aug 2026 00:00:00 GMTmarketmarketChinainsurancePICCinvasive-BCIZhejiangSAHZUHangzhouNeuracleHuashan-HospitalChinese-BCI-landscapeInnovation-MedicalShanghai-HeartcareBrainAuroraIndustrial-Builderhttps://insidebci.com/policy/2026-08-11-california-ab-1883-employer-brain-data-prohibition-isaac-bryan-cppa/https://insidebci.com/policy/2026-08-11-california-ab-1883-employer-brain-data-prohibition-isaac-bryan-cppa/California Assemblymember Isaac Bryan's AB 1883, which regulates workplace surveillance including a specific prohibition on employer collection of neural data with a safety-use carve-out, has cleared the Assembly and moved most of the way through the Senate per CalMatters' 10 August 2026 tracking. A parallel Assembly Bill 1542 authored by Assemblymember Christopher Ward would prohibit the sale of neural data. Vermont S.71 (signed 16 June 2026) and H.814 (signed May 2026) are the most recent enacted comparators.Tue, 11 Aug 2026 00:00:00 GMTpolicypolicyCaliforniaAB-1883AB-1542Isaac-BryanChristopher-WardSB-1223SB-7CPPAADMTworkplace-neurotechEmotivCognixionHitachi-SmartCapVermont-S71Vermont-H814state-patchworkNita-FarahanyNeurorights-Foundationhttps://insidebci.com/research/2026-08-11-darpa-shine-non-invasive-neuroplasticity-disruption-opportunity-defense-sciences-office/https://insidebci.com/research/2026-08-11-darpa-shine-non-invasive-neuroplasticity-disruption-opportunity-defense-sciences-office/DARPA's Defense Sciences Office has posted Special Notice DARPA-SN-26-111 for its forthcoming SHINE (Selective Harnessing of Intrinsic Neuroplasticity Engineering) Disruption Opportunity, with a prerecorded Information Session webcast on 25 August 2026 and the DO release anticipated the same month. Program manager is Robin Bonomi. SHINE aims to non-invasively induce adaptive neuroplasticity in targeted dysfunctional neural circuits for injury recovery, spanning five modality domains. Awards will be Other Transactions for prototype projects. Registration closes 14 August 2026 and is unusually open to foreign nationals.Tue, 11 Aug 2026 00:00:00 GMTresearchresearchDARPASHINEDefense-Sciences-OfficeRobin-Bonomineuroplasticitynon-invasiveDisruption-OpportunityDisruptioneeringOther-TransactionsUS-federal-researchSTRENGTHENN3TNTRE-NETSynchron-originsBrainGatehttps://insidebci.com/news/2026-08-10-xuanwu-hospital-duan-wanru-endovascular-bci-10-minutes-stairmed-nankai/https://insidebci.com/news/2026-08-10-xuanwu-hospital-duan-wanru-endovascular-bci-10-minutes-stairmed-nankai/Duan Wanru of Xuanwu Hospital in Beijing said an experienced surgeon can position a Chinese endovascular brain-computer interface in as little as 10 minutes. StairMed unveiled a separate endovascular research program in December 2025 with the Chinese Academy of Sciences, currently in sheep testing. Nankai University completed China's first interventional human BCI in June 2025. Three Chinese endovascular BCI programs are now on the public record.Mon, 10 Aug 2026 00:00:00 GMTnewsnewsChinaendovascular-BCIXuanwu-HospitalDuan-WanruStairMedZhao-ZhengtuoChinese-Academy-of-SciencesGlobal-Health-SummitNankai-UniversityDuan-FengSynchron-Stentrodevascular-deliverycerebral-infarctionChinese-BCI-landscapehttps://insidebci.com/research/2026-08-08-kist-brain-science-institute-optoelectronic-cmos-bci-chip-advanced-science/https://insidebci.com/research/2026-08-08-kist-brain-science-institute-optoelectronic-cmos-bci-chip-advanced-science/Researchers at KIST's Brain Science Institute have published a peer-reviewed BCI probe in Advanced Science that combines 416 electrodes and 832 photodiodes across 13 hair-thin silicon shanks, enabling simultaneous electrical and optical brain-signal readout on a single monolithic CMOS chip. KIST claims it as a world-first at this level of density and integration. Preclinical work in live mice; not yet in primate or human. Funded by Korea's K-Moonshot Project.Sat, 08 Aug 2026 00:00:00 GMTresearchresearchKISTChanghyuk-LeeBrain-Science-InstituteAdvanced-Scienceoptoelectronic-BCICMOSphotodiodemultimodal-neural-probeK-MoonshotCho-Il-jooKorea-BCI-Industry-AssociationYbrainIndustrial-Builder-postureKorean-BCINeuralink-comparisonhttps://insidebci.com/news/2026-08-07-naomi-bashkansky-openai-alignment-researcher-joins-conduit-bci-startup/https://insidebci.com/news/2026-08-07-naomi-bashkansky-openai-alignment-researcher-joins-conduit-bci-startup/On 23 July 2026, Naomi Bashkansky resigned from OpenAI's alignment team after eighteen months to join Conduit, a San Francisco non-invasive brain-computer interface startup co-founded by Rio Popper and Clem von Stengel. Conduit claims to have collected approximately 10,000 hours of neuro-language data from thousands of paid participants over six months, funded through undisclosed capital. Bashkansky joins as Founding Researcher.Fri, 07 Aug 2026 00:00:00 GMTnewsnewsNaomi-BashkanskyConduitOpenAIalignment-researchRio-PopperClem-von-Stengelnon-invasive-BCIthought-to-textneuro-language-datasetSan-FranciscoEEGMeta-Brain2QwertyAI-plus-BCIwestern-cohortfounding-researcherhttps://insidebci.com/market/2026-08-05-shanghai-active-technology-330-million-yuan-angel-round-tianshu-1024-channel-invasive-bci/https://insidebci.com/market/2026-08-05-shanghai-active-technology-330-million-yuan-angel-round-tianshu-1024-channel-invasive-bci/Shanghai Active Technology, founded February 2026, closed a RMB 330 million angel round announced on 3 August 2026. Gasgoo and 36Kr describe the raise as the largest single angel round in the Chinese BCI sector to date, though the lead investor was not disclosed. The company is building a full-link invasive BCI with three product lines including a 1024-channel motor system called Tianshu, which has obtained a type inspection report and is preparing to launch clinical trials.Wed, 05 Aug 2026 00:00:00 GMTmarketmarketChinaShanghai-Active-TechnologyTianshuinvasive-BCIangel-roundWu-Guojia36Kr-Medical-InsightGasgooflexible-electrodes1024-channelClass-III-devicesstrokespinal-cord-injuryALSChinese-BCI-financingindustrial-builder-posturehttps://insidebci.com/market/2026-08-02-delian-capital-jiang-donghui-chinese-bci-bubble-cycle-vcbeat/https://insidebci.com/market/2026-08-02-delian-capital-jiang-donghui-chinese-bci-bubble-cycle-vcbeat/VCBeat, the Chinese healthcare-investment media outlet, published an on-record investor take on the Chinese brain-computer interface sector on 2 August 2026. Delian Capital partner Jiang Donghui framed the sector as at risk of a bubble cycle before maturity, laid out a four-quadrant investment matrix based on demand and technological advancement, and named Chinese BCI companies across invasive, semi-invasive and non-invasive paths. H1 2026 financing alone accounted for approximately 60 per cent of the sector's thirteen-year total.Sun, 02 Aug 2026 00:00:00 GMTmarketmarketChinaVCBeatDelian-CapitalJiang-DonghuiNeuracleNeuCyberBeinaoStairMedBrainCoGestalt-TechnologyBCI-SonicsMindtrixIT-JuziSTAR-MarketAlibabaTencentSequoia-Chinafinancingbubble-cycleultrasound-BCInon-invasive-BCIhttps://insidebci.com/policy/2026-08-02-eu-ai-act-article-50-transparency-obligations-emotion-recognition-annex-iii-deferred/https://insidebci.com/policy/2026-08-02-eu-ai-act-article-50-transparency-obligations-emotion-recognition-annex-iii-deferred/On 2 August 2026, EU AI Act transparency obligations under Article 50 became applicable, requiring emotion-recognition and biometric-categorisation systems to notify natural persons exposed to them. The high-risk obligation suite under Annex III, including conformity assessment and human oversight, was deferred to 2 December 2027 by the Digital Omnibus (Regulation EU 2026/1744) adopted by the Council on 29 June and in force since 27 July 2026. Most compliance framings are conflating the two.Sun, 02 Aug 2026 00:00:00 GMTpolicypolicygovernanceEuropean-UnionAI-ActArticle-50Annex-IIIDigital-OmnibusRegulation-2026-1744emotion-recognitionbiometric-categorisationMuseEmotivNeurableChilean-Supreme-Courthorizontal-regulator-posturetransparency-obligationshigh-risk-AIconsumer-BCIhttps://insidebci.com/news/2026-07-31-chinese-bci-four-programmes-neuracle-neuroxess-stairmed-wang-ning-july-roundup/https://insidebci.com/news/2026-07-31-chinese-bci-four-programmes-neuracle-neuroxess-stairmed-wang-ning-july-roundup/In one month, four separate Chinese brain-computer interface programmes each produced a public result. Neuracle wrote the world's first commercial prescription for an invasive BCI at Huashan Hospital on 13 July. NeuroXess ran a two-patient cross-city Chinese chess demonstration between Shanghai and Nanchang. StairMed's investigational trial put three quadriplegic patients into paid remote work. And at the World AI Conference in Shanghai, a paralysed fine-arts graduate from Shenzhen demoed a mind-controlled wheelchair he had built himself with LLM-assisted DIY.Fri, 31 Jul 2026 00:00:00 GMTnewsnewsChinaNeuracleNEONeuroXessTriple-FullStairMedWRS02RISE-trialWang-NingHuashan-HospitalFirst-Affiliated-Hospital-Nanchang-UniversityNMPAindustrial-builder-posturexiangqiRedNote-hackathonWAIC-2026return-to-workOne-Person-Companycitizen-scienceinvasive-BCIsemi-invasive-BCInon-invasive-BCIhttps://insidebci.com/news/2026-07-29-science-corporation-nevada-sanchez-evp-engineering-butterfly-prima-germany/https://insidebci.com/news/2026-07-29-science-corporation-nevada-sanchez-evp-engineering-butterfly-prima-germany/Science Corporation appointed Butterfly Network co-founder Nevada Sanchez as Executive Vice President of Engineering on 29 July, one week after CE mark approval for the PRIMA retinal implant. Sanchez's remit spans PRIMA, the Biohybrid neural interface, the Vessel organ-perfusion programme, and the Science Foundry MEMS fabrication line. First commercial implants are expected in Germany this fall.Wed, 29 Jul 2026 00:00:00 GMTnewsindustryScience-CorporationPRIMANevada-SanchezButterfly-NetworkMax-HodakBiohybridVesselScience-FoundryMEMSCE-markcommercial-launchGermanyUnited-KingdomFrank-HolzUniversity-Hospital-Bonnage-related-macular-degenerationretinal-implantSeries-Chttps://insidebci.com/market/2026-07-28-china-hong-kong-bci-stocks-rally-nanjing-panda-neuracle-science-corp/https://insidebci.com/market/2026-07-28-china-hong-kong-bci-stocks-rally-nanjing-panda-neuracle-science-corp/Nanjing Panda Electronics closed up nearly 13 percent in Hong Kong on 28 July as Chinese and Hong Kong-listed BCI stocks rallied, with capital markets repricing the field on the back of Neuracle's first commercial prescription and Science Corp's European CE mark.Tue, 28 Jul 2026 00:00:00 GMTmarketmarketChinaHong-KongNanjing-PandaMicroPort-NeuroTechShanghai-Xinwei-MedicalBrainAuroraInnovation-MedicalAipeng-MedicalHainan-HaiyaoSaili-MedicalNeuracleNEO-implantScience-CorporationPRIMACE-markNMPAHuashan-Hospital15th-Five-Year-Planindustrial-builder-postureconcept-stockshttps://insidebci.com/policy/2026-07-28-nuffield-council-bioethics-uk-bci-working-group-pickersgill/https://insidebci.com/policy/2026-07-28-nuffield-council-bioethics-uk-bci-working-group-pickersgill/The Nuffield Council on Bioethics has appointed sociologist Martyn Pickersgill to chair a new brain-computer interface working group, revisiting its 2013 neurotechnology framework as BCIs converge with AI and quantum computing.Tue, 28 Jul 2026 00:00:00 GMTpolicypolicygovernanceUnited-KingdomNuffield-Council-on-BioethicsMartyn-PickersgillUniversity-of-EdinburghUsher-InstituteWellcomeMedical-Research-CouncilMHRARoyal-SocietyiHumanPOSTnoteAda-Lovelace-InstituteAI-convergencequantum-computingBCI-ethicsregulator-in-waitinghttps://insidebci.com/news/2026-07-27-neuvotion-neustim-commercial-launch-feinstein-license-bouton/https://insidebci.com/news/2026-07-27-neuvotion-neustim-commercial-launch-feinstein-license-bouton/On Monday 27 July 2026, Chad Bouton's Neuvotion announced the first US commercial launch of a product from a brain-computer interface platform. NeuStim NN-01, a wearable neuromuscular stimulator for hand recovery after stroke or C5 spinal cord injury, ships this fall. Neuvotion holds an exclusive worldwide license from the Feinstein Institutes, where Bouton is senior author of the 16 July Nature Medicine paper on the underlying double neural bypass platform. The intracortical BCI half of that platform, tested in one patient (Keith Thomas), remains investigational.Mon, 27 Jul 2026 00:00:00 GMTnewsnewsNeuvotionNeuStimChad-BoutonFeinstein-InstitutesNorthwell-HealthKeith-Thomasdouble-neural-bypassFDA-510kBioness-H200Onward-ARC-EXhand-rehabilitationstrokecervical-spinal-cord-injurySanguistatBattelle-NeuroLifeIan-BurkhartState-Patchwork-posturehttps://insidebci.com/news/2026-07-25-precision-neuroscience-appoints-john-donoghue-scientific-advisor/https://insidebci.com/news/2026-07-25-precision-neuroscience-appoints-john-donoghue-scientific-advisor/On Thursday 23 July 2026, New York-based Precision Neuroscience announced the appointment of John Donoghue - founding investigator of the BrainGate consortium at Brown, co-founder of Cyberkinetics, and inaugural director of the Wyss Center for Bio and Neuroengineering in Geneva - as a scientific advisor to the company. Donoghue will advise Precision's scientific and engineering teams on device design, signal decoding, and clinical strategy. The appointment lands two days after Precision's non-paralysed cursor-control demonstration across its 15-plus academic-medical-centre clinical network, and at exactly the moment ABILITY Neurotech, the Wyss Center spin-out whose technology was conceived under Donoghue's own directorship, prepares to begin its own chronic first-in-human implantation in ALS patients.Sat, 25 Jul 2026 00:00:00 GMTnewsnewsPrecision-NeuroscienceJohn-DonoghueBen-RapoportMichael-MagerBrainGateCyberkineticsMatthew-NagleCathy-HutchinsonWyss-CenterABILITY-NeurotechBrown-UniversityLayer-7surface-ECoGfounder-densityQueen-Elizabeth-Prize-EngineeringState-Patchwork-posturehttps://insidebci.com/news/2026-07-24-ability-neurotech-first-in-human-tum-munich-optical-bci/https://insidebci.com/news/2026-07-24-ability-neurotech-first-in-human-tum-munich-optical-bci/On Tuesday 21 July 2026, Geneva-based ABILITY Neurotech announced the first-in-human recording of its fully implantable, batteryless brain-computer interface at TUM University Hospital Rechts der Isar in Munich. The device is a 128-channel sub-scalp ECoG array with a laser-based transcutaneous optical data link streaming raw neural signals through the scalp at 50 megabits per second. The first cohort is up to five brain-tumour surgery patients recording 20 to 30 minutes of intraoperative data each. The company's separate chronic implantation trial in ALS patients at UMC Utrecht, cleared by Dutch regulators on 26 May 2026, has not yet performed a surgery.Fri, 24 Jul 2026 00:00:00 GMTnewsnewsABILITY-NeurotechRotem-KopelCraig-CookWyss-CenterJohn-DonoghueTUM-MunichTUM-Rechts-der-IsarSimon-JacobArthur-WagnerBernhard-Meyeroptical-transcutaneous-linksub-scalp-ECoGbatteryless-BCI128-channelINTRECOMUMC-UtrechtMariska-VansteenselGeneva-Campus-BiotechHorizontal-Regulator-posturehttps://insidebci.com/news/2026-07-22-science-corporation-prima-ce-mark-europe-amd-central-vision/https://insidebci.com/news/2026-07-22-science-corporation-prima-ce-mark-europe-amd-central-vision/On Wednesday 22 July 2026, Science Corporation announced the European commercial launch of PRIMA, a two-millimetre subretinal photovoltaic chip that restores functional central vision in patients blinded by geographic atrophy from age-related macular degeneration. The CE mark, granted by DEKRA under the EU Medical Device Regulation, covers 30 European countries. The first commercial implant is expected in Germany. PRIMA is the first CE-marked implant to restore, rather than merely slow, central vision loss in AMD, and the FDA has granted it Humanitarian Use Device designations on the same day. Max Hodak's five-year-old company inherited the technology from Pixium Vision after the French developer's 2024 collapse.Wed, 22 Jul 2026 00:00:00 GMTnewsnewsScience-CorporationPRIMAMax-HodakFrank-HolzJose-Alain-SahelDaniel-Palankergeographic-atrophyage-related-macular-degenerationAMDretinal-implantsubretinal-photovoltaicCE-markEU-MDRDEKRAPixium-VisionAlan-MardinlyBen-RapoportPrecision-NeuroscienceState-Patchwork-postureHorizontal-Regulator-posturehttps://insidebci.com/news/2026-07-21-precision-neuroscience-able-bodied-layer-7-cursor-control-jasaun/https://insidebci.com/news/2026-07-21-precision-neuroscience-able-bodied-layer-7-cursor-control-jasaun/On Tuesday 21 July 2026, Precision Neuroscience announced that neurosurgical patients without paralysis, temporarily implanted with its Layer 7 subdural microelectrode array during scheduled tumor or epilepsy-monitoring procedures, controlled cursors and played Mario Kart, Pong and Fruit Ninja, scrolled Instagram, and answered FaceTime calls with their thoughts. Chief clinical officer Jayme Strauss confirmed the array is removed at bedside in under five minutes at the end of each participant's hospital stay, with the first permanent implant targeted for early 2028.Tue, 21 Jul 2026 00:00:00 GMTnewsnewsPrecision-NeuroscienceLayer-7Jayme-StraussBenjamin-RapoportMichael-MagerMark-HettickDemetrios-PapageorgiouCraig-Mermelsurface-ECoGnon-penetrating-BCIFDA-510kMount-SinaiWest-Virginia-University-RockefellerMedtronic-StealthStationState-Patchwork-posturehttps://insidebci.com/news/2026-07-20-stairmed-18-patients-huashan-shanghai-penetrating-bci-trial/https://insidebci.com/news/2026-07-20-stairmed-18-patients-huashan-shanghai-penetrating-bci-trial/On 20 July 2026, at the World Artificial Intelligence Conference in Shanghai, StairMed disclosed that its cortex-penetrating invasive BCI clinical trial at Huashan Hospital has now reached 18 cumulative implants since March 2025. The Shanghai firm co-founded by Zhao Zhengtuo and Xue Li at the Chinese Academy of Sciences' Center for Excellence in Brain Science demonstrated a patient three months post-op controlling a wheelchair by thought and hitting 6.19 bits per second on a cursor task, alongside a live journalist test at 4.9 bits per second with a finger.Mon, 20 Jul 2026 00:00:00 GMTnewsnewsStairMed阶梯医疗Zhao-ZhengtuoXue-LiCEBSITHuashan-HospitalFudan-Universitypenetrating-invasive-BCIultra-flexible-electrodeWRS02WAIC-2026Shanghai-BCI-clusterNeuroXessNeuracle-NEOAlibabaTencentIndustrial-Builder-posturehttps://insidebci.com/market/2026-07-18-brainco-waic-2026-brain-to-robot-platform-nyx-he/https://insidebci.com/market/2026-07-18-brainco-waic-2026-brain-to-robot-platform-nyx-he/On Friday 17 July 2026, at the World Artificial Intelligence Conference in Shanghai, BrainCo debuted its Brain-Controlled Robot AI Platform, a graphical developer toolkit that pairs its non-invasive EEG headset with third-party humanoid, robotic-arm, and quadruped robots from Unitree, Realman, and Deep Robotics. Nyx He, partner and senior vice president, framed the launch as the next chapter of human-machine collaboration. Live demonstrations at the booth showed a person in an EEG headband directing a robotic arm to pick up a cup and an apple without buttons, voice, or muscle movement.Sat, 18 Jul 2026 00:00:00 GMTmarketmarketBrainCoWAIC-2026Shanghaibrain-controlled-robotEEGNeuro-Embodied-AINyx-HeHan-BichengHangzhou-Six-Little-DragonsBrainRoboticsHKEX-IPOIndustrial-Builder-posturehttps://insidebci.com/news/2026-07-18-feinstein-double-neural-bypass-keith-thomas-nature-medicine/https://insidebci.com/news/2026-07-18-feinstein-double-neural-bypass-keith-thomas-nature-medicine/On 16 July 2026, Nature Medicine put on its cover a three-year follow-up of Keith Thomas of Massapequa, New York, who was implanted with five microelectrode arrays in March 2023 as the first participant in the Feinstein Institutes' 'double neural bypass' trial. The Chad Bouton team's paper reports that Thomas can now feed himself, drink from a cup, feel touch on his right wrist, and pet his dog Bow, with strength and sensation gains persisting more than two years after the stimulation was switched off.Sat, 18 Jul 2026 00:00:00 GMTnewsnewsFeinstein-InstitutesNorthwell-HealthChad-BoutonKeith-ThomasNature-Medicinedouble-neural-bypasshybrid-neuroprosthesistetraplegiacervical-spinal-cord-injurytranscutaneous-spinal-cord-stimulationcortical-mirroringsomatosensory-cortexneuroplasticityBattelle-NeuroLifeIan-Burkharthttps://insidebci.com/news/2026-07-18-pitt-uchicago-icms-decade-safety-copeland-science-translational-medicine/https://insidebci.com/news/2026-07-18-pitt-uchicago-icms-decade-safety-copeland-science-translational-medicine/On 15 July 2026, Science Translational Medicine published a five-participant, ten-year safety study of intracortical microstimulation in the somatosensory cortex. The Pitt and University of Chicago team led by Robert Gaunt and Charles Greenspon delivered 168 million pulses across 27 combined years of implant time with no serious adverse events. The longest single participant is with very high confidence Nathan Copeland, first implanted on Star Wars Day 2015, still living publicly with the same Utah arrays eleven years later.Sat, 18 Jul 2026 00:00:00 GMTnewsnewsICMSintracortical-microstimulationsomatosensory-cortexNathan-CopelandRobert-GauntCharles-GreensponPittUniversity-of-ChicagoUPMCBlackrock-Utah-arrayScience-Translational-Medicinelong-term-safetySliman-Bensmaiasensory-restorationspinal-cord-injuryhttps://insidebci.com/news/2026-07-16-neuracle-neo-shanghai-huashan-first-commercial-invasive-bci-motor-restoration/https://insidebci.com/news/2026-07-16-neuracle-neo-shanghai-huashan-first-commercial-invasive-bci-motor-restoration/On Monday 13 July 2026, neurosurgeons at Huashan Hospital affiliated with Fudan University performed the first commercial implantation of Neuracle's NEO brain-computer interface in a male patient with tetraplegia from a decade-old cervical spinal cord injury. The device is coin-sized, epidural, battery-free, and drives a pneumatic glove for hand grasping. Neuracle NEO is the world's first commercial invasive brain-computer interface implant for motor restoration in paralysis, following NMPA Class III market approval on 13 March 2026.Thu, 16 Jul 2026 00:00:00 GMTnewsnewsNeuracleNEOBoruikangShanghai-Huashan-HospitalFudan-Universitycommercial-invasive-BCIcervical-spinal-cord-injurytetraplegiaChinaNMPASTAR-Market-IPOTsinghua-UniversityXu-HonglaiHuang-XiaoshanMao-YingWu-ZehanIndustrial-Builder-posturehttps://insidebci.com/market/2026-07-13-bci-vertical-broadening-beyond-motor-2026-synthesis/https://insidebci.com/market/2026-07-13-bci-vertical-broadening-beyond-motor-2026-synthesis/Across the first half of 2026 and the first weeks of the second half, three US Food and Drug Administration Breakthrough Device Designations were granted to non-motor-indication BCI and neuromodulation devices, Cortigent's existing Breakthrough-designated visual cortical prosthesis programme disclosed a secondary stroke motor rehab arm, three first-in-human or investigational-device clinical milestones landed, and two significant peer-reviewed publications extended the field's clinical use case. The motor-restoration pipeline itself continued to expand in the same window. This is a synthesis piece on what the data pattern actually shows and does not show.Mon, 13 Jul 2026 00:00:00 GMTmarketmarketsynthesisFDA-Breakthrough-Device-DesignationNia-TherapeuticsAurenarReVision-ImplantCortigent-OrionNeuronoffCoherence-NeuroMotif-NeurotechRush-ICVPBath-UlsterChalmers-ValleCorTecNeuralinkParadromicsPrecision-NeuroscienceOnward-MedicalABILITY-NeurotechEpia-Neurohttps://insidebci.com/policy/2026-07-10-xizang-lhasa-plateau-bci-clinical-center-tiantan/https://insidebci.com/policy/2026-07-10-xizang-lhasa-plateau-bci-clinical-center-tiantan/Xinhua reported on 9 July 2026 that Xizang (Tibet Autonomous Region)'s first plateau brain-computer interface clinical application centre was inaugurated at Lhasa People's Hospital. A medical assistance team from Beijing Tiantan Hospital, Capital Medical University, introduced the non-invasive EEG-based BCI technology, which drives exoskeleton and robotic-arm actuators for motor rehabilitation. The centre sits within a six-year Tiantan-Lhasa department-support partnership dating to 2020, and targets cerebral haemorrhage, cerebral ischemia, TBI, spinal cord injury, and peripheral nerve injury indications.Fri, 10 Jul 2026 00:00:00 GMTpolicypolicyChinaXizangTibetLhasaplateau-BCIBeijing-Tiantan-HospitalLhasa-Peoples-Hospitalnon-invasive-BCIEEGexoskeletonmedical-aid-TibetBai-YouqingIndustrial-Builder-posturehttps://insidebci.com/market/2026-07-10-cnbc-brainco-nyx-he-hangzhou-hk-ipo-run-up/https://insidebci.com/market/2026-07-10-cnbc-brainco-nyx-he-hangzhou-hk-ipo-run-up/CNBC published a video interview by China reporter Elaine Yu with Nyx He, Partner and Senior Vice President at BrainCo, on 10 July 2026. The interview lands six months after BrainCo confidentially filed for a Hong Kong Stock Exchange listing on 12 January 2026 with CICC and UBS Group AG as arrangers, and six months after the company closed a ¥2 billion (approximately US$286 million) financing round co-led by IDG Capital and Walden International on 8 January 2026. BrainCo is one of Hangzhou's Six Little Dragons alongside DeepSeek, Unitree Robotics, Game Science, DEEP Robotics, and Manycore Tech.Fri, 10 Jul 2026 00:00:00 GMTmarketmarketBrainCoNyx-HeHan-BichengCNBCElaine-YuHong-Kong-IPOHangzhou-Six-Little-Dragonsnon-invasive-BCIBrainRoboticsIDG-CapitalWalden-InternationalIndustrial-Builder-postureChinahttps://insidebci.com/policy/2026-07-07-beijing-changfazhan-bci-incubation-platform-changping-shanghai-financing/https://insidebci.com/policy/2026-07-07-beijing-changfazhan-bci-incubation-platform-changping-shanghai-financing/Beijing Municipal Bureau of Economy and Information Technology announced on 1 July 2026, with English release on 7 July, that the Changfazhan Brain Science and Brain-Computer Interface Incubation Platform in Changping district has been designated as one of seven newly recognised Future Industry Incubation Platforms, the first BCI-specific platform under that specific programme. Shanghai municipal science commission director Luo Dajin separately claimed on 6 July that Shanghai hosted nearly 60 per cent of China's BCI financing events, 40 per cent of the disclosed funding amount, and one-third of the country's BCI companies in the first half of 2026.Tue, 07 Jul 2026 00:00:00 GMTpolicypolicyChinaBeijingChangpingChangfazhanFuture-Industry-Incubation-Platform育新平台ZhongguancunShanghaiLuo-DajinSTCSMIndustrial-Builder-postureChina-BCI-financing-H1-2026https://insidebci.com/market/2026-07-07-paradromics-william-marks-chief-clinical-officer-verily/https://insidebci.com/market/2026-07-07-paradromics-william-marks-chief-clinical-officer-verily/Paradromics announced on 7 July 2026 that William J. Marks, Jr., MD, MS-HCM, has joined as Chief Clinical Officer, a role distinct from the Chief Medical Officer position held by neurosurgeon Stephen Ryu. Marks was Head of Clinical Neurology and Head of Clinical Science at Verily Life Sciences from 2016 to 2023, before co-founding Nexus NeuroTech Ventures, which wound down 31 March 2026. The hire lands three weeks after Paradromics' first-in-human Connexus BCI implant at University of Michigan Health on 17 June 2026.Tue, 07 Jul 2026 00:00:00 GMTmarketmarketParadromicsWilliam-MarksChief-Clinical-OfficerVerily-Life-SciencesAlphabetNexus-NeuroTech-VenturesStephen-RyuMatt-AngleConnexusConnect-Oneclinical-trialUniversity-of-Michigan-Healthhttps://insidebci.com/market/2026-07-05-nia-therapeutics-sns-fda-breakthrough-tbi-memory-implant/https://insidebci.com/market/2026-07-05-nia-therapeutics-sns-fda-breakthrough-tbi-memory-implant/Nia Therapeutics, an Allston Massachusetts company co-founded in 2018 by University of Pennsylvania memory neuroscientist Michael Kahana and cognitive neuromodulation researcher Daniel Rizzuto, received FDA Breakthrough Device Designation on 13 March 2026 for its Smart Neurostimulation System (SNS), indicated for episodic memory loss in adults with prior moderate-to-severe traumatic brain injury. The SNS is a 60-channel wireless closed-loop cortical implant whose platform hardware was validated in a sheep study published in Brain Stimulation in December 2025. It is preclinical: no human implant yet, IDE application planned for 2026.Sun, 05 Jul 2026 00:00:00 GMTmarketmarketNia-TherapeuticsSNSSmart-Neurostimulation-SystemFDA-Breakthrough-Device-DesignationTBIepisodic-memoryMichael-KahanaDaniel-RizzutoDARPARestoring-Active-MemoryUniversity-of-PennsylvaniaAllston-Massachusettsclosed-loop-neurostimulationhttps://insidebci.com/news/2026-07-04-neuralink-first-transdural-canadian-als-lee-marten-uhn-toronto-western/https://insidebci.com/news/2026-07-04-neuralink-first-transdural-canadian-als-lee-marten-uhn-toronto-western/Sgt Lee Marten of the Vancouver Police Department received a Neuralink N1 implant at Toronto Western Hospital on 20 May 2026, becoming the first Canadian ALS patient in the CAN-PRIME trial and the first human anywhere to receive the implant via Neuralink's new transdural surgical technique that preserves the dura rather than cutting it open. The story was broken by CBC News and MobiHealthNews on 2 July 2026.Sat, 04 Jul 2026 00:00:00 GMTnewsnewsNeuralinkCAN-PRIMEtransduralALSCanadaUniversity-Health-NetworkToronto-Western-HospitalAndres-LozanoLee-MartenVancouver-PoliceN1Health-Canadahttps://insidebci.com/policy/2026-07-04-nmpa-announcement-24-2026-bci-medical-device-classification-guidelines/https://insidebci.com/policy/2026-07-04-nmpa-announcement-24-2026-bci-medical-device-classification-guidelines/China's National Medical Products Administration issued Announcement No. 24 (2026) on 29 June 2026, releasing final Guiding Principles for the Classification and Definition of Brain-Computer Interface Medical Device Products plus a companion Generic Naming Guidelines. Every invasive BCI is Class III. Non-invasive BCIs are Class III by default. Non-invasive stroke-motor rehabilitation devices are Class II only if they do not incorporate artificial intelligence.Sat, 04 Jul 2026 00:00:00 GMTpolicypolicyChinaNMPAAnnouncement-24-2026medical-device-classificationBCI-regulationClass-IIClass-IIIinvasive-BCInon-invasive-BCIstroke-motor-rehabilitationAI-medical-devicesNIFDCIndustrial-Builder-posturehttps://insidebci.com/market/2026-07-03-gestala-china-ultrasound-bci-62m-angel-plus-shanghai-headquarters/https://insidebci.com/market/2026-07-03-gestala-china-ultrasound-bci-62m-angel-plus-shanghai-headquarters/Gestala (格式塔科技), a Chinese non-invasive ultrasound brain-computer interface company led by founder and CEO Phoenix Peng, announced on 3 July 2026 that it had closed a US$62 million Angel+ financing round and formally opened a Shanghai NeuroAI headquarters. The company is the third Chinese ultrasound BCI startup to disclose funding within ten days, alongside Sisen Technology (1 July 2026) and Huachao Shenkong.Fri, 03 Jul 2026 00:00:00 GMTmarketmarketChinaGestalaultrasound-BCIfunctional-ultrasoundPhoenix-PengPeng-LeiHuaying-CapitalFeng-JianfengTrevor-RobbinsBashar-BadranHuachao-ShenkongSisen-TechnologyIndustrial-Builder-postureShanghai-MinhangChengdu-Chantou-28https://insidebci.com/research/2026-07-02-farina-imperial-tsinghua-southeast-tactile-p300-supernumerary-bci-nature-communications/https://insidebci.com/research/2026-07-02-farina-imperial-tsinghua-southeast-tactile-p300-supernumerary-bci-nature-communications/Tianyu Jia and Dario Farina at Imperial College London, with collaborators at Tsinghua University and Southeast University Nanjing, published a Nature Communications paper on 2 July 2026 describing a tactile-encoded non-invasive BCI in which ten healthy participants controlled four supernumerary robotic degrees of freedom concurrently with a bimanual ball-balancing task, reaching 74.79 per cent single-task and 59.69 per cent dual-task online accuracy after three days of training.Thu, 02 Jul 2026 00:00:00 GMTresearchresearchImperial-College-LondonTsinghua-UniversitySoutheast-UniversityDario-FarinaTianyu-Jianon-invasive-BCIEEGsupernumerary-effectorstactile-P300augmentationhealthy-participantsNature-CommunicationsHybridNeurohttps://insidebci.com/market/2026-07-02-vivani-cortigent-clearone-reverse-merger-nasdaq-visual-cortical-prosthesis/https://insidebci.com/market/2026-07-02-vivani-cortigent-clearone-reverse-merger-nasdaq-visual-cortical-prosthesis/Vivani Medical announced on 2 July 2026 an all-stock reverse-merger agreement to combine its Cortigent subsidiary with Nasdaq-listed ClearOne, forming Cortigent Holdings, Inc. under the expected ticker CRGT. Vivani will hold between 59.4 and 67.5 per cent of the combined company; the deal requires a concurrent 10 to 15 million dollar registered offering and is targeted to close in the third quarter of 2026.Thu, 02 Jul 2026 00:00:00 GMTmarketmarketCortigentVivani-MedicalClearOnereverse-mergerNasdaqSecond-SightArgus-IIOrionvisual-cortical-prosthesisThinkEquityAdam-MendelsohnJonathan-Adamshttps://insidebci.com/market/2026-07-01-sisen-technology-tsinghua-eth-ultrasonic-bci-seed-round-glioblastoma/https://insidebci.com/market/2026-07-01-sisen-technology-tsinghua-eth-ultrasonic-bci-seed-round-glioblastoma/Sisen Technology, founded in December 2025 by Tsinghua and ETH Zurich alumni, raised tens of millions of yuan in seed funding co-led by Inno Angel Fund and Tsinghua Alumni Seed Fund, targeting glioblastoma blood-brain-barrier opening as its first indication.Wed, 01 Jul 2026 00:00:00 GMTmarketmarketChinaSisen-Technologyultrasonic-BCIglioblastomablood-brain-barrierTsinghua-UniversityETH-ZurichInno-Angel-FundTsinghua-Alumni-Seed-FundYan-YimoIndustrial-Builder-posturehttps://insidebci.com/research/2026-07-01-university-of-bath-du-bois-coyle-covert-consciousness-eeg-bci-nature-communications-medicine/https://insidebci.com/research/2026-07-01-university-of-bath-du-bois-coyle-covert-consciousness-eeg-bci-nature-communications-medicine/Naomi du Bois and Damien Coyle at the University of Bath and Ulster University published a Nature Communications Medicine paper on 17 April 2026, press-released by Bath on 30 June, showing a multi-session wearable EEG motor-imagery BCI lifted minimally-conscious-state detection from 39 to 69 per cent across 42 brain-injury patients.Wed, 01 Jul 2026 00:00:00 GMTresearchresearchUniversity-of-BathUlster-UniversityInstitute-for-the-Augmented-HumanNaomi-du-BoisDamien-Coylecovert-consciousnessdisorders-of-consciousnessEEG-BCImotor-imageryminimally-conscious-stateNature-Communications-MedicineNCT03827187https://insidebci.com/market/2026-06-30-aurenar-v-link-fda-breakthrough-cerebral-vasospasm-asah/https://insidebci.com/market/2026-06-30-aurenar-v-link-fda-breakthrough-cerebral-vasospasm-asah/Aurenar, a Washington University neurosurgery spinout led by Eric Leuthardt, received FDA Breakthrough Device Designation on 30 June 2026 for the V-Link System, a non-invasive transauricular vagus nerve stimulator targeting cerebral vasospasm in aneurysmal subarachnoid hemorrhage patients.Tue, 30 Jun 2026 00:00:00 GMTmarketmarketAurenarV-LinktaVNStransauricular-vagus-nerve-stimulationFDA-BreakthroughEric-LeuthardtWashUaneurysmal-subarachnoid-hemorrhagecerebral-vasospasmbioelectronic-medicinehttps://insidebci.com/research/2026-06-30-chalmers-valle-cortical-microstimulation-vision-touch-review-nature-bioengineering/https://insidebci.com/research/2026-06-30-chalmers-valle-cortical-microstimulation-vision-touch-review-nature-bioengineering/Giacomo Valle at Chalmers and co-authors from Pittsburgh, Amsterdam and Miguel Hernández University published a Nature Reviews Bioengineering paper on 1 June 2026 arguing that fifty years of parallel work on visual and somatosensory cortical microstimulation prostheses have converged into a single engineering discipline.Tue, 30 Jun 2026 00:00:00 GMTresearchresearchChalmersGiacomo-ValleNature-Reviews-Bioengineeringcortical-microstimulationvisual-prosthesissomatosensory-prosthesisICMSsense-restorationPieter-RoelfsemaEduardo-FernandezRobert-Gaunthttps://insidebci.com/market/2026-06-30-fluent-university-of-melbourne-sub-scalp-eeg-speech-decoding-seed-round/https://insidebci.com/market/2026-06-30-fluent-university-of-melbourne-sub-scalp-eeg-speech-decoding-seed-round/Fluent, a Melbourne biomedical engineering spinout founded in May 2025, has raised over two million dollars in seed capital to develop InScribe, a sub-scalp EEG device for speech decoding in patients with motor neurone disease and multiple sclerosis, with first-in-human surgery targeted for 2026.Tue, 30 Jun 2026 00:00:00 GMTmarketmarketAustraliaFluentInScribesub-scalp-EEGUniversity-of-MelbourneTim-MahoneyDavid-GraydenDean-FreestoneMNDMSspeech-decodinghttps://insidebci.com/research/2026-06-30-meta-brain2qwerty-v2-meg-non-invasive-brain-to-text-61-percent/https://insidebci.com/research/2026-06-30-meta-brain2qwerty-v2-meg-non-invasive-brain-to-text-61-percent/Meta AI released Brain2Qwerty v2 on 29 June 2026: a non-invasive system that decoded typed sentences from MEG brain signals at 61 per cent average word accuracy across nine healthy volunteers.Tue, 30 Jun 2026 00:00:00 GMTresearchresearchMeta-AIMeta-FAIRBrain2Qwertynon-invasive-BCIMEGJean-Remi-Kingbrain-to-textBCBLConformer-architecturehttps://insidebci.com/news/2026-06-28-aleph-neuro-butterfly-network-ultrasound-localization-microscopy-3d-human-brain/https://insidebci.com/news/2026-06-28-aleph-neuro-butterfly-network-ultrasound-localization-microscopy-3d-human-brain/San Francisco research lab Aleph Neuro published what it describes as the first 3D ultrasound localization microscopy (ULM) image of a living human brain through an intact skull on 24 June 2026, as a participant in Butterfly Network's Embedded licensing and co-development program.Sun, 28 Jun 2026 00:00:00 GMTnewsnewsAleph-NeuroButterfly-NetworkButterfly-EmbeddedUltrasound-on-Chipultrasound-localization-microscopyULMnon-invasive-BCIfunctional-ultrasoundmicrobubble-contrastSan-FranciscoJoseph-DeVivoJonathan-RothbergForest-NeurotechIconeushttps://insidebci.com/research/2026-06-28-stanford-deo-willett-henderson-mosaic-precentral-gyrus-bci-target-map/https://insidebci.com/research/2026-06-28-stanford-deo-willett-henderson-mosaic-precentral-gyrus-bci-target-map/A Stanford-led BrainGate study across eight paralysed participants and 20 microelectrode arrays, published in Nature on 17 June 2026, finds whole-body representation at every sampled location of the precentral gyrus.Sun, 28 Jun 2026 00:00:00 GMTresearchresearchStanford-NPTLBrainGate2precentral-gyrusmotor-cortexPenfield-homunculussingle-neuron-recordingspeech-BCIelectrode-placementimplantable-BCIhttps://insidebci.com/market/2026-06-28-ybrain-kosdaq-ipo-revival-ceragem-nh-investment-securities/https://insidebci.com/market/2026-06-28-ybrain-kosdaq-ipo-revival-ceragem-nh-investment-securities/Korean depression-tDCS device maker Ybrain has restarted its KOSDAQ IPO process in 2026, with Ceragem holding a 41.19 percent stake and NH Investment & Securities as lead bookrunner. Listing is targeted for early 2027.Sun, 28 Jun 2026 00:00:00 GMTmarketmarketSouth-KoreaYbrainKOSDAQCeragemNH-Investment-SecuritiesMINDD-STIMelectroceuticalK-MoonshotIndustrial-Builder-posturehttps://insidebci.com/policy/2026-06-26-guangdong-bci-action-plan-2026-2030-dual-core-guangzhou-shenzhen/https://insidebci.com/policy/2026-06-26-guangdong-bci-action-plan-2026-2030-dual-core-guangzhou-shenzhen/Guangzhou and Shenzhen will split the work of building China's most ambitious provincial brain-computer interface industry under a 'Dual-Core' Action Plan released 24 June 2026: 10 billion yuan core industry, 100 new enterprises, 200 BCI hospital wards by 2030.Fri, 26 Jun 2026 00:00:00 GMTpolicypolicyChinaGuangdongGuangzhouShenzhenBCI-Action-PlanDual-CorePazhou-LaboratoryZhujiang-HospitalIndustrial-Builder-postureprovincial-implementation100-new-enterprisesLi-YuanqingSeven-Ministry-OpinionsMIITNDRCnational-to-provincial-cascadehttps://insidebci.com/news/2026-06-25-activate-neuro-neurolife-battelle-spinout-2-9m-seed-stroke-rehabilitation/https://insidebci.com/news/2026-06-25-activate-neuro-neurolife-battelle-spinout-2-9m-seed-stroke-rehabilitation/ActivateNeuro launched on 25 June 2026 with $2.9M and a license to Battelle's non-invasive NeuroLife sleeve, an sEMG-driven FES wearable for stroke and spinal cord injury hand rehabilitation.Thu, 25 Jun 2026 00:00:00 GMTnewsnewsActivateNeuroNeuroLifeBattelleNeuroTech-Institutewearable-neurotechstroke-rehabilitationspinal-cord-injurysEMGFESJon-SnyderOhio-Statenon-invasivehttps://insidebci.com/policy/2026-06-25-china-vice-premier-liu-guozhong-nanjing-university-bci-research-institute/https://insidebci.com/policy/2026-06-25-china-vice-premier-liu-guozhong-nanjing-university-bci-research-institute/Vice Premier Liu Guozhong inspected the Brain-Computer Interface Research Institute at Nanjing University on 22-23 June 2026, naming BCI a 'key area of international industrial competition' per Xinhua and NJU.Thu, 25 Jun 2026 00:00:00 GMTpolicypolicyChinaLiu-GuozhongVice-PremierNanjing-UniversityNJUBrain-Computer-Interface-Research-InstituteHealthy-ChinaIndustrial-Builder-postureXinhuabiomedicine-pillar-industryZhang-Guoqinghttps://insidebci.com/news/2026-06-23-coherence-neuro-brain-tumor-implant-royal-melbourne-hospital-three-patients/https://insidebci.com/news/2026-06-23-coherence-neuro-brain-tumor-implant-royal-melbourne-hospital-three-patients/Coherence Neuro placed its cancer-targeting brain-computer interface in three patients for 30 minutes during brain tumor resection at Royal Melbourne Hospital, with a permanent-implant glioblastoma trial planned for 2027.Tue, 23 Jun 2026 00:00:00 GMTnewsnewsCoherence-Neurobrain-tumorglioblastomaRoyal-Melbourne-HospitalBCI-cancerNeuralink-tiesMatthew-MacDougallBen-WoodingtonOptuneelectroceuticalCIPHERfirst-in-humanhttps://insidebci.com/news/2026-06-23-neural-drive-singapore-sutd-startup-afore-capital-pre-seed/https://insidebci.com/news/2026-06-23-neural-drive-singapore-sutd-startup-afore-capital-pre-seed/Singapore's Neural Drive raised a US$250K pre-seed from Afore Capital for a non-invasive EEG/EOG wearable designed for paralysed users, per a Singapore University of Technology and Design release on 23 June 2026.Tue, 23 Jun 2026 00:00:00 GMTnewsnewsNeural-DriveSingaporeSUTDAfore-Capitalnon-invasive-BCIEEG-EOG-wearablepre-seedFounders-in-ResidenceTan-Tock-Seng-HospitalSoutheast-Asia-BCIhttps://insidebci.com/market/2026-06-22-neuracle-star-market-ipo-prospectus-accepted-brainco-race/https://insidebci.com/market/2026-06-22-neuracle-star-market-ipo-prospectus-accepted-brainco-race/Neuracle, maker of the world's first approved invasive BCI, had a RMB 2.5B Shanghai STAR Market IPO prospectus accepted on 11 June 2026, opening a two-horse race with BrainCo for first publicly listed pure-play BCI.Mon, 22 Jun 2026 00:00:00 GMTmarketmarketNeuracleBoruikangChinaSTAR-MarketShanghai-Stock-ExchangeIPOBrainCoCITIC-SecuritiesNEO-implantfirst-BCI-IPOTsinghua-spinouthttps://insidebci.com/policy/2026-06-21-connecticut-vermont-neural-data-privacy-1-july-five-states/https://insidebci.com/policy/2026-06-21-connecticut-vermont-neural-data-privacy-1-july-five-states/Connecticut's Public Act 25-113 (SB 1295), signed by Governor Ned Lamont on 25 June 2025, takes effect on 1 July 2026 and adds 'any information that is generated by measuring the activity of an individual's central nervous system' to the Connecticut Data Privacy Act's sensitive-data category. Vermont's Act 101 (H.814), which recognises neurological rights including mental and neural data privacy, took effect on signing on 18 May 2026. After 1 July, Colorado, California, Montana, Connecticut and Vermont will all have neural data law on the books. Of the four states that define neural data, Connecticut is the only one to limit the definition to the central nervous system.Sun, 21 Jun 2026 00:00:00 GMTpolicypolicyneural-data-privacyConnecticutVermontSB-1295H814CTDPAAct-101Public-Act-25-113state-patchworkUS-policysensitive-dataNed-LamontPhil-ScottJames-MaroneyBrian-Cinahttps://insidebci.com/market/2026-06-21-three-bci-industrial-policy-launches-china-south-korea-eight-weeks/https://insidebci.com/market/2026-06-21-three-bci-industrial-policy-launches-china-south-korea-eight-weeks/Between 1 May and 19 June 2026, three operational state-backed brain-computer interface moves landed across China and South Korea. China State Council Order No. 818 took effect on 1 May 2026, opening a parallel commercial pathway for advanced biomedical technologies that names BCI explicitly. Tianjin formally inaugurated a dedicated BCI industrial cluster with 100 million yuan in annual funding on 29 May 2026. South Korea launched its first national BCI industry association in Seoul on 16 June 2026, anchored to the K-Moonshot strategic R&D mission. Three dated, named, primary-sourced moves in eight weeks across two jurisdictions.Sun, 21 Jun 2026 00:00:00 GMTmarketmarketIndustrial-Builder-postureChinaSouth-KoreaOrder-818Tianjin-clusterKorean-BCI-AssociationK-MoonshotCho-Il-jooBaek-Nam-jongYbrainHaihe-Laboratoryindustrial-policyAsia-Pacifichttps://insidebci.com/market/2026-06-19-korea-bci-industry-association-launch-centerfield-baek-nam-jong/https://insidebci.com/market/2026-06-19-korea-bci-industry-association-launch-centerfield-baek-nam-jong/The Korean BCI Association (한국BCI협회) held its inaugural general meeting on Tuesday 16 June 2026 at Centerfield in Gangnam-gu, Seoul. Seoul National University Hospital President Baek Nam-jong was elected inaugural chair. Standing vice president is Kim Yong-jin, who chairs ISO/IEC JTC 1 SC 41 (Internet of Things and Digital Twin). Founding members include Ybrain, Dynamic Solution, Vibatrobotics, Ceragem on the industry side; Seoul National University Hospital, Severance Hospital and Korea University Anam Hospital on the medical side; and KAIST, DGIST, UNIST, Korea University, Catholic Kwandong University, Yonsei University and Hanyang University on the academic side. The association states it will actively support the K-Moonshot strategic R&D programme that launched in March 2026 with 12 missions, including a BCI mission led by Korea University Professor Cho Il-joo.Fri, 19 Jun 2026 00:00:00 GMTmarketmarketSouth-KoreaKorean-BCI-AssociationK-MoonshotBaek-Nam-jongCho-Il-jooYbrainSeoul-National-University-HospitalISO-IEC-JTC-1-SC-41Kim-Yong-jinindustrial-policyIndustrial-Builder-posturehttps://insidebci.com/news/2026-06-17-paradromics-first-connexus-bci-implant-michigan-connect-one/https://insidebci.com/news/2026-06-17-paradromics-first-connexus-bci-implant-michigan-connect-one/Paradromics announced on 17 June 2026 that University of Michigan surgeons have implanted its Connexus brain-computer interface in a woman with motor neuron disease, the first patient in the FDA-approved Connect-One early feasibility study. She will be followed for six years.Wed, 17 Jun 2026 00:00:00 GMTnewsnewsbrain-computer-interfaceBCIParadromicsConnexusConnect-OneUniversity-of-MichiganUC-DavisMass-GeneralFDA-IDEmotor-neuron-diseaseALSMatt-AngleDavid-BrandmanMatthew-WillseyAustin-Texashttps://insidebci.com/market/2026-06-17-tianjin-bci-industrial-cluster-100-million-yuan-china/https://insidebci.com/market/2026-06-17-tianjin-bci-industrial-cluster-100-million-yuan-china/Per China Daily, the city of Tianjin formally inaugurated a dedicated BCI industrial cluster at the 2026 World Intelligence Expo, with 100 million yuan (about $14.8M) annual funding committed, 22 BCI companies already incubated in the zone, and a target of 50 enterprises by 2027.Wed, 17 Jun 2026 00:00:00 GMTmarketmarketChinaTianjinBCI-industrial-clusterHaihe-LaboratoryWorld-Intelligence-Expo-2026Tianjin-Brain-Computer-Interface-Industry-GroupTianjin-Huanhu-Hospitalindustrial-policyChina-BCI-cohortcommercial-scale-upnon-invasive-BCIhttps://insidebci.com/market/2026-06-17-wise-series-d-30-million-euro-spinal-cord-stimulation-italy/https://insidebci.com/market/2026-06-17-wise-series-d-30-million-euro-spinal-cord-stimulation-italy/WISE S.p.A., an Italian implantable-electrode company working in neuromonitoring, neuromodulation and BCI, closed an oversubscribed €30 million ($34.8M) Series D on 17 June 2026. The lead application is the company's Heron percutaneous spinal cord stimulation lead.Wed, 17 Jun 2026 00:00:00 GMTmarketmarketfundingWISEENEA-Techspinal-cord-stimulationSCSneuromodulationneuromonitoringbioelectronic-medicineHeron-leadItalySupersonic-Technologyimplantable-electrodeshttps://insidebci.com/research/2026-06-16-als-power-user-brain-implant-home-3800-hours-ucdavis/https://insidebci.com/research/2026-06-16-als-power-user-brain-implant-home-3800-hours-ucdavis/Casey Harrell, who has ALS, used a UC Davis intracortical speech BCI at home for more than 3,800 hours over 22 months without researchers present. Nature Medicine published the case on 15 June 2026.Tue, 16 Jun 2026 00:00:00 GMTresearchresearchbrain-computer-interfaceBCIintracortical-BCIspeech-BCIALSCasey-HarrellUC-Davis-Neuroprosthetics-LabDavid-BrandmanSergey-StaviskyNicholas-CardNature-MedicineBrainGate2https://insidebci.com/research/2026-06-11-yale-bci-manifold-geometry-cuts-training-time/https://insidebci.com/research/2026-06-11-yale-bci-manifold-geometry-cuts-training-time/Yale's Nature Neuroscience study reports that healthy participants learned to control a video game avatar in under an hour when the fMRI decoder followed each user's individual neural manifold. Off-manifold mappings produced no learning at all.Thu, 11 Jun 2026 00:00:00 GMTresearchresearchbrain-computer-interfaceBCIfMRIneural-manifoldT-PHATEYale-UniversityNature-Neurosciencedecoder-designBCI-trainingErica-BuschSmita-KrishnaswamyNick-Turk-Brownehttps://insidebci.com/opinion/2026-06-07-bezos-multiple-layers-neurotech-only-tech-billionaire-velco-dar/https://insidebci.com/opinion/2026-06-07-bezos-multiple-layers-neurotech-only-tech-billionaire-velco-dar/In June 2026 Bezos's capital crossed into brain-inspired AI (Flourish, close to $100M at $2.5B) and basic neuroscience (Allen Institute family gift, $100M). With Bezos Expeditions in Synchron, no other tech billionaire spans this many neurotech layers.Sun, 07 Jun 2026 00:00:00 GMTopinionopinionbezos-familybezos-expeditionssynchronflourishallen-institute-brain-healthus-neurotech-capital-structurethomas-reardontech-billionaire-neurotechconcentration-riskdargentic-intelligencehttps://insidebci.com/market/2026-06-06-flourish-bezos-100m-reardon-brain-inspired-ai-500m-2-5b-valuation/https://insidebci.com/market/2026-06-06-flourish-bezos-100m-reardon-brain-inspired-ai-500m-2-5b-valuation/Flourish, a New York neuro-AI startup founded in 2024 by Thomas Reardon (Internet Explorer architect at Microsoft in 1994 and CTRL-labs co-founder who sold the company to Meta in 2019 for between $500 million and $1 billion) and former Amazon S-team executive Rob Williams, closed a $500 million round at a $2.5 billion valuation around 4 June 2026. Jeff Bezos contributed close to $100 million after nearly doubling an initial $50 million commitment. Other investors include Lux Capital, GV (Alphabet), and Catalio Capital. The company is building Cortex AI, an architecture-layer system that uses connectomics, the cell-by-cell mapping of biological neural connections, to design AI models that target 20-50 watts of energy draw, roughly the power consumption of a laptop and an order of magnitude lower than a server-grade GPU. Flourish has no product yet.Sat, 06 Jun 2026 00:00:00 GMTmarketmarketflourishthomas-reardonjeff-bezosctrl-labs-lineageconnectomicsbrain-inspired-ailux-capitalgvcatalio-capitalcortex-aiai-efficiencyhttps://insidebci.com/news/2026-06-06-neuronoff-first-patient-dod-trial-injectrode-neurogenic-bladder-sci/https://insidebci.com/news/2026-06-06-neuronoff-first-patient-dod-trial-injectrode-neurogenic-bladder-sci/Neuronoff announced on 5 June 2026 that it has implanted the first patient in a US Department of Defense-funded clinical trial of its Injectrode, a helical platinum-iridium peripheral nerve electrode delivered through a single 18-gauge needle under local anaesthesia, in patients with neurogenic bladder dysfunction following spinal cord injury. The trial (NCT07264868) is being run at UT Health Houston under principal investigator Dr Argyrios Stampas, Associate Professor and Vice Chair of Research and Innovation in the Department of Physical Medicine and Rehabilitation at McGovern Medical School. It is a Phase 1/2 randomised controlled study enrolling 21 participants across three arms (unilateral active stimulation, bilateral active stimulation, sham), with primary endpoints at 4 and 8 weeks assessing safety, stimulation accuracy, procedural feasibility, and physician and patient acceptability. This is the first-in-human spinal cord injury trial of the Injectrode.Sat, 06 Jun 2026 00:00:00 GMTnewsnewsneuronoffinjectrodeneurogenic-bladderspinal-cord-injuryus-dod-funded-trialut-health-houstonargyrios-stampasphase-1-2-trialperipheral-nerve-stimulationbioelectronic-medicinehttps://insidebci.com/market/2026-06-05-allen-institute-brain-health-accelerator-400m-bezos-aws-als/https://insidebci.com/market/2026-06-05-allen-institute-brain-health-accelerator-400m-bezos-aws-als/The Allen Institute announced on 2 June 2026 a $400 million global research initiative called the Brain Health accelerator, targeting neurodegenerative disease at the cell and circuit level. Capital is $200 million from the Allen Institute, $100 million from the Bezos family (whose Bezos Expeditions arm backs Synchron), and $100 million combined from AWS, NIH, and ALS advocacy organisation EverythingALS. The ALS focus is the most direct adjacency to the implantable BCI cohort, which has anchored most of its early commercial work on ALS patients.Fri, 05 Jun 2026 00:00:00 GMTmarketmarketallen-institutebrain-health-acceleratorbezos-familyawseverythingalsneurodegenerationals-researchnih-brain-initiativerui-costaed-leinphilanthropic-neurosciencehttps://insidebci.com/news/2026-06-03-cea-leti-bci4stroke-wimagine-post-stroke-rehabilitation/https://insidebci.com/news/2026-06-03-cea-leti-bci4stroke-wimagine-post-stroke-rehabilitation/France's CEA-Leti announced on 3 June 2026 that it has applied for regulatory authorization to begin BCI4Stroke, a brain-computer interface clinical trial extending the WIMAGINE epidural implant platform into post-stroke rehabilitation. The trial is registered on ClinicalTrials.gov as NCT07477613. WIMAGINE is the same platform that produced the 2019 tetraplegic exoskeleton walking demonstration (Benabid et al., Lancet Neurology) and the 2023 brain-spine interface paralysed-man-walks result with Gert-Jan Oskam (Lorach et al., Nature, the Courtine and Bloch programme). BrainSync is funded under France's €40 million Audace! research programme (France 2030) and the European Innovation Council under Horizon Europe.Wed, 03 Jun 2026 00:00:00 GMTnewsnewscea-letiwimaginebrainsyncbci4strokepost-stroke-rehabilitationfrance-2030audace-programmeolivier-detantelucas-struberserpil-karakasclinateceuropean-bcihorizon-europehttps://insidebci.com/policy/2026-06-03-neuralink-first-federal-lobbyists-kimbell-arnold-porter-ron-kind-medicare-coverage/https://insidebci.com/policy/2026-06-03-neuralink-first-federal-lobbyists-kimbell-arnold-porter-ron-kind-medicare-coverage/Newly filed federal disclosures show that Neuralink has engaged Jeffrey J. Kimbell & Associates and Arnold & Porter Kaye Scholer as its first registered federal lobbyists, with both firms beginning work at the end of April 2026. The scope explicitly names brain-computer interface development and commercialisation plus 'coverage of such devices' as the lobbying focus. The team on the Arnold & Porter side includes former 13-term Wisconsin Democratic Rep. Ron Kind, Senior Counsel at the firm since January 2024 and a former House Ways and Means Committee member overseeing Medicare payment programs. The hire is the first publicly visible step Neuralink has taken toward US Medicare reimbursement positioning for the N1 implant.Wed, 03 Jun 2026 00:00:00 GMTpolicypolicyneuralinkfederal-lobbyingron-kindkimbell-associatesarnold-portermedicare-coveragebci-reimbursementn1-implanthouse-ways-and-meansus-policyhttps://insidebci.com/news/2026-05-31-eoin-egan-irish-neuralink-gb-prime-thought-controlled-wheelchair/https://insidebci.com/news/2026-05-31-eoin-egan-irish-neuralink-gb-prime-thought-controlled-wheelchair/Eoin Egan, a 43-year-old Roscommon-born architect and property consultant living in London with motor neurone disease, has gone public as one of seven UK participants in Neuralink's GB-PRIME early feasibility study. Egan received his N1 Implant in December 2025 at UCLH's National Hospital for Neurology and Neurosurgery (Queen Square) in a six-hour robot-performed operation. Four days post-surgery he was driving his wheelchair through a London park with his thoughts alone, using bespoke software built by German assistive technology firm Homebrace that links the BCI cursor to wheelchair steering. He is the third UK GB-PRIME participant to surface publicly, after Paul (October 2025, also MND) and Sebastian Gomez (medical student paralysed in a diving accident).Sun, 31 May 2026 00:00:00 GMTnewsnewsneuralinkgb-primeuclhqueen-squareharith-akramwilliam-muirheadmotor-neurone-diseasethought-controlled-wheelchairhomebraceuk-bcieoin-eganhttps://insidebci.com/market/2026-05-29-omniscient-27m-series-d-connectomics-bci-expansion/https://insidebci.com/market/2026-05-29-omniscient-27m-series-d-connectomics-bci-expansion/Sydney and San Francisco-based Omniscient Neurotechnology closed a $27.2 million (AU$41.1 million) Series D funding round on 29 May 2026, co-led by OIF Ventures and the Australian National Reconstruction Fund Corporation. The capital scales the company's FDA-cleared Quicktome connectomics platform for neurosurgical planning, with the company explicitly naming brain-computer interface, stroke, and movement disorders as the next expansion indications. Omniscient is a connectomics company rather than a BCI implant company; the BCI angle is forward-looking adjacency rather than current product.Fri, 29 May 2026 00:00:00 GMTmarketmarketomniscient-neurotechnologyquicktomeconnectomicsbrain-mappingseries-doif-venturesaustralian-national-reconstruction-fundstephen-scheelerbci-adjacencyhttps://insidebci.com/news/2026-05-29-rice-baylor-join-braingate-sixth-team-texas-first/https://insidebci.com/news/2026-05-29-rice-baylor-join-braingate-sixth-team-texas-first/Rice University and Baylor College of Medicine announced on 28 May 2026 that they have joined the BrainGate research consortium, the multi-institutional clinical brain-computer interface network founded by John Donoghue at Brown University. The Texas team is the sixth in the consortium and the first based outside the eastern and western US clusters. The Rice-Baylor work focuses on decoding cortical neural signals to operate assistive robotic devices that help people with tetraplegia eat and drink independently. The expansion lands the same week Donoghue was named a 2026 Queen Elizabeth Prize for Engineering co-laureate for his BrainGate-anchored work.Fri, 29 May 2026 00:00:00 GMTnewsnewsbraingaterice-universitybaylor-college-of-medicinenishal-shahsameer-shethnicole-provenzaleigh-hochbergtexas-bci-clustertetraplegiaassistive-roboticsintracortical-bcihttps://insidebci.com/market/2026-05-29-tencent-takes-stake-nanochap-bci-chip-hangzhou/https://insidebci.com/market/2026-05-29-tencent-takes-stake-nanochap-bci-chip-hangzhou/Tencent Holdings has acquired a minority equity stake in Nanochap Electronics, a Hangzhou-based fabless semiconductor company specialising in neural interface and biosensing SoCs for brain-computer interface and medical device applications. The investment was disclosed through a 28 May 2026 business registration filing showing Shanghai Qishan Investment, a Tencent subsidiary, added as a new shareholder. Nanochap's registered capital increased to RMB 16.8853 million. Exact stake size and investment amount have not been publicly disclosed. The move follows the April 2026 StairMed funding round in which Alibaba led and Tencent joined, and signals a sustained pattern of Chinese big-tech equity participation in the country's BCI silicon supply chain.Fri, 29 May 2026 00:00:00 GMTmarketmarkettencentnanochap-electronicschina-bcihangzhoubci-supply-chainneural-interface-chipsshanghai-qishan-investmentfabless-semiconductorchinese-big-tech-bcihttps://insidebci.com/news/2026-05-28-neuroxess-mandarin-bci-300-cpm-llm-decoder/https://insidebci.com/news/2026-05-28-neuroxess-mandarin-bci-300-cpm-llm-decoder/Shanghai-based NeuroXess says a 35-year-old woman with epilepsy fitted with its 256-channel surface-cortex implant has been decoded reading Mandarin at 300 characters per minute through a large language model layer, faster than the roughly 220 cpm rate of a native Mandarin first-language speaker. Co-founder and chief scientist Tiger Tao disclosed the figure to Nature on 19 May 2026. The underlying paper has not yet been published, but the result sits on top of NeuroXess's already peer-reviewed Science Advances paper from 5 November 2025 (71.2% accuracy across 394 Mandarin syllables in a 43-year-old woman with epilepsy).Thu, 28 May 2026 00:00:00 GMTnewsnewsneuroxesschina-bcimandarin-decodingtiger-taohuashan-hospitalshanghaillm-bciai-decoderspinal-cord-injuryepilepsyimplantable-bciscience-advanceshttps://insidebci.com/news/2026-05-27-ability-neurotech-imdd-approval-first-chronic-bci-als-utrecht/https://insidebci.com/news/2026-05-27-ability-neurotech-imdd-approval-first-chronic-bci-als-utrecht/ABILITY Neurotech, the Geneva-based Wyss Center spinout building Europe's first fully implantable wireless optical-link ECoG brain-computer interface, received Investigational Medical Device Dossier (IMDD) approval from MREC NedMec in the Netherlands on 26 May 2026 to begin the first chronic implantation study of its device in ALS patients at UMC Utrecht under the INTRECOM consortium.Wed, 27 May 2026 00:00:00 GMTnewsnewsability-neurotechwyss-centerumc-utrechtintrecom-consortiumalsecog-bcifully-implantable-bcioptical-linkrotem-kopelmariska-vansteenseleuropean-bcihttps://insidebci.com/market/2026-05-27-onward-medical-q1-2026-results-arc-bci-seven-implants-empower-bp/https://insidebci.com/market/2026-05-27-onward-medical-q1-2026-results-arc-bci-seven-implants-empower-bp/ONWARD Medical reported Q1 2026 results on 26 May 2026 with EUR 2.0 million in revenue (EUR 1.3 million ARC-EX systems across 100+ clinics, 70 systems supplied including first home-use shipments to US VA patients), two additional ARC-BCI participants bringing the total to seven, and first participant enrolled plus first implant in the Empower BP pivotal study at Craig Hospital, Denver. The company holds EUR 53.4 million in cash before adding over EUR 40 million from the April equity raise, extending runway into Q1 2028.Wed, 27 May 2026 00:00:00 GMTmarketmarketonward-medicalarc-bciarc-exempower-bpcraig-hospitalspinal-cord-injuryearningsbrain-spine-interfaceeuronext-onwdhttps://insidebci.com/news/2026-05-27-revision-implant-4-million-seed-occular-cortical-vision-prosthesis/https://insidebci.com/news/2026-05-27-revision-implant-4-million-seed-occular-cortical-vision-prosthesis/Belgian neurotech ReVision Implant closed an oversubscribed €4 million seed round in May 2026 to bring manufacturing of its Occular cortical vision prosthesis in-house ahead of a first-in-human trial cleared for Q3 2026 (October surgical-window cohort), with broader early-stage trials in blind volunteers expected in summer 2027. The round follows FDA Breakthrough Device Designation granted in March 2026.Wed, 27 May 2026 00:00:00 GMTnewsnewsrevision-implantoccularvision-restorationcortical-visual-prosthesisbelgium-neurotechseed-fundingfda-breakthrough-deviceumc-utrechthttps://insidebci.com/market/2026-05-26-epfl-lausanne-geneva-neurotechnology-cluster-campus-biotech/https://insidebci.com/market/2026-05-26-epfl-lausanne-geneva-neurotechnology-cluster-campus-biotech/The Friday $7.5 million seed round for Neurosoft Bioelectronics is the latest commercial output from a Lausanne-Geneva neurotechnology cluster anchored on EPFL's Neuro-X Institute at Campus Biotech Geneva. The same cluster has produced ONWARD Medical (now NASDAQ-listed brain-spine interface company), MindMaze (Lausanne-founded brain-technology unicorn), and the academic research that China's brain-spine clinical programmes are now structurally copying.Tue, 26 May 2026 00:00:00 GMTmarketmarketepflneuro-x-institutecampus-biotech-genevaneurosoft-bioelectronicsonward-medicalmindmazestephanie-lacourgregoire-courtinesilvestro-miceradiego-ghezziwyss-centereuropean-neurotechlausanne-clusterhttps://insidebci.com/market/2026-05-26-inspire-medical-2026-guidance-cut-wiser-bofa-downgrade/https://insidebci.com/market/2026-05-26-inspire-medical-2026-guidance-cut-wiser-bofa-downgrade/Inspire Medical Systems reported Q1 2026 revenue of $204.6 million (up 1.6% year-on-year) on 4 May 2026 and cut full-year 2026 guidance to $825-875 million from the prior $950 million-$1 billion range issued in February. The company attributed approximately $20 million of Q1 impact to CMS WISeR prior authorization and CPT code transition uncertainty. Bank of America analyst Travis Steed downgraded the stock from Neutral to Underperform.Tue, 26 May 2026 00:00:00 GMTmarketmarketinspire-medicalwisercmscpt-code-64582hypoglossal-nerve-stimulationsleep-apneabofa-downgradetravis-steedneuromodulation-bifurcationhttps://insidebci.com/research/2026-05-26-rockefeller-ventral-premotor-cortex-abstract-thought-bci-decoding/https://insidebci.com/research/2026-05-26-rockefeller-ventral-premotor-cortex-abstract-thought-bci-decoding/Researchers at Rockefeller University's Laboratory of Neural Systems published evidence in Nature that the ventral premotor cortex hosts the neural substrates of abstract symbolic thought, identifying a brain region that mediates between the higher-thinking prefrontal cortex and the action-executing motor cortex. The finding has direct implications for BCI decoding targets: implants placed at the ventral premotor cortex could potentially decode user intent at a higher level of abstraction than current motor-cortex BCIs.Tue, 26 May 2026 00:00:00 GMTresearchresearchventral-premotor-cortexabstract-thoughtrockefeller-universitylaboratory-of-neural-systemscompositional-generalizationnaturebci-decoding-targetscognitive-neurosciencehttps://insidebci.com/policy/2026-05-26-tom-oxley-synchron-chalmers-cgt-australian-founder-pushback/https://insidebci.com/policy/2026-05-26-tom-oxley-synchron-chalmers-cgt-australian-founder-pushback/Synchron co-founder and CEO Tom Oxley publicly criticised Treasurer Jim Chalmers's proposed capital gains tax changes in The Australian on 25 May 2026, joining a growing Australian founder coalition arguing the 2026-27 federal budget reforms would push tech talent and startup equity offshore. The Chalmers budget, handed down 12 May 2026, proposes removing the 50% CGT discount from 1 July 2027 and replacing it with cost-based indexation plus a 30% minimum tax on net capital gains.Tue, 26 May 2026 00:00:00 GMTpolicypolicytom-oxleysynchronaustraliacapital-gains-taxjim-chalmersaustralian-tech-policystartup-equitynational-reconstruction-fundanthony-albanesehttps://insidebci.com/research/2026-05-24-china-beinao-1-brain-spine-joint-interface-paraplegic-recovery/https://insidebci.com/research/2026-05-24-china-beinao-1-brain-spine-joint-interface-paraplegic-recovery/A paraplegic patient who in May 2025 became the world's first to simultaneously receive the invasive Beinao No.1 brain-computer interface and a temporally programmed spinal cord stimulation system has improved from complete to incomplete spinal cord injury (ASIA Grade A to ASIA Grade C) after one year of staged rehabilitation, the Xuanwu Hospital Capital Medical University team disclosed on 22 May 2026.Sun, 24 May 2026 00:00:00 GMTresearchresearchbeinao-1brain-spine-interfacespinal-cord-injuryxuanwu-hospitalcapital-medical-universityepidural-spinal-stimulationneuroprostheticsasia-impairment-scalechina-clinical-bcionward-medical-comparatorhttps://insidebci.com/news/2026-05-22-neuralink-r1-surgical-robot-any-brain-region-parkinsons-epilepsy-depression/https://insidebci.com/news/2026-05-22-neuralink-r1-surgical-robot-any-brain-region-parkinsons-epilepsy-depression/Neuralink disclosed on 7 May 2026 that its next-generation R1 surgical robot can place electrode threads into virtually any region of the human brain, threading through the dura mater with real-time motion compensation and a suite of eight optical coherence tomography cameras. The scope expansion opens Parkinson's disease, refractory epilepsy, and treatment-resistant depression as new target indications beyond motor-function restoration.Fri, 22 May 2026 00:00:00 GMTnewsnewsneuralinkr1-surgical-robotparkinsonsrefractory-epilepsytreatment-resistant-depressiondura-materoptical-coherence-tomographysubcortical-bciaudrey-crewsmusk-industrial-scalehttps://insidebci.com/news/2026-05-22-neurosoft-bioelectronics-skybound-7-5-million-seed/https://insidebci.com/news/2026-05-22-neurosoft-bioelectronics-skybound-7-5-million-seed/Neurosoft Bioelectronics closed a $7.5 million oversubscribed seed round on 20 May 2026, led by Skybound Venture Capital and joined by PL Capital, IAG Capital Partners, and Connecticut Innovations. The round brings Neurosoft's total funding past $20 million and is the inaugural investment from Skybound, a new Athens-based deeptech fund publicly launched the same week with a $38 million first close anchored by the European Investment Fund.Fri, 22 May 2026 00:00:00 GMTnewsnewsneurosoft-bioelectronicsskybound-venture-capitaleuropean-investment-fundsoft-electrodesstretchable-electrodesbci-seed-fundinglausanneuthealth-houstonumc-utrechtepilepsy-surgery-guidancethaleia-misailidougeorge-varvarelishttps://insidebci.com/policy/2026-05-22-nih-brain-initiative-roadmap-four-innovation-domains-neuroai/https://insidebci.com/policy/2026-05-22-nih-brain-initiative-roadmap-four-innovation-domains-neuroai/NIH BRAIN Initiative Director John Ngai and Acting NINDS Director Amy Bany Adams jointly announced the formal publication of the BRAIN Initiative's 10-year Neuroscience Research Roadmap on 15 May 2026, with a Director's Message and a paper in Neuron. The roadmap, finalised in August 2025, organises the next decade of US federally-funded neuroscience around four Innovation Domains: BRAIN Knowledgebase, Precision Molecular Circuit Therapies, Accelerating Human Neuroscience, and BRAIN NeuroAI.Fri, 22 May 2026 00:00:00 GMTpolicypolicynih-brain-initiativeneuroscience-research-roadmapnindsjohn-ngaiamy-bany-adamsneuroaibrain-knowledgebaseprecision-molecular-circuit-therapiesaccelerating-human-neurosciencefederal-research-policyus-bci-policyhttps://insidebci.com/market/2026-05-21-medtronic-spr-therapeutics-650-million-acquisition-pns-consolidation/https://insidebci.com/market/2026-05-21-medtronic-spr-therapeutics-650-million-acquisition-pns-consolidation/Medtronic announced on 20 May 2026 its intent to acquire SPR Therapeutics, the maker of the Sprint percutaneous peripheral nerve stimulation system, for approximately $650 million in upfront cash. The deal is the second top-three neuromodulation acquisition of a PNS specialist in seven months, after Boston Scientific completed its $533 million purchase of Nalu Medical in January 2026.Thu, 21 May 2026 00:00:00 GMTmarketmarketmedtronicspr-therapeuticssprint-pnsperipheral-nerve-stimulationchronic-painm-and-abioelectronic-medicineboston-scientific-naluneuromodulation-consolidationhttps://insidebci.com/policy/2026-05-21-vermont-h814-signed-fifth-state-neural-rights/https://insidebci.com/policy/2026-05-21-vermont-h814-signed-fifth-state-neural-rights/Governor Phil Scott signed H.814 into law on 18 May 2026, making Vermont the fifth US state with neural data privacy legislation on the books after Colorado, California, Montana, and Connecticut. The enacted text is the 6-page version that passed the House after the 27-page original was cut down in the House; the consent requirement and private right of action did not survive that cut. The act took effect on signing.Thu, 21 May 2026 00:00:00 GMTpolicypolicyvermonth-814phil-scottneural-rightsneural-data-privacystate-patchworkneurorights-foundationrafael-yustecoloradocaliforniamontanaconnecticutmind-acthttps://insidebci.com/market/2026-05-20-bluewind-medical-revi-47-million-tibial-neuromodulation-oab/https://insidebci.com/market/2026-05-20-bluewind-medical-revi-47-million-tibial-neuromodulation-oab/BlueWind Medical closed $47.8 million in combined equity and debt financing on 14 May 2026 to scale US commercialisation of Revi, the only FDA-cleared implantable tibial neuromodulation device for urgency urinary incontinence. The round follows three-year OASIS pivotal trial data and Medtronic's September 2025 FDA approval of its competing Altaviva tibial system.Wed, 20 May 2026 00:00:00 GMTmarketmarketbluewind-medicalreviimplantable-tibial-neuromodulationoveractive-bladderurgency-urinary-incontinenceoasis-trialbioelectronic-medicinemedtronic-altavivasacral-neuromodulationboston-scientific-axonicshttps://insidebci.com/market/2026-05-20-mobia-medical-150-million-ipo-falls-week-one/https://insidebci.com/market/2026-05-20-mobia-medical-150-million-ipo-falls-week-one/Mobia Medical, the company behind the only FDA-approved implanted vagus nerve stimulator for chronic stroke recovery, priced its $150 million IPO at $15 on 7 May 2026 and closed week one at $11.75. The print resets implied exit math for the pre-IPO bioelectronic-medicine cohort preparing 2026-27 listings.Wed, 20 May 2026 00:00:00 GMTmarketmarketmobia-medicalmicrotranspondervivistimvagus-nerve-stimulationstroke-recoveryipobioelectronic-medicinecapital-marketsnasdaq-mobihttps://insidebci.com/market/2026-05-19-mintneuro-motif-silicon-supply-bci-supply-chain-splits/https://insidebci.com/market/2026-05-19-mintneuro-motif-silicon-supply-bci-supply-chain-splits/Imperial College London spinout MintNeuro signed a multi-year commercial supply agreement on 6 May 2026 to provide its miniaturised sensing and stimulation integrated circuits to Motif Neurotech's DOT depression implant across pre-clinical, early clinical, and pivotal trial phases. The deal lands two weeks after Motif's FDA Investigational Device Exemption clearance.Tue, 19 May 2026 00:00:00 GMTmarketmarketmintneuromotif-neurotechdot-implantsupply-chainneural-interface-chipsbci-silicontreatment-resistant-depressionbrain-meshimperial-college-londonrice-universityhttps://insidebci.com/market/2026-05-18-neuropace-q1-2026-nautilus-77-percent-seizure-reduction/https://insidebci.com/market/2026-05-18-neuropace-q1-2026-nautilus-77-percent-seizure-reduction/NeuroPace reported Q1 2026 RNS System revenue of $21.7 million (up 19.5% year-on-year), raised full-year guidance to $99-101 million, and detailed 18-month NAUTILUS trial data showing a 77% median reduction in generalised tonic-clonic seizures. FDA paused the 180-day clock on the expanded-indication review; midyear determination still anticipated.Mon, 18 May 2026 00:00:00 GMTmarketmarketneuropacerns-systemnautilusidiopathic-generalised-epilepsyfda-pmaearningsclosed-loop-neuromodulationwisercmsjoel-beckerhttps://insidebci.com/news/2026-05-17-rush-third-icvp-implant-vision-restoration-four-platform-field/https://insidebci.com/news/2026-05-17-rush-third-icvp-implant-vision-restoration-four-platform-field/Illinois Institute of Technology and Rush University Medical Center completed the third implantation of the Intracortical Visual Prosthesis on 7 May 2026, a 34-stimulator, 544-electrode wireless system bypassing the eye and optic nerve to deliver artificial sight directly to the visual cortex.Sun, 17 May 2026 00:00:00 GMTnewsnewsvision-restorationicvpintracortical-visual-prosthesisillinois-institute-of-technologyrush-universityphilip-troykchicago-lighthousecortical-visual-prosthesisneuralink-blindsightrevision-implantscience-corporation-primahttps://insidebci.com/market/2026-05-16-cvrx-humana-medicare-advantage-barostim-coverage/https://insidebci.com/market/2026-05-16-cvrx-humana-medicare-advantage-barostim-coverage/Humana issues the first Medicare Advantage coverage policy for CVRx's Barostim baroreflex neuromodulation therapy effective 1 May 2026, the fourth 2026 reimbursement and trial milestone for the bioelectronic heart-failure category.Sat, 16 May 2026 00:00:00 GMTmarketmarketbioelectronic-medicinecvrxbarostimhumanamedicare-advantageheart-failurebaroreflex-neuromodulationreimbursementbenefit-hfhttps://insidebci.com/market/2026-05-14-nicholas-opie-joins-control-bionics-board/https://insidebci.com/market/2026-05-14-nicholas-opie-joins-control-bionics-board/Opie joins ASX-listed Australian assistive-tech company Control Bionics as Non-Executive Director and strategic advisor, with 1.25 million options vesting over four years pending shareholder approval at the 2026 AGM.Thu, 14 May 2026 00:00:00 GMTmarketmarketexecutive-movementnicholas-opiecontrol-bionicssynchronultra-bionicsaustraliaassistive-technologyboard-appointmenthttps://insidebci.com/research/2026-05-12-columbia-zuckerman-brain-controlled-selective-hearing-first-human-study/https://insidebci.com/research/2026-05-12-columbia-zuckerman-brain-controlled-selective-hearing-first-human-study/Columbia's Zuckerman Institute and collaborators at UCSF, NYU and Northwell Health published the first real-time human-study evidence that an auditory attention decoding BCI can isolate a single speaker in a multi-talker environment.Tue, 12 May 2026 00:00:00 GMTresearchresearchauditory-attention-decodingaadbrain-controlled-hearingcolumbia-zuckerman-institutemesgaraniedward-changconsumer-audiointracranial-eeghttps://insidebci.com/market/2026-05-10-thailand-becomes-southeast-asia-bci-hub-cp-group-axoft-oymotion/https://insidebci.com/market/2026-05-10-thailand-becomes-southeast-asia-bci-hub-cp-group-axoft-oymotion/C.P. Group Innovation led Axoft's $55 million Series A on 29 April 2026. One day earlier, C.P. Group subsidiary True Corporation announced a clinical pilot partnership with Shanghai-based OYMotion. The Thai conglomerate is now operating across both Western and Chinese BCI capability through different mechanisms.Sun, 10 May 2026 00:00:00 GMTmarketmarketthailandchina-bcicp-groupcp-group-innovationtrue-corporationoymotionaxoftsoutheast-asiaindustrial-builderneuro-rehabilitationhttps://insidebci.com/policy/2026-05-08-china-order-818-bci-parallel-commercial-pathway/https://insidebci.com/policy/2026-05-08-china-order-818-bci-parallel-commercial-pathway/The State Council's biomedical-new-technologies regulation took effect 1 May 2026, letting Chinese hospitals charge for BCI commercially after a translation approval. Foreign-invested enterprises remain locked out.Fri, 08 May 2026 00:00:00 GMTpolicyregulationchinaorder-818nmpanhcindustrial-builderneuraclecommercial-pathwayhttps://insidebci.com/policy/2026-05-08-cms-wiser-bifurcates-neuromodulation-inspire-neuropace/https://insidebci.com/policy/2026-05-08-cms-wiser-bifurcates-neuromodulation-inspire-neuropace/Inspire's Q1 2026 print attributes a combined $120 to $150 million FY26 hit to WISeR plus coding uncertainty, six sell-side analysts cut targets through 7 May, and NeuroPace just received a 43% to 47% Medicare reimbursement increase on the same rule cycle.Fri, 08 May 2026 00:00:00 GMTpolicyregulationcmswisermedicareneuromodulationinspire-medicalneuropacereimbursementbci-read-throughhttps://insidebci.com/opinion/2026-05-08-sovereign-capital-rush-bci-multipole-velco-dar/https://insidebci.com/opinion/2026-05-08-sovereign-capital-rush-bci-multipole-velco-dar/Oman Investment Authority's Neuralink position is the latest entry in a sovereign-capital and tech-billionaire cohort racing into brain-computer interfaces.Fri, 08 May 2026 00:00:00 GMTopinionopinionsovereign-capitalgeopoliticsbci-investmenttech-giantsneuralinksynchronparadromicsinbrainsynaptrix-labsmerge-labshttps://insidebci.com/policy/2026-05-07-eu-ai-act-omnibus-medical-device-enforcement-delayed-2028/https://insidebci.com/policy/2026-05-07-eu-ai-act-omnibus-medical-device-enforcement-delayed-2028/The provisional agreement reached on 7 May 2026 pushes high-risk AI obligations by 16 to 24 months, including the rules that capture Class IIb and Class III medical-device BCIs.Thu, 07 May 2026 00:00:00 GMTpolicyregulationeu-ai-acteuropean-unionmedical-devicecompliancehorizontal-regulatordigital-omnibusmdrhttps://insidebci.com/policy/2026-05-07-vermont-h814-clears-senate-neural-rights-bill-awaits-governor/https://insidebci.com/policy/2026-05-07-vermont-h814-clears-senate-neural-rights-bill-awaits-governor/The Senate passed H.814 in concurrence with the House on 6 May. What now sits with Governor Scott is a 6-page recognition statute, with the enforcement layer stripped in committee.Thu, 07 May 2026 00:00:00 GMTpolicyregulationneurorightsvermontus-state-patchworkneural-data-privacyyustehttps://insidebci.com/market/2026-05-05-bioelectronic-medicine-commercial-inflection-four-companies-two-weeks/https://insidebci.com/market/2026-05-05-bioelectronic-medicine-commercial-inflection-four-companies-two-weeks/Spark Biomedical's CEO appointment on May 4 caps a fortnight of substantive bioelectronic-medicine milestones: SetPoint Medical's first multiple sclerosis pilot enrolment on April 30, ResMed's $340 million acquisition of Noctrix Health on the same day, and Nervonik's $52.5 million Series B on April 27. Together the four data points map onto a single maturation arc — growth-stage capital, late-stage trial expansion, commercial scaling, incumbent acquisition — and signal that the category is moving past early-clinical research into the operational layer where all four of those events run in parallel.Tue, 05 May 2026 00:00:00 GMTmarketbioelectronic-medicinespark-biomedicalsetpoint-medicalnervonikresmednoctrixanja-krammervagus-nerveperipheral-nerve-stimcommercial-inflectionm-and-ahttps://insidebci.com/market/2026-04-30-charles-lieber-leads-state-funded-shenzhen-bci-lab-i-brain/https://insidebci.com/market/2026-04-30-charles-lieber-leads-state-funded-shenzhen-bci-lab-i-brain/Reuters reported on April 30 that Charles Lieber, the former chair of Harvard's chemistry department convicted in December 2021 under the US China Initiative, has been appointed director of i-BRAIN, a newly established BCI institute at the Shenzhen Medical Academy of Research and Translation. The lab gives Lieber access to dedicated nanofabrication, advanced lithography, and primate research facilities at a scale unavailable to him at Harvard. The appointment lands the same week as Axoft's $55M Asian-led Series A — the capital and talent legs of the same bilateral BCI flow.Thu, 30 Apr 2026 00:00:00 GMTmarketlieberharvardi-brainshenzhenchinasmartmesh-electronicsnanowiretalent-flowchina-initiativestate-fundedfive-year-planhttps://insidebci.com/news/2026-04-30-uchicago-medicine-joins-precision-neuroscience-clinical-research-network-layer-7-sensorimotor/https://insidebci.com/news/2026-04-30-uchicago-medicine-joins-precision-neuroscience-clinical-research-network-layer-7-sensorimotor/Precision Neuroscience and UChicago Medicine announced on April 30 the launch of a clinical research partnership focused on AI-driven sensorimotor function and neuroprosthetics. The collaboration uses Precision's Layer 7 Cortical Interface, the FDA 510(k)-cleared high-density microelectrode array, and is the second material Precision institutional move of 2026, following the company's January integration with Medtronic's StealthStation surgical navigation system.Thu, 30 Apr 2026 00:00:00 GMTnewsprecision-neurosciencelayer-7uchicago-medicinepeter-warnkesensorimotor-decodingneuroprostheticsmedtronicstealthstationacademic-medical-centrehttps://insidebci.com/market/2026-04-29-axoft-cp-group-55m-series-a-first-acute-implant-shanghai/https://insidebci.com/market/2026-04-29-axoft-cp-group-55m-series-a-first-acute-implant-shanghai/Cambridge, Massachusetts implantable BCI company Axoft closed a $55M oversubscribed Series A on April 29, led by Thai conglomerate Charoen Pokphand's strategic arm C.P. Group Innovation with Chinese co-investors Hillhouse and Gaorong, alongside US participants Alumni Ventures and Stanford. The same announcement disclosed Axoft's first acute intraoperative test of its Fleuron polymer probe in a Shanghai patient — the first publicly confirmed clinical use of a US BCI material in China, with more Chinese trials planned this year.Wed, 29 Apr 2026 00:00:00 GMTmarketaxoftfleuronseries-acp-grouphillhousegaorongstanfordalumni-venturesshanghaichinaacute-recordingimplantable-bcipaul-le-flochhttps://insidebci.com/market/2026-04-28-neurable-launches-oem-licensing-programme-opening-its-eeg-decoder-stack-to-consumer-hardware-makers/https://insidebci.com/market/2026-04-28-neurable-launches-oem-licensing-programme-opening-its-eeg-decoder-stack-to-consumer-hardware-makers/Neurable announced on April 28 that it has formally opened its consumer-EEG technology to OEM licensing, allowing third-party hardware makers to integrate the company's brain-signal-processing stack into their own products. Named integration partners include HP Inc.'s HyperX, MeSpace, iMotions, and the United States Air Force Research Laboratory. The shift recasts Neurable from a hardware company building its own consumer products into a platform layer for the broader consumer-electronics stack.Tue, 28 Apr 2026 00:00:00 GMTmarketneurableoem-licensingconsumer-bcieeghyperxhpimotionsafrlramses-alcaideneurable-aiplatform-strategyhttps://insidebci.com/news/2026-04-27-motif-neurotech-dot-wins-fda-ide-for-first-clinical-trial-in-treatment-resistant-depression/https://insidebci.com/news/2026-04-27-motif-neurotech-dot-wins-fda-ide-for-first-clinical-trial-in-treatment-resistant-depression/The FDA has approved Motif Neurotech's investigational device exemption to begin a first-in-patient clinical trial of DOT, a millimeter-scale epidurally implanted wirelessly powered brain stimulator that targets the prefrontal cortex. The Rice University spinout, backed by former Neuralink president Max Hodak among others, becomes one of the first companies to attempt an implantable depression therapy at the size and patient-acceptance profile that has eluded every prior DBS-for-depression programme.Mon, 27 Apr 2026 00:00:00 GMTnewsmotif-neurotechdotfdaidedepressiontreatment-resistant-depressionepiduralbrain-stimulatormax-hodakrice-universitymagnetoelectricimplantablehttps://insidebci.com/news/2026-04-27-orchestra-biomed-medtronic-pacemaker-delivered-hypertension-therapy-toward-pivotal-readout/https://insidebci.com/news/2026-04-27-orchestra-biomed-medtronic-pacemaker-delivered-hypertension-therapy-toward-pivotal-readout/MODERATO II data presented at Heart Rhythm 2026 shows AVIM Therapy — bioelectronic blood pressure control delivered through a standard dual-chamber pacemaker — produced an 8.1 mmHg net reduction in 24-hour ambulatory systolic BP at six months, with the Medtronic-partnered BACKBEAT pivotal trial now actively enrolling under an FDA-amended protocol.Mon, 27 Apr 2026 00:00:00 GMTnewsorchestra-biomedmedtronicavimbioelectronichypertensionpacemakerhrs-2026fda-breakthroughbackbeatmoderato-iihttps://insidebci.com/market/2026-04-23-china-issues-guided-pricing-for-invasive-bci-procedures-as-provinces-roll-out-reimbursement/https://insidebci.com/market/2026-04-23-china-issues-guided-pricing-for-invasive-bci-procedures-as-provinces-roll-out-reimbursement/China's National Healthcare Security Administration has set government-guided prices of 6,000–6,600 yuan per invasive brain-computer interface implantation procedure, with Sichuan, Hubei and Zhejiang now attaching fee schedules at the provincial level — moving the country further ahead of the United States on the reimbursement layer that will decide whether BCIs scale as routine medicine.Thu, 23 Apr 2026 00:00:00 GMTmarketchinanhsareimbursementpricingneuroxessstairmedneuraclemarket-accessregulatorycmshttps://insidebci.com/news/2026-04-23-cortec-brain-interchange-joins-fda-total-product-life-cycle-advisory-program/https://insidebci.com/news/2026-04-23-cortec-brain-interchange-joins-fda-total-product-life-cycle-advisory-program/Two weeks after securing Breakthrough Device Designation for stroke rehabilitation, CorTec has been accepted into the FDA's TAP — a dedicated advisory track that pairs the German neurotech company with an agency liaison and early engagement with CMS, signalling an unusually long regulatory horizon for an implanted brain-computer interface.Thu, 23 Apr 2026 00:00:00 GMTnewscortecfdatapbrain-interchangeclosed-loopstrokeregulatorycmsreimbursementhttps://insidebci.com/research/2026-04-22-macaque-bci-navigates-virtual-forest-with-single-fixed-decoder/https://insidebci.com/research/2026-04-22-macaque-bci-navigates-virtual-forest-with-single-fixed-decoder/A KU Leuven team led by Peter Janssen trained three rhesus macaques to pilot avatars through virtual environments using implanted multi-array BCIs, with premotor cortex outperforming primary motor cortex and a single fixed decoder generalising across perspectives, avatars, and dynamic targets.Wed, 22 Apr 2026 00:00:00 GMTresearchKU-LeuvenJanssenmacaquepremotor-cortexmotor-decodingvirtual-realitybrain-computer-interfaceScience-AdvancesALSParkinsonshttps://insidebci.com/news/2026-04-22-maharbiz-launches-epia-neuro-stroke-focused-bci-built-for-lifelong-assistive-use/https://insidebci.com/news/2026-04-22-maharbiz-launches-epia-neuro-stroke-focused-bci-built-for-lifelong-assistive-use/Michel Maharbiz departed iota Biosciences on 1 April and has emerged with a San Francisco BCI startup targeting post-stroke upper-limb rehabilitation, with a 64-channel epidural array, motorised glove, first-in-human at Lenox Hill later this year, and an FDA submission targeted for February 2027.Wed, 22 Apr 2026 00:00:00 GMTnewsEpia-NeuroMaharbizMandelbaumstrokebrain-computer-interfaceepidural-BCILenox-Hilliota-BiosciencesAstellashttps://insidebci.com/research/2026-04-22-northwestern-prints-artificial-neurons-that-fire-action-potentials-into-live-brain-tissue/https://insidebci.com/research/2026-04-22-northwestern-prints-artificial-neurons-that-fire-action-potentials-into-live-brain-tissue/A Mark Hersam-led team at Northwestern has demonstrated aerosol-jet-printed neuromorphic devices that generate biologically realistic voltage spikes and trigger responses in mouse cerebellum slices, a first for printed electronics and a potential route to lower-cost, flexible neural interfaces.Wed, 22 Apr 2026 00:00:00 GMTresearchNorthwesternHersamprinted-electronicsneuromorphicMoS2graphenebrain-computer-interfaceneuroprostheticsNature-Nanotechnologyhttps://insidebci.com/research/2026-04-21-inbrain-completes-enrolment-in-worlds-first-in-human-graphene-brain-computer-interface-study/https://insidebci.com/research/2026-04-21-inbrain-completes-enrolment-in-worlds-first-in-human-graphene-brain-computer-interface-study/The Barcelona neurotechnology enrolled ten patients and implanted eight during brain tumour resection at Salford Royal Hospital, completing the first human cohort for any graphene-based neural interface. Full results due later in 2026.Tue, 21 Apr 2026 00:00:00 GMTresearchINBRAIN-Neuroelectronicsgraphene-BCIbrain-computer-interfaceSalford-RoyalUniversity-of-ManchesterKostarelosParkinsons-diseaseBCI-Tx-platformhttps://insidebci.com/market/2026-04-20-onward-medical-raises-40m-to-scale-arc-therapy-and-fund-implantable-pipeline/https://insidebci.com/market/2026-04-20-onward-medical-raises-40m-to-scale-arc-therapy-and-fund-implantable-pipeline/The Eindhoven-listed neurotech priced a private placement at €3.00 per share, led by EQT Life Sciences, to expand ARC-EX commercial operations and advance ARC-IM through regulatory work. Cash runway extends into Q1 2028.Mon, 20 Apr 2026 00:00:00 GMTmarketONWARD-MedicalARC-therapyspinal-cord-injuryEQT-Life-Sciencescapital-raiseEuronextneurotech-commercializationbrain-computer-interfacehttps://insidebci.com/news/2026-04-16-aneuvos-spinal-stimulator-clears-the-fda/https://insidebci.com/news/2026-04-16-aneuvos-spinal-stimulator-clears-the-fda/The ExaStim system — a transcutaneous spinal cord stimulator for people with chronic spinal cord injury — has received FDA 510(k) clearance, making it the first device of its kind cleared for both clinical and home use in the United States.Thu, 16 Apr 2026 00:00:00 GMTnewsANEUVOFDAspinal cord stimulationExaStimspinal cord injuryneuromodulation510(k)https://insidebci.com/research/2026-04-16-bidirectional-brain-computer-interface-restores-sensation-during-brain-controlled-walking/https://insidebci.com/research/2026-04-16-bidirectional-brain-computer-interface-restores-sensation-during-brain-controlled-walking/A UC Irvine-led team has demonstrated the first brain-computer interface that simultaneously controls a walking exoskeleton through decoded brain signals and feeds artificial leg sensation back to the user's sensory cortex — closing the loop on locomotion for the first time.Thu, 16 Apr 2026 00:00:00 GMTresearchUC IrvineCaltechUSCbidirectional BCIexoskeletonsensory feedbackelectrocorticographyBrain Stimulationhttps://insidebci.com/market/2026-04-16-sabi-emerges-from-stealth-with-a-thought-to-text-beanie-and-khosla-backing/https://insidebci.com/market/2026-04-16-sabi-emerges-from-stealth-with-a-thought-to-text-beanie-and-khosla-backing/California startup Sabi has exited stealth with a non-invasive EEG beanie packing up to 100,000 miniature sensors, a brain foundation model trained on 100,000 hours of neural data, and a plan to ship a consumer thought-to-text device by the end of 2026. Khosla Ventures leads.Thu, 16 Apr 2026 00:00:00 GMTmarketSabiEEGconsumer BCIwearableKhosla Venturesbrain foundation modelthought-to-texthttps://insidebci.com/policy/2026-04-15-neuroethics-2026-opens-at-stanford-as-the-field-meets-its-first-commercial-moment/https://insidebci.com/policy/2026-04-15-neuroethics-2026-opens-at-stanford-as-the-field-meets-its-first-commercial-moment/The International Neuroethics Society convenes across Stanford, Lucca and Stellenbosch as the BCI sector absorbs $960 million in Q1, a Chinese reimbursement benchmark of US$900 per implant, and 20 Neuralink patients — and the governance window is narrowing.Wed, 15 Apr 2026 00:00:00 GMTpolicyneuroethicsINSStanfordneurorightscognitive libertyneural datagovernanceBCI Pioneers Coalitionhttps://insidebci.com/news/2026-04-15-phantom-neuro-gets-green-light-for-first-human-trial-of-its-subcutaneous-prosthetic-sensor/https://insidebci.com/news/2026-04-15-phantom-neuro-gets-green-light-for-first-human-trial-of-its-subcutaneous-prosthetic-sensor/The Melbourne-based startup has received FDA approval to begin a first-in-human study of Phantom X, an implanted sensor array that reads neuromuscular signals from a residual limb without entering the nervous system — aiming to give amputees more natural prosthetic control.Wed, 15 Apr 2026 00:00:00 GMTnewsPhantom NeuroprostheticsCYBORGfirst-in-humansubcutaneous sensoramputationFDAOttobockBlackrock Neurotechhttps://insidebci.com/news/2026-04-14-china-livestreams-a-brain-implant-beinao-1-goes-live/https://insidebci.com/news/2026-04-14-china-livestreams-a-brain-implant-beinao-1-goes-live/Hundreds of specialists watched Beijing Tiantan Hospital implant Beinao-1, China's 128-channel semi-invasive brain-computer interface, in a young man paralysed in a scooter accident — part of a clinical ramp that is closing on Neuralink's implant count at roughly 1% of its price.Tue, 14 Apr 2026 00:00:00 GMTnewsBeinao-1ChinaBeijing Tiantan HospitalCIBRNeuCyber NeuroTechsemi-invasive BCIclinical trialshttps://insidebci.com/research/2026-04-14-purdue-grows-brain-electrodes-inside-the-brains-of-living-mice/https://insidebci.com/research/2026-04-14-purdue-grows-brain-electrodes-inside-the-brains-of-living-mice/A Purdue team reports in Science that a liquid monomer injected into the motor cortex self-assembles into a conductive electrode mesh — catalysed by the iron in blood — and can then modulate neural activity with external near-infrared light.Tue, 14 Apr 2026 00:00:00 GMTresearchPurdueJianguo Mein-PBDFinjectable electrodesconductive polymersSciencebioelectronicshttps://insidebci.com/market/2026-04-13-chinas-first-bci-unicorn-pivots-prosthetics-expertise-into-humanoid-robot-hands/https://insidebci.com/market/2026-04-13-chinas-first-bci-unicorn-pivots-prosthetics-expertise-into-humanoid-robot-hands/BrainCo's new Revo 3 dexterous hand applies neural decoding and tactile sensing from prosthetic limbs to humanoid robotics, backed by a US$286 million funding round.Mon, 13 Apr 2026 00:00:00 GMTmarketBrainCoroboticsprostheticsdexterous handsChinahumanoid robotshttps://insidebci.com/market/2026-04-11-neural-dust-co-inventor-headlines-bioelectronic-medicine-forum-as-neurotech-investment-accelerates/https://insidebci.com/market/2026-04-11-neural-dust-co-inventor-headlines-bioelectronic-medicine-forum-as-neurotech-investment-accelerates/Michel Maharbiz of iota Biosciences will keynote the ninth annual Bioelectronic Medicine Forum in New York on April 14, with panels on reimbursement and venture capital following a record Q1 for BCI funding.Sat, 11 Apr 2026 00:00:00 GMTmarketbioelectronic-medicine-forummichel-maharbiziota-biosciencesneural-dustventure-capitalneurotech-reportsreimbursementhttps://insidebci.com/news/2026-04-10-neuralink-reaches-twenty-implant-milestone-as-surgical-robot-relocates-to-the-uae/https://insidebci.com/news/2026-04-10-neuralink-reaches-twenty-implant-milestone-as-surgical-robot-relocates-to-the-uae/With seven UK patients implanted under the GB-PRIME study and a total of twenty worldwide, Neuralink's R1 surgical robot has moved to Cleveland Clinic Abu Dhabi for the next cohort under the UAE-PRIME trial.Fri, 10 Apr 2026 00:00:00 GMTnewsneuralinkgb-primeuae-primeuclhcleveland-clinicr1-robotn1-implantquadriplegiahttps://insidebci.com/research/2026-04-10-darpa-launches-o-circuit-to-build-living-neural-computers-for-the-battlefield/https://insidebci.com/research/2026-04-10-darpa-launches-o-circuit-to-build-living-neural-computers-for-the-battlefield/A new 42-month programme will fund teams to build biological processing units from neural organoids, benchmarked against video games and drone navigation, at energy budgets rivalling a fruit fly's brain.Fri, 10 Apr 2026 00:00:00 GMTresearchdarpao-circuitorganoidsbiological-computingbpuedge-aiolfactorychemotaxisdefencehttps://insidebci.com/news/2026-04-09-cortec-wins-fda-breakthrough-designation-for-stroke-rehab-bci-a-first-for-the-indication/https://insidebci.com/news/2026-04-09-cortec-wins-fda-breakthrough-designation-for-stroke-rehab-bci-a-first-for-the-indication/The German neurotech company becomes the first to receive FDA Breakthrough Device Designation for a brain-computer interface targeting motor recovery after stroke, with its closed-loop Brain Interchange system showing meaningful recovery in a Harborview Medical Center trial.Thu, 09 Apr 2026 00:00:00 GMTnewscortecfdabreakthrough-devicestrokebrain-interchangeclosed-loopharborviewneurostimulationhttps://insidebci.com/news/2026-04-09-colorado-performs-its-first-brain-computer-interface-surgery-targeting-higher-cognitive-regions/https://insidebci.com/news/2026-04-09-colorado-performs-its-first-brain-computer-interface-surgery-targeting-higher-cognitive-regions/Neurosurgeon Daniel Kramer implants a BCI in a quadriplegic patient at UCHealth University of Colorado Hospital, with electrodes placed in higher-level brain areas rather than motor cortex alone.Thu, 09 Apr 2026 00:00:00 GMTnewscu-anschutzuchealthcoloradoutah-arraycognitive-bcisensory-stimulationdaniel-kramerquadriplegiahttps://insidebci.com/research/2026-04-08-precision-neurosciences-layer-7-decodes-speech-and-movement-in-first-peer-reviewed-intraoperative-study/https://insidebci.com/research/2026-04-08-precision-neurosciences-layer-7-decodes-speech-and-movement-in-first-peer-reviewed-intraoperative-study/A Johns Hopkins team reports 77.5% speech classification and 78–84% motor decoding accuracy using Precision's 1,024-channel thin-film cortical array during awake brain surgery in four patients.Wed, 08 Apr 2026 00:00:00 GMTresearchprecision-neurosciencelayer-7electrocorticographyspeech-decodingmotor-decodingjohns-hopkinsmedtronichttps://insidebci.com/policy/2026-04-06-gao-names-neural-implants-among-three-emerging-priorities-for-congress/https://insidebci.com/policy/2026-04-06-gao-names-neural-implants-among-three-emerging-priorities-for-congress/A Government Accountability Office report warns that the FDA has no framework for augmentation uses of brain-computer interfaces, even as military and commercial applications advance.Mon, 06 Apr 2026 00:00:00 GMTpolicygaofdapolicyaugmentationregulationhttps://insidebci.com/research/2026-04-06-living-rat-neurons-learn-to-generate-complex-signals-in-real-time-reservoir-computing-first/https://insidebci.com/research/2026-04-06-living-rat-neurons-learn-to-generate-complex-signals-in-real-time-reservoir-computing-first/Tohoku University researchers trained cultured rat cortical neurons to produce sine waves, square waves, and chaotic Lorenz attractors using closed-loop FORCE learning, demonstrating that biological neural networks can serve as computational resources.Mon, 06 Apr 2026 00:00:00 GMTresearchreservoir-computingbiocomputingtohoku-universityorganoid-intelligenceneuroprostheticspnashttps://insidebci.com/market/2026-04-06-synchrons-neural-data-ambitions-earn-fast-company-recognition-as-bci-dataset-grows/https://insidebci.com/market/2026-04-06-synchrons-neural-data-ambitions-earn-fast-company-recognition-as-bci-dataset-grows/Synchron ranked eighth on Fast Company's 2026 most innovative data science companies list, reflecting a strategic pivot from hardware maker to neural data platform.Mon, 06 Apr 2026 00:00:00 GMTmarketsynchronneural-datachiralfoundation-modelfast-companyhttps://insidebci.com/market/2026-04-05-neuronoffs-needle-delivered-electrode-works-with-standard-pulse-generators-in-chronic-animal-study/https://insidebci.com/market/2026-04-05-neuronoffs-needle-delivered-electrode-works-with-standard-pulse-generators-in-chronic-animal-study/Cleveland-based Neuronoff showed its Injectrode platform can connect to off-the-shelf implantable pulse generators, opening neuromodulation targets beyond the spine.Sun, 05 Apr 2026 00:00:00 GMTmarketneuronoffinjectrodeneuromodulationchronic-painperipheral-nerve-stimulationhttps://insidebci.com/policy/2026-04-04-china-elevates-bci-to-government-work-report-as-clinical-programmes-expand/https://insidebci.com/policy/2026-04-04-china-elevates-bci-to-government-work-report-as-clinical-programmes-expand/Brain-computer interfaces appeared in China's government work report for the first time during the 2026 'two sessions,' placing the technology alongside quantum computing and 6G as a national strategic priority.Sat, 04 Apr 2026 00:00:00 GMTpolicyChinagovernment work reporttwo sessionsNPCCPPCCBCI policyChongqingclinical trialsneuromodulationstroke rehabilitationhttps://insidebci.com/news/2026-04-04-paralysed-punk-rocker-turns-blackrock-neurotech-implants-into-a-musical-instrument/https://insidebci.com/news/2026-04-04-paralysed-punk-rocker-turns-blackrock-neurotech-implants-into-a-musical-instrument/Galen Buckwalter, a quadriplegic research psychologist with six Utah arrays in his brain, is using a Caltech-developed interface to generate music directly from neural signals.Sat, 04 Apr 2026 00:00:00 GMTnewsblackrock-neurotechcaltechcreative-expressionutah-arraybrain-computer-interfacehttps://insidebci.com/research/2026-04-04-personalised-tms-reaches-the-hippocampus-without-surgery-iowa-study-shows/https://insidebci.com/research/2026-04-04-personalised-tms-reaches-the-hippocampus-without-surgery-iowa-study-shows/University of Iowa researchers have demonstrated for the first time that non-invasive transcranial magnetic stimulation can modulate hippocampal activity when the stimulation site is tailored to each patient's brain connectivity.Sat, 04 Apr 2026 00:00:00 GMTresearchTMShippocampusnon-invasiveneuromodulationUniversity of IowaNature Communicationspersonalised medicineAlzheimer'sdepressionfMRIhttps://insidebci.com/policy/2026-04-03-us-states-build-patchwork-of-neural-data-privacy-laws-as-bci-market-accelerates/https://insidebci.com/policy/2026-04-03-us-states-build-patchwork-of-neural-data-privacy-laws-as-bci-market-accelerates/Four states now classify brain data as sensitive personal information, with at least seven more bills advancing in 2026 — but definitions vary widely and no federal standard is in sight.Fri, 03 Apr 2026 00:00:00 GMTpolicyneural dataprivacylegislationConnecticutCaliforniaColoradoMontananeurorightsUNESCOBCIhttps://insidebci.com/news/2026-04-03-epia-neuro-launches-with-read-write-bci-platform-for-stroke-rehabilitation/https://insidebci.com/news/2026-04-03-epia-neuro-launches-with-read-write-bci-platform-for-stroke-rehabilitation/The startup, led by iota Biosciences founder Michel Maharbiz, is developing a minimally invasive brain-computer interface that pairs neural decoding with a motorized grip-assist glove to restore movement after stroke.Fri, 03 Apr 2026 00:00:00 GMTnewsEpia NeurostrokerehabilitationBCIMichel Maharbiziota BiosciencesLenox Hill Hospitalclosed-loophttps://insidebci.com/market/2026-03-31-bci-sector-closes-record-first-quarter-with-over-960-million-raised/https://insidebci.com/market/2026-03-31-bci-sector-closes-record-first-quarter-with-over-960-million-raised/At least nine significant funding rounds in Q1 2026 brought total BCI investment past $960 million, with capital spreading across invasive, endovascular, ultrasound, and neurostimulation modalities.Tue, 31 Mar 2026 00:00:00 GMTmarketfundingBCIinvestmentQ1 2026analysisMerge LabsSynchronScience Corphttps://insidebci.com/news/2026-03-31-paradromics-begins-recruiting-patients-for-connexus-speech-restoration-trial/https://insidebci.com/news/2026-03-31-paradromics-begins-recruiting-patients-for-connexus-speech-restoration-trial/The Austin-based company is now enrolling participants at the University of Michigan and Massachusetts General Hospital for the Connect-One study, the first clinical trial of a fully implantable BCI designed to restore speech.Tue, 31 Mar 2026 00:00:00 GMTnewsParadromicsConnexusConnect-Oneclinical trialspeech restorationFDABCIhttps://insidebci.com/policy/2026-03-29-asilomar-summit-convenes-to-build-governance-toolkit-for-neurotechnology/https://insidebci.com/policy/2026-03-29-asilomar-summit-convenes-to-build-governance-toolkit-for-neurotechnology/A four-day invitation-only summit modelled on the landmark 1975 DNA conference brings together neuroethicists, investors, and policymakers to create practical governance tools for the BCI industry.Sun, 29 Mar 2026 00:00:00 GMTpolicypolicyneuroethicsgovernanceAsilomarOECDIEEEUNESCOhttps://insidebci.com/market/2026-03-28-merge-labs-252m-bet-on-ultrasound-bci-faces-scientific-scrutiny/https://insidebci.com/market/2026-03-28-merge-labs-252m-bet-on-ultrasound-bci-faces-scientific-scrutiny/Sam Altman's brain-computer interface startup raised the second-largest BCI round in history. The scientific community is asking whether the physics adds up.Sat, 28 Mar 2026 00:00:00 GMTmarketMerge LabsBCIfundingOpenAIultrasoundSam Altmananalysishttps://insidebci.com/market/2026-03-28-octane-neuro-tech-forum-draws-industry-heavyweights-to-newport-beach/https://insidebci.com/market/2026-03-28-octane-neuro-tech-forum-draws-industry-heavyweights-to-newport-beach/The second annual forum brought together device makers, investors, and six early-stage startups for two days of panels on BCI, neuromodulation, and digital health.Sat, 28 Mar 2026 00:00:00 GMTmarketneurotechinvestmentBCIBlackrock NeurotechOctanemedtechhttps://insidebci.com/policy/2026-03-28-uk-funds-1m-philosophy-of-neurotechnology-research-lab/https://insidebci.com/policy/2026-03-28-uk-funds-1m-philosophy-of-neurotechnology-research-lab/Four philosophers at Glasgow and Oxford will lead a new interdisciplinary lab examining the ethical and epistemological implications of brain-computer interfaces.Sat, 28 Mar 2026 00:00:00 GMTpolicypolicyethicsUKneurotechnologyphilosophyUKRIGlasgowOxfordhttps://insidebci.com/news/2026-03-25-synchron-returns-to-melbourne-for-first-trial-of-next-generation-stentrode/https://insidebci.com/news/2026-03-25-synchron-returns-to-melbourne-for-first-trial-of-next-generation-stentrode/The FOCUS-AU trial will test Synchron's advanced brain-computer interface in ten MND patients across three Australian hospitals, with surgery beginning in April.Wed, 25 Mar 2026 00:00:00 GMTnewsSynchronStentrodeAustraliaFOCUS-AUMNDALSclinical trialApplehttps://insidebci.com/market/2026-03-24-cambridge-innovation-institute-acquires-neurotech-reports-after-25-years/https://insidebci.com/market/2026-03-24-cambridge-innovation-institute-acquires-neurotech-reports-after-25-years/CII absorbs the neurotechnology sector's longest-running trade publication into its venture and innovation division, with founder James Cavuoto and team staying on.Tue, 24 Mar 2026 00:00:00 GMTmarketNeurotech ReportsCambridge Innovation Instituteacquisitionneurotech industryJames Cavuotobioelectronic medicinehttps://insidebci.com/news/2026-03-24-chinas-beinao-1-matches-neuralinks-patient-count-with-semi-invasive-brain-chip/https://insidebci.com/news/2026-03-24-chinas-beinao-1-matches-neuralinks-patient-count-with-semi-invasive-brain-chip/Five patients now carry the coin-sized wireless implant that sits on the brain's protective membrane rather than penetrating tissue, with one ALS patient decoding nearly 100 Chinese words.Tue, 24 Mar 2026 00:00:00 GMTnewsBeinao-1NeuCyberChinasemi-invasiveBCINeuralinkALShttps://insidebci.com/news/2026-03-24-nia-therapeutics-wins-fda-breakthrough-designation-for-ai-guided-memory-implant/https://insidebci.com/news/2026-03-24-nia-therapeutics-wins-fda-breakthrough-designation-for-ai-guided-memory-implant/The Pennsylvania company's 60-channel Smart Neurostimulation System is the first device to receive Breakthrough Device Designation for TBI-related memory loss.Tue, 24 Mar 2026 00:00:00 GMTnewsNia TherapeuticsFDAmemoryTBIneurostimulationclosed-loopbreakthrough devicehttps://insidebci.com/market/2026-03-23-cleveland-startup-sells-350-brain-stimulation-headset-without-fda-clearance-while-clinical-trials-continue/https://insidebci.com/market/2026-03-23-cleveland-startup-sells-350-brain-stimulation-headset-without-fda-clearance-while-clinical-trials-continue/U: The Mind Company began taking orders for a consumer neuromodulation device on March 18, marketing bold clinical claims that have not appeared in peer-reviewed literature. An FDA submission is planned for 2027.Mon, 23 Mar 2026 00:00:00 GMTmarketconsumer-neurotechbrain-stimulationtRNSFDAwellness-devicesregulationhttps://insidebci.com/news/2026-03-23-flow-neuroscience-brings-first-fda-approved-at-home-brain-stimulation-for-depression-to-us-market/https://insidebci.com/news/2026-03-23-flow-neuroscience-brings-first-fda-approved-at-home-brain-stimulation-for-depression-to-us-market/The Swedish company's FL-100 headset, cleared via the FDA's most stringent PMA pathway, launches in the US in Q2 2026 after a 174-person Nature Medicine trial. A second device, Neurolief's ProlivRx, was approved weeks later.Mon, 23 Mar 2026 00:00:00 GMTnewsFlow-NeuroscienceFDAdepressiontDCSneuromodulationat-home-therapyNeuroliefhttps://insidebci.com/research/2026-03-23-spinal-cord-stimulation-restores-both-movement-and-sensation-in-complete-paralysis-for-first-time/https://insidebci.com/research/2026-03-23-spinal-cord-stimulation-restores-both-movement-and-sensation-in-complete-paralysis-for-first-time/A Brown University-led trial published in Nature Biomedical Engineering demonstrates simultaneous motor and sensory restoration in three people with complete spinal cord injuries using patterned electrical stimulation and machine learning.Mon, 23 Mar 2026 00:00:00 GMTresearchspinal-cord-injuryspinal-stimulationBrown-UniversityNature-Biomedical-Engineeringparalysissensory-restorationmotor-restorationhttps://insidebci.com/research/2026-03-22-brain-implants-malfunction-at-night-dutch-study-reveals-critical-gap-in-round-the-clock-bci-use/https://insidebci.com/research/2026-03-22-brain-implants-malfunction-at-night-dutch-study-reveals-critical-gap-in-round-the-clock-bci-use/A UMC Utrecht study found that a brain-computer interface trained on daytime neural signals produced 245 false commands per hour when the patient slept, exposing a fundamental problem for 24/7 assistive devices.Sun, 22 Mar 2026 00:00:00 GMTresearchUMC UtrechtECoGALSsleepsignal driftnightmodeassistive technologyhttps://insidebci.com/policy/2026-03-22-fdas-one-trial-default-lands-just-as-bci-companies-approach-pivotal-studies/https://insidebci.com/policy/2026-03-22-fdas-one-trial-default-lands-just-as-bci-companies-approach-pivotal-studies/The agency's new policy ending the two-trial requirement was written for drugs, but brain implant makers watching Synchron, Neuralink, and Paradromics navigate FDA are asking whether the same logic could eventually ease their path.Sun, 22 Mar 2026 00:00:00 GMTpolicyFDAregulationpivotal trialSynchronNeuralinkParadromicsMakaryPrasadcommercializationhttps://insidebci.com/research/2026-03-21-cambridge-memristor-mimics-brain-synapses-to-slash-ai-energy-use/https://insidebci.com/research/2026-03-21-cambridge-memristor-mimics-brain-synapses-to-slash-ai-energy-use/A new hafnium oxide memristor from the University of Cambridge mimics biological synapses with a million-fold reduction in switching current, pointing toward more efficient neuromorphic hardware.Sat, 21 Mar 2026 00:00:00 GMTresearchneuromorphicmemristorcambridgeenergy-efficiencyhardwareresearchhttps://insidebci.com/policy/2026-03-21-medicares-missing-coverage-pathway-for-brain-computer-interfaces/https://insidebci.com/policy/2026-03-21-medicares-missing-coverage-pathway-for-brain-computer-interfaces/A Health Affairs analysis argues that CMS needs a dedicated coverage pathway for implantable BCIs before the technology outpaces the reimbursement system that patients depend on.Sat, 21 Mar 2026 00:00:00 GMTpolicymedicareCMSpolicyreimbursementhealth-affairspatient-accessFDAhttps://insidebci.com/news/2026-03-21-neucyber-concedes-three-year-gap-with-neuralink-as-china-expands-bci-trials/https://insidebci.com/news/2026-03-21-neucyber-concedes-three-year-gap-with-neuralink-as-china-expands-bci-trials/NeuCyber Neurotech's rotating CEO concedes a significant technology gap with Musk's outfit, even as China pours state funding into catching up and expanding human trials to 50 patients.Sat, 21 Mar 2026 00:00:00 GMTnewsneucyberneuralinkchinabci-trialsbeinaogeopoliticshttps://insidebci.com/policy/2026-03-18-south-korea-designates-bci-as-national-future-industry-with-seven-mission-strategy/https://insidebci.com/policy/2026-03-18-south-korea-designates-bci-as-national-future-industry-with-seven-mission-strategy/The Ministry of Science and ICT has designated brain-computer interfaces as a core future industry, setting seven mission areas from paralysis treatment to defence applications, with full-scale project funding beginning in 2027.Wed, 18 Mar 2026 00:00:00 GMTpolicySouth KoreaK-Moonshotpolicynational strategyYbraindefencehttps://insidebci.com/news/2026-03-17-paradromics-launches-apex-partnership-to-expand-bci-applications/https://insidebci.com/news/2026-03-17-paradromics-launches-apex-partnership-to-expand-bci-applications/The Austin-based neurotech company launches its APEX Partnership Program with five leading research institutions, aiming to push its Connexus brain-computer interface beyond speech restoration into stroke recovery, Parkinson's and motor rehabilitation.Tue, 17 Mar 2026 00:00:00 GMTnewsParadromicsConnexusAPEXStanfordacademic partnershipsspeech restorationhttps://insidebci.com/research/2026-03-16-braingate-bci-enables-record-speed-typing-for-two-paralyzed-patients/https://insidebci.com/research/2026-03-16-braingate-bci-enables-record-speed-typing-for-two-paralyzed-patients/A brain-computer interface developed by Mass General Brigham and Brown University enabled two paralysed individuals to type at speeds rivalling able-bodied texting, with a word error rate of just 1.6 per cent.Mon, 16 Mar 2026 00:00:00 GMTresearchBrainGatetypingALSspinal cord injuryNature Neurosciencehttps://insidebci.com/news/2026-03-16-revision-implant-secures-fda-breakthrough-device-designation-for-visual-cortical-prosthesis/https://insidebci.com/news/2026-03-16-revision-implant-secures-fda-breakthrough-device-designation-for-visual-cortical-prosthesis/The Leuven-based neurotech company's Occular system, which uses thousands of micro-electrodes implanted in the visual cortex to restore functional sight, has received FDA Breakthrough Device Designation.Mon, 16 Mar 2026 00:00:00 GMTnewsReVision ImplantFDAvisual prosthesisOccularbreakthrough devicehttps://insidebci.com/opinion/2026-03-14-inside-chinas-sprint-to-own-the-brain-computer-interface-industry/https://insidebci.com/opinion/2026-03-14-inside-chinas-sprint-to-own-the-brain-computer-interface-industry/In just nine months China has issued a national BCI blueprint, overtaken the United States in BCI patent filings, funnelled hundreds of millions into startups, and has just granted the world's first commercial implant approval.Sat, 14 Mar 2026 00:00:00 GMTopinionchinaeditorialneuraclestairmedgestalaneuroxessneuralinkindustrial-policyregulationhttps://insidebci.com/market/2026-03-13-alibaba-leads-72-million-round-in-stairmed-as-chinese-tech-giants-enter-bci/https://insidebci.com/market/2026-03-13-alibaba-leads-72-million-round-in-stairmed-as-chinese-tech-giants-enter-bci/The invasive-BCI startup has now raised over $160 million in a year, with Alibaba and Tencent both on the cap table and multicenter clinical trials planned for later this year.Fri, 13 Mar 2026 00:00:00 GMTmarketstairmedalibabatencentchinafundinginvasive-bcihttps://insidebci.com/news/2026-03-13-china-grants-first-commercial-approval-for-an-implantable-brain-computer-interface/https://insidebci.com/news/2026-03-13-china-grants-first-commercial-approval-for-an-implantable-brain-computer-interface/Neuracle Medical Technology secures NMPA clearance, making its coin-sized cortical implant the first invasive BCI anywhere in the world authorised for routine clinical sale.Fri, 13 Mar 2026 00:00:00 GMTnewsneuraclechinanmparegulatoryimplantable-bcicommercialisationhttps://insidebci.com/market/2026-03-12-gestala-raises-21-million-for-ultrasound-bci-in-record-chinese-early-stage-round/https://insidebci.com/market/2026-03-12-gestala-raises-21-million-for-ultrasound-bci-in-record-chinese-early-stage-round/The two-month-old startup founded by Shanda billionaire Tianqiao Chen and former NeuroXess founder Phoenix Peng secures the largest early-stage BCI funding in China, betting that focused ultrasound can reach deeper brain circuits than any implant.Thu, 12 Mar 2026 00:00:00 GMTmarketGestalaultrasound BCIChinafundingnon-invasivechronic painTianqiao ChenPhoenix Penghttps://insidebci.com/news/2026-03-12-synaptrix-labs-unveils-atlas-non-invasive-bci-driving-a-wheelchair-with-thought-alone/https://insidebci.com/news/2026-03-12-synaptrix-labs-unveils-atlas-non-invasive-bci-driving-a-wheelchair-with-thought-alone/The Mark Cuban-backed startup releases a behind-the-scenes demo of Atlas, a non-invasive brain-computer interface that translates scalp-measured neural activity into real-time wheelchair navigation using deep learning and large-scale neural datasets.Thu, 12 Mar 2026 00:00:00 GMTnewsSynaptrix LabsAtlasnon-invasive BCIEEGwheelchairdeep learningMark Cubanassistive technologyhttps://insidebci.com/research/2026-03-11-brain-oscillations-don-t-work-how-we-thought-they-did/https://insidebci.com/research/2026-03-11-brain-oscillations-don-t-work-how-we-thought-they-did/New research upends a foundational assumption in neuroscience and BCI design: that individual frequency bands reliably map to neural activity. The discovery could reshape how we decode brain signals.Wed, 11 Mar 2026 00:00:00 GMTresearchneural oscillationsbrain decodingprefrontal cortexBCI learningneural ensembleshttps://insidebci.com/research/2026-03-11-invisible-flickers-could-make-brain-monitoring-disappear-into-everyday-interface/https://insidebci.com/research/2026-03-11-invisible-flickers-could-make-brain-monitoring-disappear-into-everyday-interface/Researchers developed a near-invisible BCI technique using texture-based visual stimuli to monitor mental workload in pilots without the distraction of traditional flickering screens.Wed, 11 Mar 2026 00:00:00 GMTresearchc-VEPpassive BCImental workloadaviationvisual stimulihttps://insidebci.com/news/2026-03-10-dayone-and-cortical-labs-to-build-singapores-first-biological-data-centre/https://insidebci.com/news/2026-03-10-dayone-and-cortical-labs-to-build-singapores-first-biological-data-centre/The $20 billion data centre operator partners with the Melbourne startup that taught neurons to play Doom, planning to deploy up to 1,000 biological compute units powered by living human brain cells.Tue, 10 Mar 2026 00:00:00 GMTnewsCortical LabsDayOneSingaporebiological computingwetwareNUS Medicinedata centreshttps://insidebci.com/news/2026-03-10-neuralink-and-rivals-push-brain-chips-toward-commercial-reality/https://insidebci.com/news/2026-03-10-neuralink-and-rivals-push-brain-chips-toward-commercial-reality/Multiple companies, including Elon Musk's Neuralink, are racing to bring brain-computer interface technology out of research labs and into commercial markets.Tue, 10 Mar 2026 00:00:00 GMTnewsNeuralinkcommercializationbrain chipsneural implantsmarket expansionhttps://insidebci.com/research/2026-03-10-self-healing-hydrogel-makes-neuromorphic-prosthetics-resilient-to-body-s-chaos/https://insidebci.com/research/2026-03-10-self-healing-hydrogel-makes-neuromorphic-prosthetics-resilient-to-body-s-chaos/A new iontronic reservoir built from self-healing hydrogel creates neuromorphic prostheses that can withstand the unpredictable physiological environment inside the human body.Tue, 10 Mar 2026 00:00:00 GMTresearchneuromorphic computinghydrogelneuroprostheticsbiocompatibilityphysical reservoir computinghttps://insidebci.com/news/2026-03-09-a-paralyzed-man-in-munich-controls-computers-with-his-thoughts/https://insidebci.com/news/2026-03-09-a-paralyzed-man-in-munich-controls-computers-with-his-thoughts/Michael, a quadriplegic patient, uses 256 microelectrodes implanted in his brain to regain autonomy through thought-controlled computing. Researchers in Munich demonstrate how BCIs are moving from experimental to practical.Mon, 09 Mar 2026 00:00:00 GMTnewsinvasive BCIparalysismicroelectrodesclinical applicationsGermanyhttps://insidebci.com/news/2026-03-09-mit-s-alterego-demonstrates-silent-speech-interface-in-new-demo/https://insidebci.com/news/2026-03-09-mit-s-alterego-demonstrates-silent-speech-interface-in-new-demo/AlterEgo, spun out from MIT Media Lab, showcases wearable device that translates internal speech into digital commands without vocalization.Mon, 09 Mar 2026 00:00:00 GMTnewssilent speechMIT Media Labwearable BCIAlterEgoneural interfacehttps://insidebci.com/research/2026-03-08-new-database-maps-global-neuroimaging-data-for-vision-decoding/https://insidebci.com/research/2026-03-08-new-database-maps-global-neuroimaging-data-for-vision-decoding/A researcher has compiled an index of datasets used to reconstruct what people see from brain activity, potentially accelerating development of visual BCIs and neuroprosthetics.Sun, 08 Mar 2026 00:00:00 GMTresearchvisual perceptionneuroimagingdatasetsmachine learningneural decodinghttps://insidebci.com/news/2026-03-09-neuroxess-breaks-ground-on-chinas-first-bci-super-factory/https://insidebci.com/news/2026-03-09-neuroxess-breaks-ground-on-chinas-first-bci-super-factory/The Chinese neural interface company begins construction of the country's first dedicated manufacturing facility for implantable brain-computer interfaces in Nanchang, signaling a shift from lab to production line.Sun, 08 Mar 2026 00:00:00 GMTnewsNeuroXessChinamanufacturingJiangxiimplantable BCIhttps://insidebci.com/market/2026-03-07-cognito-therapeutics-105m-alzheimers-neuromodulation-spectris/https://insidebci.com/market/2026-03-07-cognito-therapeutics-105m-alzheimers-neuromodulation-spectris/The neuromodulation startup closed an oversubscribed Series C led by Morningside Ventures, pushing total funding to $233M as its pivotal Alzheimer's trial nears readout.Sat, 07 Mar 2026 00:00:00 GMTmarketcognito-therapeuticsalzheimersneuromodulationseries-cspectrishttps://insidebci.com/research/2026-03-07-evoked-potentials-could-personalize-stroke-rehab-through-bci-integration/https://insidebci.com/research/2026-03-07-evoked-potentials-could-personalize-stroke-rehab-through-bci-integration/A comprehensive review maps how brain signals measured during stroke recovery are converging with BCI systems and closed-loop neuromodulation to move rehabilitation beyond generic protocols toward individualized treatment.Sat, 07 Mar 2026 00:00:00 GMTresearchstroke rehabilitationevoked potentialsclosed-loop neuromodulationclinical BCIbiomarkershttps://insidebci.com/policy/2026-03-07-india-neurotechnology-readiness-iisc-bci-moonshot/https://insidebci.com/policy/2026-03-07-india-neurotechnology-readiness-iisc-bci-moonshot/As China and the US race ahead in neurotechnology, India's premier research institute launches an AI brain co-processor project while analysts urge strategic preparation.Sat, 07 Mar 2026 00:00:00 GMTpolicyindiaiiscneurotechnologypolicyglobal-bci-racehttps://insidebci.com/news/2026-03-07-neuralink-12-patients-thread-retraction-mass-production/https://insidebci.com/news/2026-03-07-neuralink-12-patients-thread-retraction-mass-production/With 12+ patients implanted and mass production planned for 2026, Neuralink's clinical reality is more complicated and more human than the headlines suggest.Sat, 07 Mar 2026 00:00:00 GMTnewsneuralinkclinical-trialsbrain-implantpatient-outcomesmass-productionhttps://insidebci.com/market/2026-03-07-salma-health-80m-series-a-brain-health-neuromodulation/https://insidebci.com/market/2026-03-07-salma-health-80m-series-a-brain-health-neuromodulation/Backed by Mubadala and ARCH Venture Partners, the startup is merging AI diagnostics with FDA-cleared neuromodulation to consolidate fragmented psychiatric and neurological care.Sat, 07 Mar 2026 00:00:00 GMTmarketsalma-healthseries-aneuromodulationtmssaintbrain-healthhttps://insidebci.com/policy/2026-03-07-fda-redraws-line-between-wellness-device-and-medical-device/https://insidebci.com/policy/2026-03-07-fda-redraws-line-between-wellness-device-and-medical-device/New guidance expands the 'general wellness' exemption for wearables and loosens oversight of AI clinical decision tools — with major implications for every company building consumer neurotechnology.Sat, 07 Mar 2026 00:00:00 GMTpolicyfdaregulationwellness-devicesneurotech-regulationclinical-decision-supportwearableshttps://insidebci.com/research/2026-03-06-dual-pathway-model-reconstructs-speech-from-brain-signals-in-20-minutes/https://insidebci.com/research/2026-03-06-dual-pathway-model-reconstructs-speech-from-brain-signals-in-20-minutes/New framework resolves the historic trade-off between acoustic richness and linguistic clarity in neural speech decoding, achieving 4.0/5.0 intelligibility with minimal training data.Fri, 06 Mar 2026 00:00:00 GMTresearchspeech BCIECoGneural decodingspeech synthesismachine learninghttps://insidebci.com/news/2026-03-06-tether-invests-in-eight-sleep-health-intelligence-play/https://insidebci.com/news/2026-03-06-tether-invests-in-eight-sleep-health-intelligence-play/The stablecoin giant invests in AI-powered sleep technology company Eight Sleep, extending a biotech investment strategy that began with its $200 million majority stake in Blackrock Neurotech.Fri, 06 Mar 2026 00:00:00 GMTnewsTetherEight SleepBlackrock Neurotechhealth techinvestmentQVAChttps://insidebci.com/market/2026-03-06-science-corp-raises-230-million-series-c-prima-retinal-implant/https://insidebci.com/market/2026-03-06-science-corp-raises-230-million-series-c-prima-retinal-implant/Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.Fri, 06 Mar 2026 00:00:00 GMTmarketScience CorpfundingSeries CPRIMAvision restorationretinal implantKhosla VenturesLightspeedhttps://insidebci.com/news/2026-03-05-blind-korean-youtuber-volunteers-neuralink-blindsight-trial/https://insidebci.com/news/2026-03-05-blind-korean-youtuber-volunteers-neuralink-blindsight-trial/Kim Han-sol, a blind YouTuber with 1.68 million subscribers, has publicly applied for Neuralink's Blindsight clinical trial, bringing significant public attention to the experimental vision-restoring brain implant.Thu, 05 Mar 2026 00:00:00 GMTnewsNeuralinkBlindsightclinical trialvision restorationbrain implantSouth Koreahttps://insidebci.com/policy/2026-03-05-china-bci-strategic-policy-push-constrained-frontier/https://insidebci.com/policy/2026-03-05-china-bci-strategic-policy-push-constrained-frontier/Seven Chinese government bodies have released guidelines establishing a roadmap for brain-computer interface development, with BCI procedures now receiving medical insurance reimbursement in parts of the country.Thu, 05 Mar 2026 00:00:00 GMTpolicyChinaBCI policyregulationmedical insuranceglobal marketinvestmenthttps://insidebci.com/research/2026-03-05-chinese-team-decodes-semantic-meaning-from-brain-waves-in-aphasia-patients/https://insidebci.com/research/2026-03-05-chinese-team-decodes-semantic-meaning-from-brain-waves-in-aphasia-patients/Researchers developed TFSANet, a deep learning model that decodes language comprehension from EEG signals, achieving 60.73% accuracy in aphasia patients using Chinese linguistic stimuli.Thu, 05 Mar 2026 00:00:00 GMTresearchsemantic decodingaphasiaEEGspeech BCIlanguage processinghttps://insidebci.com/market/2026-03-05-gobi-partners-invests-in-cortical-labs-biological-computing/https://insidebci.com/market/2026-03-05-gobi-partners-invests-in-cortical-labs-biological-computing/Malaysia-based Gobi Partners has invested in Cortical Labs through its Dana Impak Ventures fund, joining Horizon Ventures and Synchron founder Tom Oxley in backing the biological computing startup.Thu, 05 Mar 2026 00:00:00 GMTmarketCortical LabsGobi Partnersbiological computingMalaysiainvestmentHorizon VenturesSynchronhttps://insidebci.com/research/2026-03-05-seven-tesla-brain-scans-reveal-optimal-target-for-gesture-decoding-implants/https://insidebci.com/research/2026-03-05-seven-tesla-brain-scans-reveal-optimal-target-for-gesture-decoding-implants/New fMRI research identifies precise cortical locations for implantable BCI electrodes, finding that surface recordings from gyral regions may suffice for gesture decoding without penetrating sulcal depths.Thu, 05 Mar 2026 00:00:00 GMTresearchimplantable BCImotor cortex mappinggesture decodingelectrode placementfMRIhttps://insidebci.com/news/2026-03-05-science-corp-neurosoft-partnership-slashes-bci-trial-costs/https://insidebci.com/news/2026-03-05-science-corp-neurosoft-partnership-slashes-bci-trial-costs/A new partnership between Science Corp and Neurosoft AI aims to dramatically reduce the cost and timeline of brain-computer interface clinical trials through shared infrastructure and software tools.Thu, 05 Mar 2026 00:00:00 GMTnewsScience CorpNeurosoftclinical trialspartnershipsBCI infrastructurehttps://insidebci.com/research/2026-03-05-software-testing-technique-exposes-safety-flaws-in-ml-neurostimulation/https://insidebci.com/research/2026-03-05-software-testing-technique-exposes-safety-flaws-in-ml-neurostimulation/Researchers adapted automated fuzzing from software security to stress-test machine learning models that control neural implants, revealing widespread violations of biophysical safety limits in retinal and cortical devices.Thu, 05 Mar 2026 00:00:00 GMTresearchmachine learningneural stimulationsafetyvisual prosthesesregulatoryhttps://insidebci.com/news/2026-03-04-indian-child-regains-hearing-through-brainstem-neural-implant/https://insidebci.com/news/2026-03-04-indian-child-regains-hearing-through-brainstem-neural-implant/AIIMS Delhi performs first auditory brainstem implant in India, demonstrating neural bypass technology's potential for patients unsuitable for conventional cochlear devices.Wed, 04 Mar 2026 00:00:00 GMTnewsauditory brainstem implantAIIMSneural bypasshearing restorationIndiahttps://insidebci.com/news/2026-03-03-chinese-startup-gestala-enters-ultrasound-bci-race-for-pain-treatment/https://insidebci.com/news/2026-03-03-chinese-startup-gestala-enters-ultrasound-bci-race-for-pain-treatment/A Chinese company is developing non-invasive ultrasound brain-computer interfaces to treat chronic pain, intensifying competition in alternatives to surgical neural implants.Tue, 03 Mar 2026 00:00:00 GMTnewsultrasoundnon-invasive BCIChinachronic painGestalahttps://insidebci.com/news/2026-03-03-wireless-retinal-implant-restores-vision-in-80-of-trial-participants/https://insidebci.com/news/2026-03-03-wireless-retinal-implant-restores-vision-in-80-of-trial-participants/A major clinical trial shows wireless neural implants restored meaningful central vision to those blinded by macular degeneration, with participants reading letters and words.Tue, 03 Mar 2026 00:00:00 GMTnewsretinal implantsvisual prostheticsclinical trialsmacular degenerationsensory restorationhttps://insidebci.com/research/2026-03-02-brain-stimulation-improves-bci-control-through-two-distinct-neural-pathways/https://insidebci.com/research/2026-03-02-brain-stimulation-improves-bci-control-through-two-distinct-neural-pathways/New research reveals how targeting different brain regions with theta burst stimulation enhances motor imagery performance through separate mechanisms, offering potential solutions for stroke patients struggling with BCI control.Mon, 02 Mar 2026 00:00:00 GMTresearchtranscranial magnetic stimulationmotor imagerystroke rehabilitationbrain stimulationfunctional connectivityhttps://insidebci.com/news/2026-03-01-living-neurons-learn-doom-in-a-week-signaling-new-era/https://insidebci.com/news/2026-03-01-living-neurons-learn-doom-in-a-week-signaling-new-era/Cortical Labs demonstrated human brain cells on a chip mastering basic gameplay within seven days, advancing the case for biological computing in real-world applications.Sun, 01 Mar 2026 00:00:00 GMTnewsorganoid intelligencebiological computingCortical Labsin vitro neuronssynthetic biologyhttps://insidebci.com/news/2026-03-01-neuroxess-completes-human-trials-as-china-accelerates-bci-race/https://insidebci.com/news/2026-03-01-neuroxess-completes-human-trials-as-china-accelerates-bci-race/Chinese BCI company NeuroXess has surpassed human trial milestones, positioning itself as a direct competitor to Neuralink in the global neural interface market.Sun, 01 Mar 2026 00:00:00 GMTnewsNeuroXessChinaNeuralinkhuman trialsinternational competitionhttps://insidebci.com/news/2026-03-01-nicolelis-study-in-china-shows-brain-reorganization-restores-movement/https://insidebci.com/news/2026-03-01-nicolelis-study-in-china-shows-brain-reorganization-restores-movement/Brazilian neuroscientist Miguel Nicolelis leads research with Chinese collaborators demonstrating that brain-computer interface technology can trigger neural reorganization and restore movement in paralyzed patients.Sun, 01 Mar 2026 00:00:00 GMTnewsMiguel Nicolelisparalysisneural plasticityChinamotor recoveryhttps://insidebci.com/research/2026-03-01-personalized-brain-decoders-track-chronic-pain-without-patient-input/https://insidebci.com/research/2026-03-01-personalized-brain-decoders-track-chronic-pain-without-patient-input/Researchers demonstrate that individualized fMRI models can decode spontaneous pain in chronic pain patients, marking a shift toward objective, brain-based pain measurement that could reshape treatment and neurotech interventions.Sun, 01 Mar 2026 00:00:00 GMTresearchpain decodingfMRIchronic painpersonalized medicineneuroimaginghttps://insidebci.com/news/neuralink-fda-expanded-trial/https://insidebci.com/news/neuralink-fda-expanded-trial/FDA grants approval for Neuralink to enroll significantly more participants in its brain-computer interface clinical trials, marking a major step toward commercialization.Sat, 28 Feb 2026 00:00:00 GMTnewsneuralinkFDAclinical-trialsbrain-computer-interfacehttps://insidebci.com/policy/eu-neuro-rights-framework/https://insidebci.com/policy/eu-neuro-rights-framework/European Commission outlines sweeping rules protecting cognitive liberty and neural data, setting global standard for brain-computer interface regulation.Sun, 22 Feb 2026 00:00:00 GMTpolicyEU-regulationneuro-rightsprivacypolicy